https://news.syenza.com 2026-07-18T08:09:17.764Z daily 1 https://news.syenza.com/about 2025-01-15T00:00:00.000Z monthly 0.5 https://news.syenza.com/events/upcoming 2026-07-18T08:09:17.765Z daily 0.7 https://news.syenza.com/events/coverage 2026-07-18T08:09:17.765Z weekly 0.6 https://news.syenza.com/contact 2025-01-15T00:00:00.000Z monthly 0.4 https://news.syenza.com/pembrolizumab-dmmr-endometrial-cancer-pfs-benefit-confirmed 2026-07-17T19:42:37.000Z weekly 0.8 https://news.syenza.com/eu-oral-semaglutide-approval-boosts-weight-management-options 2026-07-17T08:34:50.000Z weekly 0.8 https://news.syenza.com/portugal-ai-health-governance-pioneers-global-standards 2026-07-16T19:39:39.000Z weekly 0.8 https://news.syenza.com/nice-finerenone-hfpef-approval-advances-hfpef-therapy-options 2026-07-16T19:39:40.000Z weekly 0.8 https://news.syenza.com/generic-semaglutide-south-africa-approved-post-patent-expiration 2026-07-16T12:47:03.000Z weekly 0.8 https://news.syenza.com/fda-gedatolisib-fulvestrant-approval 2026-07-16T10:19:54.000Z weekly 0.8 https://news.syenza.com/digital-medical-device-regulations-enable-rapid-approvals 2026-07-15T08:59:55.000Z weekly 0.8 https://news.syenza.com/celltrion-q2-biosimilar-growth-fuels-margin-expansion 2026-07-15T08:49:23.000Z weekly 0.8 https://news.syenza.com/tablet-manufacturing-capacity-expansion-enhances-supply-resilience 2026-07-15T08:45:37.000Z weekly 0.8 https://news.syenza.com/eit-health-2027-grants-key-provisions-implications 2026-07-15T08:42:25.000Z weekly 0.8 https://news.syenza.com/us-health-economics-policy-challenges 2026-07-14T09:24:15.000Z weekly 0.8 https://news.syenza.com/gkv-manufacturer-discount-reform-stabilizes-german-health-funding 2026-07-14T09:07:51.000Z weekly 0.8 https://news.syenza.com/dostarlimab-rectal-cancer-organ-preservation-via-monotherapy 2026-07-14T08:57:01.000Z weekly 0.8 https://news.syenza.com/pimart-south-africa-hiv-pharmacists-boost-treatment-access 2026-07-14T09:27:37.000Z weekly 0.8 https://news.syenza.com/portuguese-hospital-data-platform-enables-population-health-analysis 2026-07-13T13:25:56.000Z weekly 0.8 https://news.syenza.com/ai-in-european-healthcare-integrates-with-human-oversight 2026-07-13T10:30:03.000Z weekly 0.8 https://news.syenza.com/botulinum-toxin-episodic-migraine-phase-iii-dual-indication-success 2026-07-10T09:44:19.000Z weekly 0.8 https://news.syenza.com/ema-critical-comments-patient-reported-outcomes-eu-approvals 2026-07-10T09:40:14.000Z weekly 0.8 https://news.syenza.com/cipla-complex-generics-us-expansion 2026-07-09T09:36:08.000Z weekly 0.8 https://news.syenza.com/early-tavr-surveillance-cost-effectiveness-dominance 2026-07-09T09:32:41.000Z weekly 0.8 https://news.syenza.com/natco-pharma-adcock-ingram-stake-african-growth 2026-07-09T09:28:20.000Z weekly 0.8 https://news.syenza.com/global-instability-generic-pharmaceutical-sustainability-portugal 2026-07-08T10:36:40.000Z weekly 0.8 https://news.syenza.com/bfi-healthcare-procurement-south-africa-driving-infrastructure 2026-07-08T09:45:11.000Z weekly 0.8 https://news.syenza.com/omaveloxolone-appropriate-utilization-consensus-friedreich-ataxia 2026-07-08T09:39:07.000Z weekly 0.8 https://news.syenza.com/conditional-adoption-pathways-endometriosis-diagnostics 2026-07-08T09:30:38.000Z weekly 0.8 https://news.syenza.com/biologic-dispensing-implementation-gaps-patient-access-portugal 2026-07-07T10:23:57.000Z weekly 0.8 https://news.syenza.com/curative-therapy-commercialization-gap-global-access 2026-07-07T09:51:00.000Z weekly 0.8 https://news.syenza.com/transatlantic-reference-pricing-innovation-global-pharma-impact 2026-07-07T09:44:14.000Z weekly 0.8 https://news.syenza.com/practice-level-telehealth-quality-outcomes-chronic-care-impact 2026-07-06T09:56:31.000Z weekly 0.8 https://news.syenza.com/large-language-models-evidence-based-medicine 2026-07-03T10:16:50.000Z weekly 0.8 https://news.syenza.com/african-pharmacogenomic-integration-essential-medicines 2026-07-03T10:12:27.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-manufacturing-affordability-south-africa-local-production 2026-07-03T10:09:30.000Z weekly 0.8 https://news.syenza.com/catalysts-portugal-biotech-growth-europe 2026-07-02T10:42:06.000Z weekly 0.8 https://news.syenza.com/shingles-vaccine-affordability-south-africa-public-health 2026-07-02T10:36:09.000Z weekly 0.8 https://news.syenza.com/barriers-health-innovation-access-portugal 2026-07-02T10:31:10.000Z weekly 0.8 https://news.syenza.com/orphan-drug-designation-zoci-pulmonary-neuroendocrine-carcinomas 2026-07-01T09:56:12.000Z weekly 0.8 https://news.syenza.com/belgium-fast-access-medicines-atrasentan-iga-nephropathy 2026-07-01T09:52:44.000Z weekly 0.8 https://news.syenza.com/retracted-trial-publication-undermines-avacopan-aav 2026-07-01T09:50:00.000Z weekly 0.8 https://news.syenza.com/regulatory-validation-taletrectinib-nsclc-access 2026-06-30T12:49:10.000Z weekly 0.8 https://news.syenza.com/global-impact-portuguese-biotech-innovation 2026-06-30T11:23:22.000Z weekly 0.8 https://news.syenza.com/cannabis-regulatory-exploitation-portugal-medicinal 2026-06-30T10:14:12.000Z weekly 0.8 https://news.syenza.com/fda-approval-lumvoa-therapeutics-thyroid-eye-disease 2026-06-29T13:16:00.000Z weekly 0.8 https://news.syenza.com/public-private-partnership-hiv-treatment-access-drug-integration 2026-06-29T12:23:48.000Z weekly 0.8 https://news.syenza.com/ema-chmp-meeting-highlights-regulatory-insights 2026-06-26T13:02:14.000Z weekly 0.8 https://news.syenza.com/keytruda-combination-therapy-fda-approval-tnbc 2026-06-26T10:48:56.000Z weekly 0.8 https://news.syenza.com/calcified-carotid-lesion-preparation-stroke-management 2026-06-26T10:43:37.000Z weekly 0.8 https://news.syenza.com/cemdisiran-gmg-treatment-fda-ema-review 2026-06-25T08:42:10.000Z weekly 0.8 https://news.syenza.com/trodelvy-adc-approval-first-line-metastatic-tnbc 2026-06-25T08:39:48.000Z weekly 0.8 https://news.syenza.com/cemiplimab-cervical-cancer-access-navigating-treatment-value 2026-06-24T09:41:07.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-innovation-roi-socioeconomic-returns-europe 2026-06-24T09:25:57.000Z weekly 0.8 https://news.syenza.com/car-t-cell-therapy-advanced-gastric-cancer 2026-06-24T06:55:16.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-innovation-benefits-europe-returns 2026-06-23T10:20:22.000Z weekly 0.8 https://news.syenza.com/tulisokibart-ulcerative-colitis-phase-3-remission 2026-06-23T10:15:55.000Z weekly 0.8 https://news.syenza.com/teplizumab-type-1-diabetes-nice-recommendation 2026-06-23T10:13:16.000Z weekly 0.8 https://news.syenza.com/lingjian-morphology-diagnostics-transforming-clinical-labs 2026-06-22T10:49:48.000Z weekly 0.8 https://news.syenza.com/mapping-vulnerable-elderly-care-netherlands 2026-06-22T10:50:08.000Z weekly 0.8 https://news.syenza.com/joint-scientific-consultation-eu-medical-device-strategies 2026-06-19T14:31:50.000Z weekly 0.8 https://news.syenza.com/eu-joint-clinical-assessment-insights-high-risk-medical-devices 2026-06-19T14:25:32.000Z weekly 0.8 https://news.syenza.com/lesionattn-skin-cancer-ai-enhances-fairness 2026-06-19T10:35:35.000Z weekly 0.8 https://news.syenza.com/capvaxive-pediatric-vaccine-approval-high-risk-youth 2026-06-19T10:31:14.000Z weekly 0.8 https://news.syenza.com/ustr-germany-pharma-investigation-impact-global-drug-pricing 2026-06-19T10:28:34.000Z weekly 0.8 https://news.syenza.com/biotechnology-act-europe-driving-innovation-investment 2026-06-18T10:47:14.000Z weekly 0.8 https://news.syenza.com/rising-early-onset-colorectal-cancer-burden 2026-06-18T09:35:19.000Z weekly 0.8 https://news.syenza.com/fda-importation-program-analysis-colorado-prescription-drug-initiative 2026-06-18T09:31:59.000Z weekly 0.8 https://news.syenza.com/real-world-evidence-portugal-adaptive-hta 2026-06-17T14:04:22.000Z weekly 0.8 https://news.syenza.com/integrating-portuguese-hta-regulation-national-health-systems 2026-06-17T14:00:47.000Z weekly 0.8 https://news.syenza.com/ai-pico-scoping-tool-eu-jca 2026-06-17T12:25:39.000Z weekly 0.8 https://news.syenza.com/dapagliflozin-pricing-framework-portugal-reimbursement 2026-06-17T10:11:09.000Z weekly 0.8 https://news.syenza.com/multistakeholder-oncology-market-access-strategy 2026-06-16T12:33:17.000Z weekly 0.8 https://news.syenza.com/advancing-real-world-evidence-ai-medicines-regulation 2026-06-16T12:25:15.000Z weekly 0.8 https://news.syenza.com/medicine-shortages-management-enhanced-availability-access 2026-06-16T12:19:10.000Z weekly 0.8 https://news.syenza.com/ai-healthcare-liability-ethical-accountability-clinical-practice 2026-06-16T12:12:12.000Z weekly 0.8 https://news.syenza.com/regulatory-expansion-otc-glucose-monitoring-children 2026-06-15T09:23:24.000Z weekly 0.8 https://news.syenza.com/fda-medical-device-exemptions-low-risk-unclassified-products 2026-06-15T09:20:39.000Z weekly 0.8 https://news.syenza.com/medtech-reimbursement-strategies-navigating-innovation 2026-06-15T09:15:39.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-access-initiative-unified-europe-health-systems 2026-06-12T09:14:40.000Z weekly 0.8 https://news.syenza.com/ai-regulatory-research-priorities-medicine-lifecycle 2026-06-12T09:10:33.000Z weekly 0.8 https://news.syenza.com/health-economic-security-cee-growth 2026-06-12T09:10:57.000Z weekly 0.8 https://news.syenza.com/gene-therapy-reimbursement-vision-restoration 2026-06-12T09:10:52.000Z weekly 0.8 https://news.syenza.com/delpacibart-braxlosiran-fshd-disease-modifying-promise 2026-06-11T10:21:27.000Z weekly 0.8 https://news.syenza.com/athlete-risk-stratification-predictive-frameworks 2026-06-11T10:18:50.000Z weekly 0.8 https://news.syenza.com/innovative-therapies-access-portugal-delays-hta-reform 2026-06-11T10:14:17.000Z weekly 0.8 https://news.syenza.com/dutch-medicine-access-delay-patient-care 2026-06-10T12:46:26.000Z weekly 0.8 https://news.syenza.com/factor-xia-inhibition-stroke-asundexian-ema-validation 2026-06-10T12:43:33.000Z weekly 0.8 https://news.syenza.com/transforming-clinical-skill-assessment-ai-evaluation 2026-06-10T12:41:29.000Z weekly 0.8 https://news.syenza.com/advancing-medical-ai-federated-generative-learning 2026-06-10T12:41:24.000Z weekly 0.8 https://news.syenza.com/medtech-market-access-strategy-stakeholder-engagement 2026-06-09T19:32:55.000Z weekly 0.8 https://news.syenza.com/fda-approval-hemophilia-treatment-subcutaneous-prophylaxis 2026-06-09T16:50:17.000Z weekly 0.8 https://news.syenza.com/advancing-hiv-weekly-treatment-options 2026-06-09T14:40:40.000Z weekly 0.8 https://news.syenza.com/tovorafenib-clinical-assessment-evidence-gaps 2026-06-09T14:37:47.000Z weekly 0.8 https://news.syenza.com/mdd-treatment-modeling-optimal-care-pathways 2026-06-08T10:06:32.000Z weekly 0.8 https://news.syenza.com/levacetylleucine-a-t-treatment-phase-3-results 2026-06-08T12:00:56.000Z weekly 0.8 https://news.syenza.com/insulin-cost-policy-impact-medicare-beneficiaries 2026-06-08T12:00:50.000Z weekly 0.8 https://news.syenza.com/parkinsons-cognitive-measurement-precision-forecasting 2026-06-08T09:56:08.000Z weekly 0.8 https://news.syenza.com/mifepristone-safety-study-regulatory-oversight 2026-06-06T20:04:43.000Z weekly 0.8 https://news.syenza.com/hiv-prevention-access-strategies-south-africa 2026-06-06T19:59:53.000Z weekly 0.8 https://news.syenza.com/cancer-productivity-asia-pacific-disparities 2026-06-05T13:53:20.000Z weekly 0.8 https://news.syenza.com/generative-ai-diagnosis-improves-non-specialist-accuracy 2026-06-05T12:10:13.000Z weekly 0.8 https://news.syenza.com/tuberculosis-counselling-incentives-improve-adherence 2026-06-05T12:06:44.000Z weekly 0.8 https://news.syenza.com/nice-guidance-mirvetuximab-ovarian-cancer 2026-06-05T13:59:18.000Z weekly 0.8 https://news.syenza.com/immunotherapy-for-liver-cancer-emerald-3-trial 2026-06-05T11:04:22.000Z weekly 0.8 https://news.syenza.com/multistakeholder-biosimilar-policy-development-portugal 2026-06-03T11:52:34.000Z weekly 0.8 https://news.syenza.com/pharmacy-network-value-healthcare-access-efficiency 2026-06-03T11:50:12.000Z weekly 0.8 https://news.syenza.com/us-vaccine-recommendations-alignment-global-standards 2026-06-03T11:56:28.000Z weekly 0.8 https://news.syenza.com/advancing-biovac-vaccine-manufacturing-africa 2026-06-03T09:32:07.000Z weekly 0.8 https://news.syenza.com/galicia-north-portugal-biotech-alliance 2026-06-03T09:29:39.000Z weekly 0.8 https://news.syenza.com/health-investment-strategies-resilience-innovation 2026-06-02T15:17:58.000Z weekly 0.8 https://news.syenza.com/mandatory-quarterly-medicinal-cannabis-reporting 2026-06-02T11:53:01.000Z weekly 0.8 https://news.syenza.com/patient-access-innovation-european-healthcare 2026-06-02T11:50:08.000Z weekly 0.8 https://news.syenza.com/durable-melanoma-therapy-outcomes-5-year-data 2026-06-02T12:06:30.000Z weekly 0.8 https://news.syenza.com/alora-medical-respipep-award-global-recognition 2026-06-02T10:15:11.000Z weekly 0.8 https://news.syenza.com/dual-immunotherapy-reimbursement-hepatocellular-carcinoma-recommendation 2026-06-01T10:46:37.000Z weekly 0.8 https://news.syenza.com/immunology-treatment-advancements-eular-2026 2026-06-01T10:43:45.000Z weekly 0.8 https://news.syenza.com/fda-breakthrough-kras-inhibitor-therapy 2026-06-01T10:10:10.000Z weekly 0.8 https://news.syenza.com/subcutaneous-amivantamab-cancer-head-and-neck-trial-results 2026-06-01T10:03:05.000Z weekly 0.8 https://news.syenza.com/local-medical-device-production-uct-licence 2026-06-01T10:03:13.000Z weekly 0.8 https://news.syenza.com/expanded-glp-1-medication-access-formulary-updates 2026-05-29T19:10:25.000Z weekly 0.8 https://news.syenza.com/integration-comparative-effectiveness-research-drug-pricing 2026-05-29T07:50:15.000Z weekly 0.8 https://news.syenza.com/european-pharmacists-preparation-health-crisis-response 2026-05-29T07:46:07.000Z weekly 0.8 https://news.syenza.com/imfinzi-bladder-cancer-approval-immunotherapy-breakthrough 2026-05-30T08:53:53.000Z weekly 0.8 https://news.syenza.com/advancements-radioligand-therapy-prostate-cancer 2026-05-29T07:49:44.000Z weekly 0.8 https://news.syenza.com/conversational-agent-interventions-mental-health 2026-05-29T07:18:14.000Z weekly 0.8 https://news.syenza.com/uc-biomed-building-investment-advancing-research-coimbra 2026-05-27T10:50:05.000Z weekly 0.8 https://news.syenza.com/health-innovation-award-2026-sustainable-healthcare 2026-05-27T09:47:11.000Z weekly 0.8 https://news.syenza.com/commitment-health-strategies-portugal-sustainable-change 2026-05-27T09:25:50.000Z weekly 0.8 https://news.syenza.com/european-health-resilience-strengthening-preparedness-geopolitical-challenges 2026-05-27T09:23:48.000Z weekly 0.8 https://news.syenza.com/sahpra-sapc-regulatory-enforcement-unregistered-glp-1-gip-products 2026-05-26T11:29:08.000Z weekly 0.8 https://news.syenza.com/mdr-software-regulations-medtech-innovation 2026-05-26T11:27:04.000Z weekly 0.8 https://news.syenza.com/gba-pd-therapy-development-activate-study-completion 2026-05-26T11:23:15.000Z weekly 0.8 https://news.syenza.com/menstrual-health-monitoring-wearable-insights 2026-05-26T09:25:39.000Z weekly 0.8 https://news.syenza.com/perioperative-bladder-cancer-therapy-keytruda-padcev-chmp-opinion 2026-05-25T13:12:34.000Z weekly 0.8 https://news.syenza.com/emergence-ai-healthcare-policy-fragmented-governance 2026-05-25T13:09:51.000Z weekly 0.8 https://news.syenza.com/hepcludex-hdv-approval-chronic-hepatitis-delta 2026-05-25T13:06:24.000Z weekly 0.8 https://news.syenza.com/chmp-recommendations-2026-new-approvals-health-economics 2026-05-25T13:04:28.000Z weekly 0.8 https://news.syenza.com/clinical-trial-monitoring-q1-2026-eu-eea-insights 2026-05-22T10:11:57.000Z weekly 0.8 https://news.syenza.com/novartis-oncology-advancements-trial-findings-market-access 2026-05-22T10:05:08.000Z weekly 0.8 https://news.syenza.com/eudamed-implementation-2026-national-adaptations 2026-05-22T10:02:48.000Z weekly 0.8 https://news.syenza.com/baxfendy-hypertension-treatment-fda-approval-aldosterone-inhibitor 2026-05-22T10:02:41.000Z weekly 0.8 https://news.syenza.com/trumprx-gov-expansion-medication-price-transparency 2026-05-22T09:58:07.000Z weekly 0.8 https://news.syenza.com/trastuzumab-deruxtecan-reimbursement-cost-effectiveness-gastric-cancer 2026-05-22T10:15:48.000Z weekly 0.8 https://news.syenza.com/portugal-health-spending-2025-record-4-417bn-rising-demand 2026-05-22T09:55:55.000Z weekly 0.8 https://news.syenza.com/substandard-medicines-south-africa-regulatory-economic-implications 2026-05-21T20:22:52.000Z weekly 0.8 https://news.syenza.com/first-in-human-trials-foundations-market-implications 2026-05-21T18:31:35.000Z weekly 0.8 https://news.syenza.com/strategic-purchasing-healthcare-south-africa-value 2026-05-20T11:22:36.000Z weekly 0.8 https://news.syenza.com/global-best-practices-healthcare-pricing-regulation 2026-05-20T11:17:52.000Z weekly 0.8 https://news.syenza.com/psa-response-improvement-pluvicto-mhspc 2026-05-19T09:31:33.000Z weekly 0.8 https://news.syenza.com/vaccine-manufacturing-africa-biovac-cape-town-facility 2026-05-19T09:29:33.000Z weekly 0.8 https://news.syenza.com/portugal-map02-medication-adherence 2026-05-19T09:34:47.000Z weekly 0.8 https://news.syenza.com/healthcare-innovation-trends-lisbon-insights 2026-05-26T13:28:25.000Z weekly 0.8 https://news.syenza.com/enhertu-breast-cancer-treatment-fda-approvals-neoadjuvant-adjuvant 2026-05-18T10:42:20.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-onshoring-agreements-tariff-relief-security 2026-05-18T10:39:53.000Z weekly 0.8 https://news.syenza.com/dynamic-risk-stratification-thromboembolism-cancer 2026-05-18T10:36:39.000Z weekly 0.8 https://news.syenza.com/core-recommendations-equitable-digital-medicine-access 2026-05-18T10:33:52.000Z weekly 0.8 https://news.syenza.com/intranasal-drug-delivery-hovione-idc-commercial-platform 2026-05-15T10:08:25.000Z weekly 0.8 https://news.syenza.com/portugal-cannabis-market-decline-licensing-reductions 2026-05-15T10:06:19.000Z weekly 0.8 https://news.syenza.com/africa-vaccine-manufacturing-local-production-supply-security 2026-05-15T10:02:55.000Z weekly 0.8 https://news.syenza.com/nice-approves-durvalumab-gastric-cancer 2026-05-15T10:00:48.000Z weekly 0.8 https://news.syenza.com/bladder-cancer-treatment-impact-quality-of-life 2026-05-15T09:58:45.000Z weekly 0.8 https://news.syenza.com/global-growth-challenges-pharmacy-vaccination-training 2026-05-13T13:32:59.000Z weekly 0.8 https://news.syenza.com/neonatal-infection-management-nice-guideline-ng195 2026-05-13T13:29:46.000Z weekly 0.8 https://news.syenza.com/merck-oncology-advancements-asco-2026 2026-05-13T13:24:53.000Z weekly 0.8 https://news.syenza.com/strengthening-supply-chains-eu-critical-medicines-act 2026-05-12T12:14:43.000Z weekly 0.8 https://news.syenza.com/slug-output-johnson-johnson-neuropsychiatry-treatment-innovations-apa-ascp 2026-05-12T12:09:33.000Z weekly 0.8 https://news.syenza.com/marstacimab-cost-effectiveness-analysis-hemophilia-portugal 2026-05-12T12:09:39.000Z weekly 0.8 https://news.syenza.com/overcoming-challenges-managed-entry-agreements-atmps 2026-05-12T11:49:58.000Z weekly 0.8 https://news.syenza.com/biocatalysis-breakthrough-oral-pcsk9-inhibitors 2026-05-11T10:49:35.000Z weekly 0.8 https://news.syenza.com/workshop-ai-in-gmp-manufacturing-ema-guidance 2026-05-11T10:48:59.000Z weekly 0.8 https://news.syenza.com/developer-engagement-misalignment-advanced-therapies 2026-05-11T10:29:14.000Z weekly 0.8 https://news.syenza.com/mea-adoption-challenges-atmp-reimbursement 2026-05-11T10:25:18.000Z weekly 0.8 https://news.syenza.com/dutch-elderly-care-challenges-navigating-fragmentation 2026-05-08T09:33:54.000Z weekly 0.8 https://news.syenza.com/procurement-regulations-south-africa-health-supplier-compliance 2026-05-08T09:27:00.000Z weekly 0.8 https://news.syenza.com/preferential-procurement-regulations-impact-health-suppliers-2026 2026-05-08T09:21:15.000Z weekly 0.8 https://news.syenza.com/strategic-procurement-regulations-south-africa-2026-pharma-medtech 2026-05-08T09:15:30.000Z weekly 0.8 https://news.syenza.com/fda-endorses-truqap-prostate-cancer-therapy-pten-deficient 2026-05-07T11:03:30.000Z weekly 0.8 https://news.syenza.com/eucope-pharmaceutical-regulation-innovative-smes 2026-05-07T11:00:43.000Z weekly 0.8 https://news.syenza.com/unlocking-benefits-cardiovascular-health-checks 2026-05-07T10:58:06.000Z weekly 0.8 https://news.syenza.com/rui-santos-ivo-regulatory-frameworks-innovation-raps-euro-convergence-2026 2026-05-07T10:53:00.000Z weekly 0.8 https://news.syenza.com/mfn-drug-pricing-savings-593-billion-us-healthcare-savings 2026-05-07T10:47:33.000Z weekly 0.8 https://news.syenza.com/sandoz-mobile-health-initiative-empowering-communities 2026-05-05T14:02:47.000Z weekly 0.8 https://news.syenza.com/investment-boosts-medical-device-distribution-africa 2026-05-05T13:58:42.000Z weekly 0.8 https://news.syenza.com/navigating-challenges-patient-centered-ai-systems-postpartum-depression 2026-05-05T13:45:37.000Z weekly 0.8 https://news.syenza.com/jnj-4804-ibd-therapy-effective-refractory-disease 2026-05-05T13:58:32.000Z weekly 0.8 https://news.syenza.com/south-african-medical-research-council-transforming-health 2026-05-04T10:46:56.000Z weekly 0.8 https://news.syenza.com/portugal-medicines-reserve-health-system-resilience 2026-05-04T10:34:03.000Z weekly 0.8 https://news.syenza.com/high-cost-drug-evaluation-dutch-institute-reduces-assessment-times 2026-05-04T10:52:39.000Z weekly 0.8 https://news.syenza.com/amgen-financial-results-q1-2026-performance-breakdown 2026-05-04T10:52:47.000Z weekly 0.8 https://news.syenza.com/nice-endorses-rozanolixizumab-myasthenia-gravis 2026-05-01T10:42:40.000Z weekly 0.8 https://news.syenza.com/accelerating-biotechnology-patient-access-eu-reforms 2026-05-01T10:39:57.000Z weekly 0.8 https://news.syenza.com/insulin-substitution-portugal-novo-nordisk-discontinuation 2026-05-01T10:35:46.000Z weekly 0.8 https://news.syenza.com/dementia-pharmacotherapy-guidelines-non-pharmacological-dutch-care 2026-05-01T10:31:11.000Z weekly 0.8 https://news.syenza.com/gaps-ai-governance-healthcare-frameworks-patient-safety 2026-05-01T10:28:17.000Z weekly 0.8 https://news.syenza.com/health-technology-assessment-infarmed-real-time-tracker 2026-04-30T12:37:35.000Z weekly 0.8 https://news.syenza.com/merck-q1-2026-performance-oncology-cardiometabolic-growth 2026-04-30T12:34:28.000Z weekly 0.8 https://news.syenza.com/advancing-high-risk-oncology-interventions-asco-2026 2026-04-30T12:34:38.000Z weekly 0.8 https://news.syenza.com/vaccine-confidence-strategy-ema-advisory-group 2026-04-30T12:25:16.000Z weekly 0.8 https://news.syenza.com/supply-chain-resilience-europe-off-patent-medicines 2026-04-28T14:14:06.000Z weekly 0.8 https://news.syenza.com/advancing-subcutaneous-diuretic-therapy-heart-failure 2026-04-28T14:07:25.000Z weekly 0.8 https://news.syenza.com/tiktok-opioid-overdose-forecasting-predictive-insights 2026-04-28T14:03:37.000Z weekly 0.8 https://news.syenza.com/breakthrough-medical-device-access-ema-pilot 2026-04-28T14:01:00.000Z weekly 0.8 https://news.syenza.com/medical-device-innovation-south-africa-systemic-barriers 2026-04-27T11:26:45.000Z weekly 0.8 https://news.syenza.com/hormonal-iud-south-africa-avibela-generic-access 2026-04-27T11:18:08.000Z weekly 0.8 https://news.syenza.com/psma-targeted-therapy-regulatory-divergence-eu-access 2026-04-27T11:17:59.000Z weekly 0.8 https://news.syenza.com/pioneer-teens-oral-semaglutide-diabetes-breakthrough 2026-04-24T11:31:31.000Z weekly 0.8 https://news.syenza.com/terminal-complement-inhibition-igan-i-can-trial 2026-04-24T11:38:40.000Z weekly 0.8 https://news.syenza.com/multicenter-aki-prediction-collaborative-vs-local 2026-04-24T11:23:33.000Z weekly 0.8 https://news.syenza.com/chmp-april-2026-rare-disease-therapies-economics 2026-04-24T11:18:27.000Z weekly 0.8 https://news.syenza.com/europe-pharmaceutical-access-critical-crossroads-us-pricing 2026-04-23T13:18:57.000Z weekly 0.8 https://news.syenza.com/economic-impact-fragmented-care-obesity-diabetes-cardiovascular-disease 2026-04-23T13:15:07.000Z weekly 0.8 https://news.syenza.com/zanidatamab-biliary-cancer-therapy-nice-approval 2026-04-23T13:10:49.000Z weekly 0.8 https://news.syenza.com/hiv-two-drug-regimen-fda-approves-idvynso 2026-04-23T13:08:04.000Z weekly 0.8 https://news.syenza.com/fda-accelerated-approval-pathway-progress-challenges-heor 2026-04-21T18:42:43.000Z weekly 0.8 https://news.syenza.com/chronic-pain-rehabilitation-conditional-reimbursement 2026-04-20T09:45:20.000Z weekly 0.8 https://news.syenza.com/advancing-psychedelic-therapy-access 2026-04-20T09:28:24.000Z weekly 0.8 https://news.syenza.com/hypertension-control-interventions-underserved-populations 2026-04-20T09:24:16.000Z weekly 0.8 https://news.syenza.com/prenatal-acetaminophen-autism-no-link-denmark-study 2026-04-17T09:44:36.000Z weekly 0.8 https://news.syenza.com/amyloid-beta-treatment-impact-limited-benefits-increased-risks 2026-04-17T09:44:31.000Z weekly 0.8 https://news.syenza.com/hiv-prevention-partnerships-expand-lenacapavir-access 2026-04-17T09:33:58.000Z weekly 0.8 https://news.syenza.com/semaglutide-off-label-use-250-million-fraud-portugal 2026-04-17T09:30:00.000Z weekly 0.8 https://news.syenza.com/b7-h3-targeted-therapy-relapsed-es-sclc 2026-04-15T16:33:05.000Z weekly 0.8 https://news.syenza.com/inclusive-healthcare-strategies-social-impact-sustainability 2026-04-15T16:28:57.000Z weekly 0.8 https://news.syenza.com/advancing-access-generic-dapagliflozin-approval 2026-04-14T08:55:21.000Z weekly 0.8 https://news.syenza.com/closing-east-west-healthcare-investment-disparities-cee 2026-04-14T11:12:42.000Z weekly 0.8 https://news.syenza.com/utah-ai-medication-prescribing-risks-autonomous-systems 2026-04-14T08:41:26.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-cost-pressures-portugal-access 2026-04-13T10:16:03.000Z weekly 0.8 https://news.syenza.com/inequality-adjusted-icer-enhancing-cost-effectiveness 2026-04-13T10:13:00.000Z weekly 0.8 https://news.syenza.com/semaglutide-distribution-flexibility-ema-approves-room-temp-delivery-wegovy 2026-04-13T10:01:18.000Z weekly 0.8 https://news.syenza.com/portuguese-pediatric-vaccination-policy-shift-risk-benefit 2026-04-10T09:17:04.000Z weekly 0.8 https://news.syenza.com/pulsed-field-ablation-varipulse-pro-launch-europe 2026-04-09T09:55:28.000Z weekly 0.8 https://news.syenza.com/novartis-expands-community-health-programs-to-tackle-global-disparities 2026-04-09T09:51:47.000Z weekly 0.8 https://news.syenza.com/antimicrobial-resistance-art-bridging-science-health-storytelling 2026-04-09T09:47:14.000Z weekly 0.8 https://news.syenza.com/differentiated-visceral-fat-reduction-wve-007 2026-04-07T19:02:52.000Z weekly 0.8 https://news.syenza.com/insulin-copay-caps-medicare-health-spending 2026-04-07T13:37:44.000Z weekly 0.8 https://news.syenza.com/biosimilar-approval-framework-analytical-comparability 2026-04-06T10:36:13.000Z weekly 0.8 https://news.syenza.com/outcome-transparency-healthcare-netherlands-stagnation 2026-04-06T09:43:16.000Z weekly 0.8 https://news.syenza.com/immunotherapy-ovarian-cancer-eu-approval-keytruda 2026-04-06T09:37:48.000Z weekly 0.8 https://news.syenza.com/immunotherapy-hepatocellular-carcinoma-emerald-3-results 2026-04-03T10:23:02.000Z weekly 0.8 https://news.syenza.com/reimbursement-bladder-cancer-inlexzo-j9183 2026-04-03T10:19:50.000Z weekly 0.8 https://news.syenza.com/tariffs-pharmaceutical-manufacturing-national-security 2026-04-03T10:14:21.000Z weekly 0.8 https://news.syenza.com/obesity-treatment-pricing-south-africa-competitive-strategies 2026-04-02T10:09:32.000Z weekly 0.8 https://news.syenza.com/real-world-evidence-integration-cancer-hta-scotland 2026-04-01T11:17:17.000Z weekly 0.8 https://news.syenza.com/personalised-fertility-endometriosis-care-uk 2026-04-01T10:27:53.000Z weekly 0.8 https://news.syenza.com/eu-india-pharmaceutical-trade-innovation-access 2026-03-31T14:34:05.000Z weekly 0.8 https://news.syenza.com/virtual-control-groups-advancing-nonclinical-safety 2026-03-31T14:34:19.000Z weekly 0.8 https://news.syenza.com/advancing-health-technology-assessment-mena-frameworks 2026-03-31T12:30:18.000Z weekly 0.8 https://news.syenza.com/advancing-participatory-arts-health-dutch-care 2026-03-30T21:39:39.000Z weekly 0.8 https://news.syenza.com/tarlatamab-small-cell-lung-survival-benefit 2026-03-31T14:34:56.000Z weekly 0.8 https://news.syenza.com/fda-approves-once-weekly-basal-insulin-awiqli-type-2-diabetes 2026-03-30T14:11:50.000Z weekly 0.8 https://news.syenza.com/inflation-reduction-act-impact-clinical-trial-investment-trends 2026-03-26T13:48:52.000Z weekly 0.8 https://news.syenza.com/eu-alzheimer-approval-challenges-anavex-blarcamesine-withdrawal 2026-03-26T13:44:37.000Z weekly 0.8 https://news.syenza.com/south-africa-health-reform-rescue-plan 2026-03-26T13:41:26.000Z weekly 0.8 https://news.syenza.com/nice-pembrolizumab-recommendation-resectable-head-neck-cancer 2026-03-25T12:39:04.000Z weekly 0.8 https://news.syenza.com/pepfar-tb-impact-averting-millions-cases-deaths 2026-03-25T12:34:33.000Z weekly 0.8 https://news.syenza.com/vitamin-b6-depletion-risk-carbidopa-levodopa-seizures 2026-03-25T12:34:46.000Z weekly 0.8 https://news.syenza.com/collaborative-tb-innovation-drug-resistance 2026-03-24T11:19:14.000Z weekly 0.8 https://news.syenza.com/rwe-citation-analysis-medicare-drug-price-negotiations 2026-03-24T11:12:13.000Z weekly 0.8 https://news.syenza.com/serplulimab-lung-cancer-treatment-portugal-evaluation 2026-03-24T11:06:18.000Z weekly 0.8 https://news.syenza.com/t1d-screening-effectiveness-canadian-children-costs 2026-03-23T11:51:58.000Z weekly 0.8 https://news.syenza.com/novartis-acquires-mutant-selective-pi3kalpha-inhibitor-breast-cancer 2026-03-23T11:27:50.000Z weekly 0.8 https://news.syenza.com/semaglutide-india-partnership-diabetes-access 2026-03-23T11:14:05.000Z weekly 0.8 https://news.syenza.com/wegovy-hd-approval-obesity-weight-loss 2026-03-20T13:29:10.000Z weekly 0.8 https://news.syenza.com/invasive-brain-computer-interface-approval-spinal-cord-injury 2026-03-20T13:25:49.000Z weekly 0.8 https://news.syenza.com/mhra-nice-alignment-accelerating-patient-access 2026-03-20T13:13:31.000Z weekly 0.8 https://news.syenza.com/hpv-vaccine-effectiveness-long-term-cervical-protection 2026-03-19T17:56:49.000Z weekly 0.8 https://news.syenza.com/tavi-reimbursement-expansion-low-intermediate-risk-patients 2026-03-19T14:20:14.000Z weekly 0.8 https://news.syenza.com/prime-scheme-evaluation-enhanced-tools-pilot 2026-03-19T13:54:44.000Z weekly 0.8 https://news.syenza.com/imfinzi-gastric-cancer-treatment-eu-perioperative-approval 2026-03-17T11:42:20.000Z weekly 0.8 https://news.syenza.com/europe-life-sciences-competitiveness-unlock-potential 2026-03-17T11:38:34.000Z weekly 0.8 https://news.syenza.com/cost-per-event-avoided-glp-1-agonists 2026-03-17T10:51:17.000Z weekly 0.8 https://news.syenza.com/eu-medicines-regulation-achievements-ema-2025-highlights 2026-03-16T10:56:06.000Z weekly 0.8 https://news.syenza.com/cancer-productivity-losses-europe-economic-impact 2026-03-16T10:45:39.000Z weekly 0.8 https://news.syenza.com/biomarin-withdraws-voxzogo-reimbursement-netherlands 2026-03-16T10:30:45.000Z weekly 0.8 https://news.syenza.com/cardiovascular-health-innovation-urban-interventions 2026-03-12T22:08:26.000Z weekly 0.8 https://news.syenza.com/ema-submits-teclistamab-multiple-myeloma-earlier-line-approval 2026-03-12T15:41:00.000Z weekly 0.8 https://news.syenza.com/european-cancer-care-economic-stability-survival 2026-03-12T15:38:08.000Z weekly 0.8 https://news.syenza.com/biosimilar-approval-reforms-accelerate-access-reduce-drug-costs 2026-03-11T14:34:18.000Z weekly 0.8 https://news.syenza.com/fda-warning-letter-novo-nordisk-adverse-drug-reporting-failures 2026-03-11T13:37:06.000Z weekly 0.8 https://news.syenza.com/methodological-gaps-in-economic-evaluations-vaccines 2026-03-10T13:32:07.000Z weekly 0.8 https://news.syenza.com/enhertu-early-breast-cancer-fda-priority-review-recurrence 2026-03-10T13:25:45.000Z weekly 0.8 https://news.syenza.com/rapid-genetic-testing-saves-neonatal-hearing 2026-03-09T14:08:41.000Z weekly 0.8 https://news.syenza.com/ema-clinical-trials-guidance-public-health-emergencies 2026-03-09T10:43:49.000Z weekly 0.8 https://news.syenza.com/portugal-clinical-trials-regulation-eu-compliance-participant-protection 2026-03-09T10:36:59.000Z weekly 0.8 https://news.syenza.com/aspen-pharmacare-financial-growth-h1-2026 2026-03-05T11:39:33.000Z weekly 0.8 https://news.syenza.com/south-africa-push-local-lenacapavir-production 2026-03-05T11:35:30.000Z weekly 0.8 https://news.syenza.com/urgent-call-precision-oncology-access-europe 2026-03-05T11:32:27.000Z weekly 0.8 https://news.syenza.com/harmonizing-non-clinical-microbiome-medicinal-products-eu 2026-03-04T12:59:59.000Z weekly 0.8 https://news.syenza.com/tirzepatide-cost-effectiveness-t2d-management 2026-03-03T11:56:19.000Z weekly 0.8 https://news.syenza.com/chmp-february-2026-approvals-medicines-biosimilars 2026-03-03T11:45:11.000Z weekly 0.8 https://news.syenza.com/ema-mcombriax-vaccine-recommendation-dual-covid-influenza-protection 2026-03-03T11:45:23.000Z weekly 0.8 https://news.syenza.com/hernexeos-lung-cancer-treatment-first-line-fda-approval-her2-nsclc 2026-03-02T09:56:41.000Z weekly 0.8 https://news.syenza.com/keytruda-padcev-mibc-survival-keynote-b15-results 2026-03-02T09:50:29.000Z weekly 0.8 https://news.syenza.com/novartis-drug-discovery-innovation-advancing-global-health 2026-02-26T11:05:46.000Z weekly 0.8 https://news.syenza.com/infarmed-regulatory-activity-january-2026-highlights-market-access 2026-02-26T10:57:39.000Z weekly 0.8 https://news.syenza.com/bic-len-hiv-treatment-artistry-trials-results 2026-02-26T10:55:18.000Z weekly 0.8 https://news.syenza.com/novo-nordisk-semaglutide-price-reduction-access 2026-02-26T10:45:22.000Z weekly 0.8 https://news.syenza.com/nice-approves-ruxolitinib-cream-vitiligo-facial 2026-02-25T12:07:47.000Z weekly 0.8 https://news.syenza.com/sahpra-gmp-compliance-adcock-ingram-clayville 2026-02-25T12:07:39.000Z weekly 0.8 https://news.syenza.com/industry-clinical-trials-europe-economic-impact 2026-02-24T11:17:29.000Z weekly 0.8 https://news.syenza.com/merck-portfolio-optimization-restructure-oncology-specialty 2026-02-24T11:10:35.000Z weekly 0.8 https://news.syenza.com/economic-burden-nsclc-healthcare-costs-resource-utilization 2026-02-24T10:54:05.000Z weekly 0.8 https://news.syenza.com/ai-literature-review-integration-enhancing-systematic-reviews 2026-02-23T12:38:02.000Z weekly 0.8 https://news.syenza.com/clerical-error-infarmed-vaccine-data-transparency 2026-02-23T12:29:21.000Z weekly 0.8 https://news.syenza.com/ema-executive-director-recruitment-future-medicines-regulation 2026-02-23T12:09:49.000Z weekly 0.8 https://news.syenza.com/biopharma-ecosystem-competitiveness-post-covid-opportunities 2026-02-20T11:25:56.000Z weekly 0.8 https://news.syenza.com/ema-validates-enhertu-breast-cancer-treatment-post-neoadjuvant 2026-02-20T10:58:53.000Z weekly 0.8 https://news.syenza.com/type-2-diabetes-guidelines-nice-sglt2-cardiorenal 2026-02-19T13:05:09.000Z weekly 0.8 https://news.syenza.com/eu-medical-device-panels-enhancing-safety-performance 2026-02-19T12:29:54.000Z weekly 0.8 https://news.syenza.com/debunking-mfn-policy-effectiveness-drug-pricing-innovation 2026-02-19T12:20:22.000Z weekly 0.8 https://news.syenza.com/zorginstituut-lecanemab-health-insurance-rejection-alzheimers-implications 2026-02-18T12:45:19.000Z weekly 0.8 https://news.syenza.com/european-commission-approves-enhanced-wegovy-obesity-treatment 2026-02-18T12:39:50.000Z weekly 0.8 https://news.syenza.com/menacwy-vaccination-strategy-adolescents-germany 2026-02-18T12:45:08.000Z weekly 0.8 https://news.syenza.com/genotype-ecg-prediction-capecg-cvd-risk 2026-02-17T13:07:57.000Z weekly 0.8 https://news.syenza.com/glofitamab-cost-effectiveness-conditional-reimbursement-dlbcl 2026-02-17T13:04:18.000Z weekly 0.8 https://news.syenza.com/nice-endorses-pegzilarginase-arginase-deficiency 2026-02-17T13:00:59.000Z weekly 0.8 https://news.syenza.com/pbm-reform-legislation-signed-into-law 2026-02-16T12:15:48.000Z weekly 0.8 https://news.syenza.com/advancing-cancer-screening-slovenia-equitable-care 2026-02-16T10:29:44.000Z weekly 0.8 https://news.syenza.com/late-breaking-bladder-cancer-treatments-keynote-b15 2026-02-13T10:06:08.000Z weekly 0.8 https://news.syenza.com/prescription-drug-pricing-cost-plus-disruption 2026-02-13T10:01:27.000Z weekly 0.8 https://news.syenza.com/robotic-surgery-portugal-uls-viseu-dao-lafoes-debut 2026-02-12T10:43:39.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-tender-investigation-south-africa-regulatory-scrutiny 2026-02-12T10:34:39.000Z weekly 0.8 https://news.syenza.com/infarmed-2026-priorities-regulatory-reform 2026-02-12T10:14:19.000Z weekly 0.8 https://news.syenza.com/astrazeneca-financial-results-fy-2025-revenue-pipeline 2026-02-11T12:38:22.000Z weekly 0.8 https://news.syenza.com/keytruda-ovarian-cancer-treatments-fda-approval-platinum-resistant 2026-02-11T12:34:49.000Z weekly 0.8 https://news.syenza.com/south-africa-health-reform-2026-innovations-challenges 2026-02-10T12:40:30.000Z weekly 0.8 https://news.syenza.com/uncertainty-aware-diagnostics-confidx-llm 2026-02-10T12:33:51.000Z weekly 0.8 https://news.syenza.com/early-stage-cancer-treatment-overcoming-barriers 2026-02-10T12:28:30.000Z weekly 0.8 https://news.syenza.com/output-european-pharma-competitiveness-eu-economic-resilience 2026-02-09T14:12:38.000Z weekly 0.8 https://news.syenza.com/healthtech-nhs-access-national-programme-equity 2026-02-09T14:05:30.000Z weekly 0.8 https://news.syenza.com/tislelizumab-nsclc-inclusion-dutch-health-package 2026-02-09T14:00:27.000Z weekly 0.8 https://news.syenza.com/trumprx-drug-pricing-launch-revolutionary-savings 2026-02-06T14:40:22.000Z weekly 0.8 https://news.syenza.com/healthcare-innovation-trends-jp-morgan-2026 2026-02-06T14:32:03.000Z weekly 0.8 https://news.syenza.com/novo-nordisk-growth-projections-2026-outlook 2026-02-04T14:45:58.000Z weekly 0.8 https://news.syenza.com/ai-healthcare-costs-navigating-financial-hurdles 2026-02-04T14:40:13.000Z weekly 0.8 https://news.syenza.com/datroway-metastatic-breast-cancer-fda-priority-review 2026-02-04T14:36:05.000Z weekly 0.8 https://news.syenza.com/ozempic-public-funding-approval-portugal-insights 2026-02-03T11:21:15.000Z weekly 0.8 https://news.syenza.com/surge-in-obesity-intervention-costs-netherlands 2026-02-03T11:21:23.000Z weekly 0.8 https://news.syenza.com/enhancing-patient-safety-africa 2026-02-02T10:55:22.000Z weekly 0.8 https://news.syenza.com/hpv-vaccination-benefits-portugal 2026-02-02T10:46:03.000Z weekly 0.8 https://news.syenza.com/glp-1-ra-safety-review-no-increased-suicidal-risk 2026-02-02T10:54:59.000Z weekly 0.8 https://news.syenza.com/portugal-generic-medicines-authorization-928-approvals-2025 2026-02-02T10:11:50.000Z weekly 0.8 https://news.syenza.com/chmp-january-2026-approvals-expanding-access-innovative-therapies 2026-02-02T10:04:39.000Z weekly 0.8 https://news.syenza.com/output-risicoverevening-policy-updates-2022-2025-amendments 2026-01-27T19:51:02.000Z weekly 0.8 https://news.syenza.com/burnout-health-professionals-beats-portugal 2026-01-27T13:01:45.000Z weekly 0.8 https://news.syenza.com/latin-america-pharma-growth-boehringer-ingelheim-investments-trends 2026-01-27T10:47:30.000Z weekly 0.8 https://news.syenza.com/nice-endorses-dupilumab-eosinophilic-copd 2026-01-26T16:04:07.000Z weekly 0.8 https://news.syenza.com/accelerating-fast-eu-clinical-trials-regulatory-efficiency 2026-01-26T15:59:47.000Z weekly 0.8 https://news.syenza.com/nice-recommends-talazoparib-enzalutamide-prostate-cancer 2026-01-23T12:04:03.000Z weekly 0.8 https://news.syenza.com/sandoz-biosimilars-strategy-capturing-opportunities-affordable-healthcare 2026-01-23T11:59:06.000Z weekly 0.8 https://news.syenza.com/trump-economic-revival-davos-2026-policies-impacts 2026-01-23T11:49:50.000Z weekly 0.8 https://news.syenza.com/alzheimers-care-innovation-across-europe 2026-01-21T12:30:58.000Z weekly 0.8 https://news.syenza.com/composite-treatment-targets-long-term-benefits-type-2-diabetes-management 2026-01-21T12:21:19.000Z weekly 0.8 https://news.syenza.com/economic-resilience-life-sciences-investment 2026-01-20T11:28:21.000Z weekly 0.8 https://news.syenza.com/eu-medicine-authorizations-2025-innovation-accessibility 2026-01-20T11:18:27.000Z weekly 0.8 https://news.syenza.com/fda-febrile-seizure-influenza-vaccine-labeling-children 2026-01-19T15:07:25.000Z weekly 0.8 https://news.syenza.com/ethical-ai-integration-drug-development 2026-01-19T14:59:30.000Z weekly 0.8 https://news.syenza.com/obesity-medication-guidelines-evidence-based-treatment 2026-01-15T12:09:41.000Z weekly 0.8 https://news.syenza.com/equity-based-pricing-primary-care-socioeconomic 2026-01-15T11:53:40.000Z weekly 0.8 https://news.syenza.com/eu-launches-joint-scientific-consultations-hta 2026-01-14T14:58:17.000Z weekly 0.8 https://news.syenza.com/beta-blockers-myocardial-infarction-ejection-fraction 2026-01-14T12:08:23.000Z weekly 0.8 https://news.syenza.com/epidyolex-spending-portugal-exceeds-3-million 2026-01-13T12:57:50.000Z weekly 0.8 https://news.syenza.com/global-pharma-executive-course-empowering-leaders 2026-01-13T12:39:37.000Z weekly 0.8 https://news.syenza.com/johnson-johnson-medicine-access-agreement-cost-reduction-us-manufacturing 2026-01-12T19:42:53.000Z weekly 0.8 https://news.syenza.com/nhs-cost-effectiveness-thresholds-boost-drug-approvals 2026-01-12T14:19:30.000Z weekly 0.8 https://news.syenza.com/driving-economic-transformation-brain-health-investment-africa 2026-01-09T11:03:23.000Z weekly 0.8 https://news.syenza.com/nice-expands-natalizumab-rrms-treatment-for-refractory-cases 2026-01-09T10:48:44.000Z weekly 0.8 https://news.syenza.com/bausch-health-cardiometabolic-innovation-latin-american-pharmaceuticals 2026-01-08T12:03:03.000Z weekly 0.8 https://news.syenza.com/johnson-johnson-ema-application-teclistamab-daratumumab-therapy 2026-01-08T11:55:44.000Z weekly 0.8 https://news.syenza.com/childhood-immunization-reforms-align-us-with-global-standards 2026-01-07T12:29:17.000Z weekly 0.8 https://news.syenza.com/novartis-drug-pricing-agreement-strategic-innovation-access 2026-01-07T12:19:32.000Z weekly 0.8 https://news.syenza.com/mrna-vaccine-advancements-infectious-disease-prevention-equity 2026-01-06T12:02:07.000Z weekly 0.8 https://news.syenza.com/africa-medicine-roadmap-sustainable-access-quality-pharmaceuticals 2026-01-06T11:54:58.000Z weekly 0.8 https://news.syenza.com/infarmed-leadership-appointments-health-regulation 2026-01-06T11:50:50.000Z weekly 0.8 https://news.syenza.com/preparing-eu-health-technology-assessment-webinar 2026-01-05T17:58:11.000Z weekly 0.8 https://news.syenza.com/eu-pharmaceutical-legislation-ema-innovation-access 2026-01-05T11:46:29.000Z weekly 0.8 https://news.syenza.com/avalere-health-appointments-enhance-leadership 2025-12-17T12:01:05.000Z weekly 0.8 https://news.syenza.com/bic-len-hiv-regimen-artistry-2-results 2025-12-17T11:47:12.000Z weekly 0.8 https://news.syenza.com/accelerating-tec-dara-multiple-myeloma-therapy-review 2025-12-16T14:35:56.000Z weekly 0.8 https://news.syenza.com/chmp-meeting-highlights-december-2025-advancements-new-medicines 2025-12-16T14:00:28.000Z weekly 0.8 https://news.syenza.com/akeega-brca2-approval-fda-precision-mcspc 2025-12-16T13:50:46.000Z weekly 0.8 https://news.syenza.com/translational-medicine-portugal-collaborative-innovations 2025-12-15T13:47:57.000Z weekly 0.8 https://news.syenza.com/arexvy-rsv-vaccine-expansion-broader-access-adult-health 2025-12-15T13:07:44.000Z weekly 0.8 https://news.syenza.com/provisional-deal-eu-pharmaceutical-reform-innovation-amr 2025-12-12T13:42:18.000Z weekly 0.8 https://news.syenza.com/ai-governance-pharmaceuticals-ethical-integration-medicines-lifecycle 2025-12-09T15:52:38.000Z weekly 0.8 https://news.syenza.com/2025-china-drug-catalog-114-new-drugs-access 2025-12-09T15:26:48.000Z weekly 0.8 https://news.syenza.com/nice-approves-seven-digital-cardiac-rehabilitation-technologies 2025-12-08T17:03:06.000Z weekly 0.8 https://news.syenza.com/repurposing-off-patent-medicines-eu-pilot-insights 2025-12-08T16:38:31.000Z weekly 0.8 https://news.syenza.com/innovations-haematology-cell-therapy-ash-2025 2025-12-05T11:44:24.000Z weekly 0.8 https://news.syenza.com/advancing-eu-health-technology-assessment-htacg-2026-priorities 2025-12-04T20:23:11.000Z weekly 0.8 https://news.syenza.com/who-guidelines-glp-1-obesity-therapies-adults 2025-12-04T14:41:21.000Z weekly 0.8 https://news.syenza.com/eu-pharmaceutical-supply-security-critical-medicines-act 2025-12-03T19:56:21.000Z weekly 0.8 https://news.syenza.com/biomanufacturing-excellence-act-strengthening-us-biopharma-manufacturing 2025-12-03T19:47:33.000Z weekly 0.8 https://news.syenza.com/medicare-drug-price-negotiations-savings-seniors-2027 2025-12-01T15:00:40.000Z weekly 0.8 https://news.syenza.com/fast-eu-clinical-trials-efficiency 2025-12-01T12:06:52.000Z weekly 0.8 https://news.syenza.com/continuous-glucose-monitoring-advances-type-2-diabetes 2025-11-27T15:19:47.000Z weekly 0.8 https://news.syenza.com/glp-1ras-psychiatric-care-metabolic-management 2025-11-27T15:06:45.000Z weekly 0.8 https://news.syenza.com/nice-endorses-obecabtagene-autoleucel-therapy-for-adult-relapsed-b-cell-leukaemia 2025-11-25T13:44:45.000Z weekly 0.8 https://news.syenza.com/accelerating-access-latin-america-innovative-therapies 2025-11-25T12:23:25.000Z weekly 0.8 https://news.syenza.com/rethinking-heor-market-access-integration-early-engagement-phase-3 2025-11-24T20:22:53.000Z weekly 0.8 https://news.syenza.com/patient-reported-outcomes-trends-clinical-trials-2008-2023 2025-11-24T15:16:11.000Z weekly 0.8 https://news.syenza.com/ai-polyp-detection-gaps-evidence-roadmap-nhs 2025-11-24T12:30:14.000Z weekly 0.8 https://news.syenza.com/health-investment-returns-economic-asset 2025-11-18T12:12:19.000Z weekly 0.8 https://news.syenza.com/emblaveo-mdr-infections-evaluating-new-solution-gram-negative 2025-11-18T11:08:20.000Z weekly 0.8 https://news.syenza.com/sacituzumab-govitecan-tnbc-first-line-therapy 2025-11-17T21:24:25.000Z weekly 0.8 https://news.syenza.com/interchangeable-biosimilar-approval-poherdy-first-perjeta 2025-11-17T15:31:31.000Z weekly 0.8 https://news.syenza.com/hiv-therapy-advancements-bictegravir-lenacapavir-single-tablet 2025-11-14T13:55:33.000Z weekly 0.8 https://news.syenza.com/targeted-therapy-access-innovations-challenges 2025-11-18T10:22:54.000Z weekly 0.8 https://news.syenza.com/advances-hormone-based-obesity-treatments 2025-11-12T14:28:25.000Z weekly 0.8 https://news.syenza.com/nice-nhs-prioritization-strategic-shift-healthcare-challenges 2025-11-12T14:18:16.000Z weekly 0.8 https://news.syenza.com/beta-blockers-heart-attack-research-insights 2025-11-10T16:42:50.000Z weekly 0.8 https://news.syenza.com/ctx310-lipid-disorder%e6%b2%bb%e7%96%97-phase-1-ldl-triglyceride-reductions 2025-11-10T12:57:39.000Z weekly 0.8 https://news.syenza.com/output-koselugo-eu-approval-plexiform-neurofibromas-adult-nf1-patients 2025-11-07T10:23:19.000Z weekly 0.8 https://news.syenza.com/eloralintide-obesity-treatment-phase-2-trial-results 2025-11-07T10:02:01.000Z weekly 0.8 https://news.syenza.com/kidney-transplant-transparency-patient-involvement 2025-11-06T19:18:16.000Z weekly 0.8 https://news.syenza.com/uk-clinical-trial-reforms-accelerate-approvals-with-ai 2025-11-05T19:07:36.000Z weekly 0.8 https://news.syenza.com/ai-in-south-african-healthcare-professionals-confidence-reducing-admissions-efficiency 2025-11-05T11:33:56.000Z weekly 0.8 https://news.syenza.com/sustainable-reimbursement-models-south-africa 2025-11-04T21:30:53.000Z weekly 0.8 https://news.syenza.com/antidepressant-side-effects-cardiometabolic-health-risks 2025-11-03T21:39:53.000Z weekly 0.8 https://news.syenza.com/china-medical-research-challenges-ethical-quality-concerns 2025-11-04T21:36:27.000Z weekly 0.8 https://news.syenza.com/medical-schemes-affordability-crisis-cms-report-2024 2025-10-31T10:49:21.000Z weekly 0.8 https://news.syenza.com/african-pharmaceutical-growth-regulatory-procurement 2025-11-04T21:57:24.000Z weekly 0.8 https://news.syenza.com/aligning-medical-schemes-national-health-insurance-south-africa 2025-10-30T11:43:35.000Z weekly 0.8 https://news.syenza.com/obesity-health-economics-forecasting-trends-costs-us 2025-11-04T21:59:03.000Z weekly 0.8 https://news.syenza.com/ai-chatbot-delusions-risks-validation-mental-health 2025-10-28T09:45:24.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-innovation-funding-challenging-narrative 2025-10-27T10:29:53.000Z weekly 0.8 https://news.syenza.com/nice-endorses-darolutamide-prostate-cancer-treatment-access 2025-10-24T12:17:39.000Z weekly 0.8 https://news.syenza.com/rethinking-health-technology-assessment-economic-evaluations 2025-10-24T09:15:45.000Z weekly 0.8 https://news.syenza.com/fda-cancer-trial-guidelines-prioritizing-overall-survival 2025-10-23T10:11:51.000Z weekly 0.8 https://news.syenza.com/novo-nordisk-board-changes-leadership-growth-strategy 2025-10-21T16:21:20.000Z weekly 0.8 https://news.syenza.com/fabhalta-kidney-treatment-slows-igan-disease-progression 2025-10-21T11:11:37.000Z weekly 0.8 https://news.syenza.com/keytruda-lung-cancer-treatment-long-term-survival-nsclc 2025-10-20T16:26:20.000Z weekly 0.8 https://news.syenza.com/promising-psma-targeted-therapy-delays-prostate-cancer-progress 2025-10-20T13:50:58.000Z weekly 0.8 https://news.syenza.com/cabotegravir-hiv-prevention-first-injectable-prep-uk 2025-10-17T11:41:04.000Z weekly 0.8 https://news.syenza.com/social-media-policy-action-protecting-youth-cognitive-risks 2025-10-16T15:57:23.000Z weekly 0.8 https://news.syenza.com/johnson-johnson-advances-solid-tumor-research-esmo-2025 2025-10-16T09:21:04.000Z weekly 0.8 https://news.syenza.com/output-colorectal-cancer-markers-region-specific-drivers 2025-10-15T16:06:56.000Z weekly 0.8 https://news.syenza.com/tukysa-breast-cancer-therapy-progression-free-survival 2025-10-15T09:10:36.000Z weekly 0.8 https://news.syenza.com/datroway-tnbc-therapy-first-line-treatment-metastatic-breast-cancer 2025-10-13T10:42:45.000Z weekly 0.8 https://news.syenza.com/obesity-prevention-strategies-evolving-burden-us 2025-10-10T17:00:47.000Z weekly 0.8 https://news.syenza.com/simponi-pediatric-approval-fda-ulcerative-colitis 2025-10-09T17:17:00.000Z weekly 0.8 https://news.syenza.com/digital-health-technologies-nice-nhs-strategy 2025-10-09T09:30:42.000Z weekly 0.8 https://news.syenza.com/health-misinformation-autism-political-science-dangers 2025-10-07T14:46:04.000Z weekly 0.8 https://news.syenza.com/lurbinectedin-sclc-therapy-fda-approval-economic-implications 2025-10-06T09:25:06.000Z weekly 0.8 https://news.syenza.com/enhertu-breast-cancer-treatment-advances-invasive-disease-free-survival 2025-10-03T16:53:35.000Z weekly 0.8 https://news.syenza.com/transforming-healthcare-gene-therapy-access-model 2025-10-01T13:51:45.000Z weekly 0.8 https://news.syenza.com/pfizer-trump-drug-prices-affordable-medications 2025-10-01T08:31:58.000Z weekly 0.8 https://news.syenza.com/phrma-patient-access-investment-500-billion-commitment 2025-09-30T15:43:25.000Z weekly 0.8 https://news.syenza.com/sanofi-insulin-savings-guide-2025 2025-09-29T16:27:30.000Z weekly 0.8 https://news.syenza.com/empowering-innovation-clinical-trials-reform-ema-2025 2025-09-29T10:45:56.000Z weekly 0.8 https://news.syenza.com/track-one-patents-strategies 2025-09-26T11:39:53.000Z weekly 0.8 https://news.syenza.com/biosimilars-market-trends-2025-erosion-growth 2025-09-26T10:15:34.000Z weekly 0.8 https://news.syenza.com/nhs-productivity-gains-risk-innovation-cost-control 2025-09-25T11:33:17.000Z weekly 0.8 https://news.syenza.com/subcutaneous-pembrolizumab-approval-impact-on-cancer-treatment 2025-09-24T09:14:09.000Z weekly 0.8 https://news.syenza.com/nivopostop-trial-results-head-neck-cancer-breakthrough 2025-09-23T08:47:05.000Z weekly 0.8 https://news.syenza.com/c-auris-outbreak-europe-alarming-spread-resistance 2025-09-22T12:22:05.000Z weekly 0.8 https://news.syenza.com/addressing-glp-1-access-inequity 2025-09-19T11:38:34.000Z weekly 0.8 https://news.syenza.com/nice-kidney-cancer-guideline-biopsy-minimize-surgery 2025-09-18T14:37:52.000Z weekly 0.8 https://news.syenza.com/capvaxive-pneumococcal-vaccine-immune-response-at-risk-youth 2025-09-18T14:41:47.000Z weekly 0.8 https://news.syenza.com/oral-semaglutide-benefits-ema-approves-first-oral-glp1-ra 2025-09-16T19:41:20.000Z weekly 0.8 https://news.syenza.com/ravulizumab-ahus-reimbursement-reassessment 2025-09-15T10:39:08.000Z weekly 0.8 https://news.syenza.com/new-federal-actions-misleading-prescription-drug-ads 2025-09-11T10:34:58.000Z weekly 0.8 https://news.syenza.com/ending-unproven-fertility-treatments-nice-calls-evidence-based-care 2025-09-10T10:38:11.000Z weekly 0.8 https://news.syenza.com/medicare-aco-outcomes-surgical-benefits-costs-team-model 2025-09-09T10:40:21.000Z weekly 0.8 https://news.syenza.com/uk-risks-underestimating-life-sciences-investment-potential 2025-09-08T12:06:21.000Z weekly 0.8 https://news.syenza.com/glp-1-therapy-bariatric-surgery-insights 2025-09-04T13:05:00.000Z weekly 0.8 https://news.syenza.com/impact-of-generic-liraglutide-launch-on-weight-management 2025-09-03T08:39:43.000Z weekly 0.8 https://news.syenza.com/collaboration-cardiac-surgery-boosting-surgical-volumes 2025-09-01T21:56:05.000Z weekly 0.8 https://news.syenza.com/mounjaro-price-increase-uk-impacts-access-health-economics 2025-09-01T08:39:51.000Z weekly 0.8 https://news.syenza.com/moonlake-immunotherapeutics-hs-targeting-inflammatory-diseases 2025-08-30T11:33:07.000Z weekly 0.8 https://news.syenza.com/revolutionizing-remote-atrial-fibrillation-screening-amalfi-trial 2025-08-29T12:00:43.000Z weekly 0.8 https://news.syenza.com/nice-endorses-bladder-cancer-treatment 2025-08-25T20:58:24.000Z weekly 0.8 https://news.syenza.com/uk-pharmaceutical-pricing-analysis-vpag-review-impasse 2025-08-25T10:07:55.000Z weekly 0.8 https://news.syenza.com/efpia-response-tariffs-us-eu-trade-impact-pharma 2025-08-22T10:53:28.000Z weekly 0.8 https://news.syenza.com/tavi-cost-effectiveness-brazil-analysis 2025-08-21T22:06:38.000Z weekly 0.8 https://news.syenza.com/type-2-diabetes-management-nice-guideline-update-2025 2025-08-21T08:27:50.000Z weekly 0.8 https://news.syenza.com/fda-guidance-overall-survival-assessment-oncology-trials 2025-08-20T20:51:10.000Z weekly 0.8 https://news.syenza.com/guiding-future-digital-cardiac-rehabilitation-nice-recommendations 2025-08-20T11:19:31.000Z weekly 0.8 https://news.syenza.com/glofitamab-gemcitabine-dlbcl-assessment-results 2025-08-19T20:12:59.000Z weekly 0.8 https://news.syenza.com/key-decisions-health-technology-assessment-acp124 2025-08-19T09:26:22.000Z weekly 0.8 https://news.syenza.com/eli-lilly-innovation-statement-drug-pricing-manufacturing 2025-08-18T21:19:31.000Z weekly 0.8 https://news.syenza.com/unlocking-self-care-south-africa-strategies-challenges 2025-08-18T21:09:22.000Z weekly 0.8 https://news.syenza.com/rare-medications-coverage-netherlands-price-reductions 2025-08-15T22:12:07.000Z weekly 0.8 https://news.syenza.com/sanofi-rilzabrutinib-orphan-designation-igg4-related-disease 2025-08-15T17:00:39.000Z weekly 0.8 https://news.syenza.com/strengthening-us-pharmaceutical-supply-chain-api-reserve 2025-08-15T09:24:30.000Z weekly 0.8 https://news.syenza.com/most-expensive-drugs-2025-trends-implications 2025-08-13T21:25:45.000Z weekly 0.8 https://news.syenza.com/padcev-keytruda-urothelial-cancer-survival-outcomes-economic-impact 2025-08-13T13:39:55.000Z weekly 0.8 https://news.syenza.com/urgent-care-effectiveness-canadian-centre-models 2025-08-12T17:17:36.000Z weekly 0.8 https://news.syenza.com/frances-has-denies-ribociclib-breast-cancer-therapy 2025-08-12T10:18:00.000Z weekly 0.8 https://news.syenza.com/fda-approved-eye-drops-lenz-therapeutics-vizz-presbyopia 2025-08-11T21:22:05.000Z weekly 0.8 https://news.syenza.com/iqwig-real-world-data-report-benefit-assessments 2025-08-11T10:46:09.000Z weekly 0.8 https://news.syenza.com/donanemab-alzheimers-approval-new-era-treatment 2025-08-11T07:19:45.000Z weekly 0.8 https://news.syenza.com/building-better-ecosystem-digitally-enabled-diabetes-care 2025-08-11T07:20:31.000Z weekly 0.8 https://news.syenza.com/ai-in-real-world-evidence-insights-mitch-higashi 2025-08-08T10:27:58.000Z weekly 0.8 https://news.syenza.com/achieving-international-drug-price-parity-trumps-mandate 2025-08-08T10:20:06.000Z weekly 0.8 https://news.syenza.com/nicest-2025-guidance-obesity-management-support 2025-08-08T10:09:07.000Z weekly 0.8 https://news.syenza.com/patient-involvement-eu-jcas-lessons-global-hta-practices 2025-08-08T10:11:47.000Z weekly 0.8 https://news.syenza.com/nice-healthtech-methods-update-enhancing-value-assessment 2025-08-08T10:07:54.000Z weekly 0.8 https://news.syenza.com/ai-act-implementation-challenges-medtech 2025-08-08T10:15:40.000Z weekly 0.8 https://news.syenza.com/access-innovative-medicines-small-countries-challenges 2025-07-31T20:53:23.000Z weekly 0.8 https://news.syenza.com/mental-health-policy-integration-cross-sector-imperative 2025-07-31T08:53:46.000Z weekly 0.8 https://news.syenza.com/novartis-approval-malaria-treatment-for-infants 2025-08-08T10:17:18.000Z weekly 0.8 https://news.syenza.com/viiv-healthcare-licensing-access-long-acting-hiv-treatment 2025-08-08T10:23:41.000Z weekly 0.8 https://news.syenza.com/arvs-water-impact-environmental-consequences-south-africa 2025-07-30T10:18:52.000Z weekly 0.8 https://news.syenza.com/fda-approval-anzupgo-chronic-hand-eczema-treatment 2025-07-30T10:19:33.000Z weekly 0.8 https://news.syenza.com/urgent-call-to-action-eu-clinical-trials-strategy 2025-07-30T10:22:11.000Z weekly 0.8 https://news.syenza.com/tagrisso-chemotherapy-combo-lung-cancer-survival-benefits 2025-07-30T10:22:46.000Z weekly 0.8 https://news.syenza.com/transforming-brain-health-innovation-patient-experience-data 2025-07-30T10:23:41.000Z weekly 0.8 https://news.syenza.com/thimerosal-vaccine-removal-hhs-decision-flu-vaccines 2025-07-30T10:24:43.000Z weekly 0.8 https://news.syenza.com/comprehensive-review-type-2-diabetes-treatment 2025-07-30T10:40:16.000Z weekly 0.8 https://news.syenza.com/dutch-pharmacoeconomic-redesign-streamlined-structure-transparency 2025-07-23T20:48:08.000Z weekly 0.8 https://news.syenza.com/global-health-technology-assessment-nice-role-challenges 2025-07-23T08:59:41.000Z weekly 0.8 https://news.syenza.com/ai-medical-imaging-barriers 2025-07-22T19:27:03.000Z weekly 0.8 https://news.syenza.com/revolutionizing-pharmacoeconomic-evaluations-nederland 2025-07-22T11:35:45.000Z weekly 0.8 https://news.syenza.com/model-type-impact-pneumococcal-vaccine-cost-effectiveness 2025-07-21T19:16:22.000Z weekly 0.8 https://news.syenza.com/gas-intraoperative-diagnosis-platform 2025-07-21T09:28:07.000Z weekly 0.8 https://news.syenza.com/dtc-telehealth-partnerships-navigating-risks-pharma 2025-07-18T09:02:41.000Z weekly 0.8 https://news.syenza.com/maf-test-breast-cancer-personalized-treatment-spain 2025-07-17T17:00:07.000Z weekly 0.8 https://news.syenza.com/ribociclib-breast-cancer-guidance-nice-nhs 2025-07-17T11:53:20.000Z weekly 0.8 https://news.syenza.com/efficacy-insights-transdiagnostic-mental-health-apps 2025-07-16T17:32:31.000Z weekly 0.8 https://news.syenza.com/national-bulk-purchasing-strategy-drug-affordability-canada 2025-08-08T10:41:49.000Z weekly 0.8 https://news.syenza.com/elderly-care-costs-2025-rising-financial-pressures 2025-07-15T17:14:24.000Z weekly 0.8 https://news.syenza.com/silencing-science-impact-political-interference-global-health 2025-07-15T11:52:29.000Z weekly 0.8 https://news.syenza.com/caution-advised-conflicts-aap-childhood-obesity-guidelines 2025-07-14T16:59:33.000Z weekly 0.8 https://news.syenza.com/revolutionizing-diabetes-care-with-implantable-glucose-device 2025-07-14T08:53:16.000Z weekly 0.8 https://news.syenza.com/federated-learning-governance-healthcare 2025-07-30T10:29:15.000Z weekly 0.8 https://news.syenza.com/cecolin-9-hpv-vaccine-cervical-cancer-prevention-china 2025-07-30T10:29:44.000Z weekly 0.8 https://news.syenza.com/lenacapavir-hiv-prevention-gilead-global-fund-access 2025-07-30T10:49:15.000Z weekly 0.8 https://news.syenza.com/malaria-medicine-newborns-approval-pediatric-care 2025-07-30T10:49:41.000Z weekly 0.8 https://news.syenza.com/talquetamab-multiple-myeloma-impact-evidence-policy 2025-07-09T21:10:36.000Z weekly 0.8 https://news.syenza.com/masitinib-prostate-cancer-trial-fda-ema-phase-3-approval 2025-07-14T23:32:58.000Z weekly 0.8 https://news.syenza.com/bebt-908-dlbcl-treatment-approval-china 2025-07-08T06:30:00.000Z weekly 0.8 https://news.syenza.com/ai-clinician-in-pediatric-icu 2025-07-07T17:00:29.000Z weekly 0.8 https://news.syenza.com/10-year-health-plan-england-nhs-future 2025-07-07T11:02:34.000Z weekly 0.8 https://news.syenza.com/eu-life-sciences-strategy-leadership-2030 2025-07-03T12:12:11.000Z weekly 0.8 https://news.syenza.com/ticagrelor-data-integrity-flaws-clinical-trials 2025-07-03T10:19:57.000Z weekly 0.8 https://news.syenza.com/value-of-self-care-public-health 2025-07-02T12:55:44.000Z weekly 0.8 https://news.syenza.com/pharma-ad-spending-trends-2024-top-drug-advertisers 2025-07-03T12:03:29.000Z weekly 0.8 https://news.syenza.com/dutch-health-disruption-reimagining-care-social-entrepreneurship 2025-07-01T14:46:26.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-industry-europe-key-insights-2025 2025-07-01T08:43:23.000Z weekly 0.8 https://news.syenza.com/streamlining-prior-authorization-reforms-impacts-insights 2025-06-30T14:32:53.000Z weekly 0.8 https://news.syenza.com/navigating-private-health-funding-south-africa-nhi-act 2025-07-30T10:50:41.000Z weekly 0.8 https://news.syenza.com/oz-proposes-stricter-drug-price-transparency-regulations 2025-06-27T11:58:29.000Z weekly 0.8 https://news.syenza.com/ai-driven-mental-healthcare-sword-health-mind 2025-06-25T11:00:01.000Z weekly 0.8 https://news.syenza.com/transparency-in-industry-partnerships-building-trust 2025-06-25T09:16:49.000Z weekly 0.8 https://news.syenza.com/ai-driven-daly-modeling-methods-health-economics-policy 2025-06-25T07:03:28.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-pricing-issues-analysis 2025-06-24T07:57:43.000Z weekly 0.8 https://news.syenza.com/zimislecel-type-1-diabetes-trial-results 2025-07-30T10:31:35.000Z weekly 0.8 https://news.syenza.com/redefining-biosimilar-development-biosimilar-clinical-approach 2025-06-23T07:57:34.000Z weekly 0.8 https://news.syenza.com/gileads-yeztugo-hiv-prevention-injection-fda-approval 2025-06-20T11:13:01.000Z weekly 0.8 https://news.syenza.com/canada-launches-consultation-essential-prescription-drugs 2025-06-20T08:19:06.000Z weekly 0.8 https://news.syenza.com/acip-vaccine-policy-concerns-dismissals 2025-06-19T15:47:13.000Z weekly 0.8 https://news.syenza.com/donanemab-alzheimers-treatment-cost-effectiveness 2025-06-19T08:11:21.000Z weekly 0.8 https://news.syenza.com/ultomiris-pediatric-tma-treatment-efficacy-hsct 2025-06-18T16:14:44.000Z weekly 0.8 https://news.syenza.com/eli-lilly-verve-acquisition-gene-editing-therapies-ascvd-treatment 2025-06-18T10:25:42.000Z weekly 0.8 https://news.syenza.com/ema-2024-report-highlights-innovations-regulatory-advances 2025-06-17T12:19:04.000Z weekly 0.8 https://news.syenza.com/pcv20-reimbursement-guidelines-analysis-dutch-advisory-council 2025-06-17T07:46:42.000Z weekly 0.8 https://news.syenza.com/transformative-multiple-myeloma-treatment-approved-nice 2025-06-16T10:45:38.000Z weekly 0.8 https://news.syenza.com/keytruda-head-neck-cancer-approval 2025-06-16T08:56:18.000Z weekly 0.8 https://news.syenza.com/mavyret-acute-hepatitis-c-treatment-expansion-economic-implications 2025-06-13T10:31:07.000Z weekly 0.8 https://news.syenza.com/advancements-in-hiv-vaccine-trials 2025-06-13T06:48:34.000Z weekly 0.8 https://news.syenza.com/ehk-clusters-2026-report-enhancements-dutch-risk-equalization 2025-06-12T11:47:54.000Z weekly 0.8 https://news.syenza.com/telemedicine-growth-strategies-who-european-region 2025-06-12T07:11:14.000Z weekly 0.8 https://news.syenza.com/future-proofing-hospitals-singapore 2025-07-08T11:11:56.000Z weekly 0.8 https://news.syenza.com/pfizer-conference-insights-bourla-strategic-vision 2025-06-11T07:17:43.000Z weekly 0.8 https://news.syenza.com/rfk-jr-acip-overhaul-vaccine-policy-implications 2025-06-10T19:55:47.000Z weekly 0.8 https://news.syenza.com/fda-ai-tool-insights-eliminate-regulatory-bottlenecks 2025-06-10T12:44:23.000Z weekly 0.8 https://news.syenza.com/keytruda-biosimilar-collaboration-alvotech-dr-reddy 2025-06-09T07:59:50.000Z weekly 0.8 https://news.syenza.com/transparency-in-peer-review-enhancing-scientific-integrity 2025-06-09T07:55:43.000Z weekly 0.8 https://news.syenza.com/eu-medicines-access-challenges 2025-06-06T09:22:33.000Z weekly 0.8 https://news.syenza.com/uk-medicine-payment-rates-impact-life-sciences 2025-06-06T08:00:54.000Z weekly 0.8 https://news.syenza.com/blinatumomab-benefit-assessment-acl-treatment-health-economics 2025-06-05T16:38:34.000Z weekly 0.8 https://news.syenza.com/enhertu-reimbursement-analysis-clinical-efficacy-cost-effectiveness 2025-06-05T07:06:36.000Z weekly 0.8 https://news.syenza.com/drug-pricing-analysis-international-comparisons 2025-06-04T09:59:42.000Z weekly 0.8 https://news.syenza.com/nice-healthtech-reforms-accelerating-digital-innovation-nhs 2025-06-04T08:32:07.000Z weekly 0.8 https://news.syenza.com/biontech-bms-collaboration-bnt327-solid-tumor-treatment 2025-06-03T19:01:21.000Z weekly 0.8 https://news.syenza.com/pluvicto-prostate-cancer-trial-phase-iii-results 2025-06-03T13:26:05.000Z weekly 0.8 https://news.syenza.com/novo-nordisk-glp1-market-share-loss 2025-07-30T10:27:43.000Z weekly 0.8 https://news.syenza.com/tolebrutinib-ms-analysis-efficacy-safety-economic-impact 2025-06-02T08:45:32.000Z weekly 0.8 https://news.syenza.com/allopurinol-marfan-syndrome-orphan-drug-implications 2025-05-30T08:14:45.000Z weekly 0.8 https://news.syenza.com/marstacimab-hemophilia-b-nice-approval-economic-implications 2025-05-30T07:02:56.000Z weekly 0.8 https://news.syenza.com/hpv-related-cancer-trends-south-africa-incidence 2025-05-30T08:31:34.000Z weekly 0.8 https://news.syenza.com/fda-clears-alzheimers-blood-test-diagnostics 2025-05-30T06:55:11.000Z weekly 0.8 https://news.syenza.com/us-argentina-who-withdrawal-global-health-governance 2025-05-29T08:06:22.000Z weekly 0.8 https://news.syenza.com/eu-patent-licensing-framework-crisis-management 2025-05-29T07:57:55.000Z weekly 0.8 https://news.syenza.com/lung-health-resolution 2025-05-28T10:25:49.000Z weekly 0.8 https://news.syenza.com/south-africa-health-reform-universal-coverage-analysis 2025-05-28T06:58:42.000Z weekly 0.8 https://news.syenza.com/eu-establishes-expert-panel-for-orphan-paediatric-devices 2025-05-27T07:18:20.000Z weekly 0.8 https://news.syenza.com/glp-1-drug-access-models 2025-05-26T12:52:32.000Z weekly 0.8 https://news.syenza.com/high-orphan-drug-prices-persist-despite-exclusivity-expiration 2025-05-26T09:17:49.000Z weekly 0.8 https://news.syenza.com/mfn-drug-price-biosimilar-impact 2025-07-08T11:16:48.000Z weekly 0.8 https://news.syenza.com/eu-ai-act-healthcare-compliance-navigating-ethical-ai-integration 2025-05-23T09:15:49.000Z weekly 0.8 https://news.syenza.com/hepatitis-vaccine-uptake-trends-challenges-pharmacists 2025-05-22T20:30:56.000Z weekly 0.8 https://news.syenza.com/biosimilars-price-competition-impact-us-pharmaceutical-market 2025-05-22T09:04:46.000Z weekly 0.8 https://news.syenza.com/mfn-drug-pricing-lowering-us-costs-international-alignment 2025-05-21T11:43:10.000Z weekly 0.8 https://news.syenza.com/hta-reform-analysis-patterns-global-trends 2025-05-21T08:42:45.000Z weekly 0.8 https://news.syenza.com/drug-pricing-analysis-icers-launch-price-access-report 2025-05-20T14:41:36.000Z weekly 0.8 https://news.syenza.com/trends-in-anticancer-drug-pricing-medicare-ira 2025-05-20T13:29:28.000Z weekly 0.8 https://news.syenza.com/ema-endorses-nash-ai-tool 2025-05-19T11:16:58.000Z weekly 0.8 https://news.syenza.com/publication-delays-impact-careers-early-career-researchers 2025-07-30T10:42:13.000Z weekly 0.8 https://news.syenza.com/systems-dynamics-approach-lowering-drug-prices 2025-07-30T10:32:52.000Z weekly 0.8 https://news.syenza.com/efpia-advocates-stronger-life-sciences-eu-multiannual-financial-framework 2025-05-16T10:02:38.000Z weekly 0.8 https://news.syenza.com/evolving-nice-health-technology-evaluations-patient-perspectives 2025-05-15T16:17:56.000Z weekly 0.8 https://news.syenza.com/canada-drug-agency-plan-shaping-health-systems-2025-2030 2025-05-15T09:35:08.000Z weekly 0.8 https://news.syenza.com/vietnarms-trial-innovative-hepatitis-c-treatment-options 2025-05-14T09:05:36.000Z weekly 0.8 https://news.syenza.com/revolutionizing-hepatitis-c-treatment-direct-acting-antivirals 2025-05-14T11:24:22.000Z weekly 0.8 https://news.syenza.com/hepatitis-c-investment-impact-china 2025-07-30T10:44:44.000Z weekly 0.8 https://news.syenza.com/teal-wand-cervical-screening-at-home-cancer-detection 2025-05-13T10:29:40.000Z weekly 0.8 https://news.syenza.com/viatris-non-opioid-pain-management 2025-05-12T11:33:39.000Z weekly 0.8 https://news.syenza.com/bulevirtide-hdv-therapy-promising-results 2025-05-12T07:30:32.000Z weekly 0.8 https://news.syenza.com/prevention-valuation 2025-05-09T12:49:10.000Z weekly 0.8 https://news.syenza.com/fda-ai-drug-approval-revolutionizing-therapy-reviews 2025-07-30T10:28:21.000Z weekly 0.8 https://news.syenza.com/hcv-treatment-advancements-ateas-kol-panel-insights 2025-05-08T07:42:16.000Z weekly 0.8 https://news.syenza.com/trump-science-publishing-critique-political-interference-methodological-issues 2025-05-08T06:26:08.000Z weekly 0.8 https://news.syenza.com/nhi-bill-court-ruling-ramaphosa-justification 2025-07-30T10:30:59.000Z weekly 0.8 https://news.syenza.com/implementing-health-technology-assessment-oman 2025-07-30T10:47:40.000Z weekly 0.8 https://news.syenza.com/tavr-asymptomatic-approval-new-era-aortic-stenosis 2025-05-06T06:15:30.000Z weekly 0.8 https://news.syenza.com/cvs-wegovy-hybrid-market-access-strategy 2025-05-05T17:26:06.000Z weekly 0.8 https://news.syenza.com/self-care-and-ncds-global-health-policy 2025-05-05T09:14:35.000Z weekly 0.8 https://news.syenza.com/ivonescimab-lung-cancer-treatment-approved 2025-05-02T12:11:56.000Z weekly 0.8 https://news.syenza.com/cdc-hepatitis-lab-closure-impact-risks-opportunities 2025-05-02T10:15:19.000Z weekly 0.8 https://news.syenza.com/promising-results-peanut-oral-immunotherapy-young-children 2025-05-01T08:13:48.000Z weekly 0.8 https://news.syenza.com/zevaskyn-gene-therapy-revolutionary-rdeb-breakthrough 2025-05-01T07:57:34.000Z weekly 0.8 https://news.syenza.com/nipocalimab-myasthenia-gravis-approval-breakthrough-treatment 2025-04-30T18:18:30.000Z weekly 0.8 https://news.syenza.com/trodelvy-keytruda-combination-metastatic-tnbc-results 2025-04-30T12:17:30.000Z weekly 0.8 https://news.syenza.com/enhancing-pediatric-pain-management-portugal-emergency-departments 2025-04-29T09:47:45.000Z weekly 0.8 https://news.syenza.com/ai-pediatric-sarcoma-diagnosis-speed-accuracy 2025-04-29T09:35:39.000Z weekly 0.8 https://news.syenza.com/urgent-need-for-pediatric-heart-devices 2025-04-28T09:59:05.000Z weekly 0.8 https://news.syenza.com/suzetrigine-pain-management-non-opioid-analgesics 2025-04-25T12:03:52.000Z weekly 0.8 https://news.syenza.com/defunding-scientific-research-implications-gawande-harvard 2025-04-25T07:08:18.000Z weekly 0.8 https://news.syenza.com/fda-approves-perioperative-immunotherapy-bladder-cancer 2025-04-24T21:39:53.000Z weekly 0.8 https://news.syenza.com/optimizing-value-based-drug-pricing-japan-marie-framework 2025-04-24T21:35:56.000Z weekly 0.8 https://news.syenza.com/modifiable-shared-risk-pathways-stroke-dementia-depression 2025-04-23T11:25:21.000Z weekly 0.8 https://news.syenza.com/navigating-drug-price-regulation-executive-order-impact 2025-04-23T10:14:03.000Z weekly 0.8 https://news.syenza.com/ai-patient-education-chatgpt-gemini-pediatric-conditions 2025-07-30T10:48:11.000Z weekly 0.8 https://news.syenza.com/advancing-pediatric-leukemia-trial-precision-medicine 2025-04-22T07:28:28.000Z weekly 0.8 https://news.syenza.com/eli-lilly-orforglipron-oral-glp-1-medication-diabetes-obesity 2025-04-20T18:47:34.000Z weekly 0.8 https://news.syenza.com/environmental-exposures-pediatric-thyroid-cancer-risk 2025-04-21T08:14:54.000Z weekly 0.8 https://news.syenza.com/capivasertib-cost-effectiveness 2025-04-18T11:25:58.000Z weekly 0.8 https://news.syenza.com/reserve-antibiotics-benefits-meropenem-vaborbactam 2025-04-18T07:20:21.000Z weekly 0.8 https://news.syenza.com/nice-grants-robotic-surgery-approval-enhance-patient-care 2025-04-17T08:58:13.000Z weekly 0.8 https://news.syenza.com/sugary-drinks-cancer-risk-women-oral-cavity 2025-04-17T08:37:24.000Z weekly 0.8 https://news.syenza.com/cab-la-cost-effectiveness-hiv-prevention 2025-04-16T16:07:11.000Z weekly 0.8 https://news.syenza.com/global-health-limitations-critical-assessment-structural-constraints 2025-04-16T07:46:31.000Z weekly 0.8 https://news.syenza.com/neoadjuvant-immunotherapy-efficacy-head-neck-cancer 2025-04-15T08:20:20.000Z weekly 0.8 https://news.syenza.com/uk-clinical-trials-inclusivity-opportunities-innovations 2025-04-15T07:59:37.000Z weekly 0.8 https://news.syenza.com/cost-effective-interventions-hiv-malaria-tb 2025-04-14T11:06:27.000Z weekly 0.8 https://news.syenza.com/advancing-early-childhood-health-purehealth-abu-dhabi 2025-04-14T09:07:17.000Z weekly 0.8 https://news.syenza.com/accelerating-paediatric-medicine 2025-04-11T04:58:23.000Z weekly 0.8 https://news.syenza.com/balancing-pandemic-preparedness-priorities-military-spending 2025-04-11T05:27:48.000Z weekly 0.8 https://news.syenza.com/reassuring-private-sector-national-health-insurance-south-africa 2025-04-10T05:51:57.000Z weekly 0.8 https://news.syenza.com/masld-ckd-socioeconomic-link-geographic-insights 2025-04-10T05:18:16.000Z weekly 0.8 https://news.syenza.com/toripalimab-evidence-journey 2025-04-09T13:43:24.000Z weekly 0.8 https://news.syenza.com/nice-breakthrough-positive-recommendations-blood-cancer-treatments-2024 2025-04-09T06:17:42.000Z weekly 0.8 https://news.syenza.com/approval-of-pembrolizumab-enfortumab-therapy 2025-04-08T06:07:32.000Z weekly 0.8 https://news.syenza.com/cancer-control-month-2025-review 2025-04-07T07:34:12.000Z weekly 0.8 https://news.syenza.com/tobacco-head-neck-cancer-mutational-signatures-prevention-strategies 2025-04-07T07:33:07.000Z weekly 0.8 https://news.syenza.com/enhancing-diabetes-care-south-africa-shared-value 2025-04-04T14:49:33.000Z weekly 0.8 https://news.syenza.com/addressing-oral-cancer-east-africa-toombak-early-detection 2025-04-03T08:01:09.000Z weekly 0.8 https://news.syenza.com/pharma-patent-expiration-strategy 2025-07-08T11:22:07.000Z weekly 0.8 https://news.syenza.com/improving-diabetes-medicine-access 2025-04-02T08:23:15.000Z weekly 0.8 https://news.syenza.com/advancements-in-hpv-testing-hnscc 2025-04-02T08:22:48.000Z weekly 0.8 https://news.syenza.com/improving-oral-health-africa-addressing-challenges 2025-04-01T13:09:31.000Z weekly 0.8 https://news.syenza.com/early-benefit-assessment-tislelizumab-nsclc-treatment 2025-04-01T07:36:39.000Z weekly 0.8 https://news.syenza.com/advancements-in-colorectal-cancer-screening 2025-03-28T10:43:28.000Z weekly 0.8 https://news.syenza.com/neoadjuvant-chemoimmunotherapy-hnscc-advanced-hpv-negative-patients 2025-03-31T07:24:31.000Z weekly 0.8 https://news.syenza.com/prior-authorization-elimination-optum-rx-80-drugs-may-2025 2025-03-28T10:42:31.000Z weekly 0.8 https://news.syenza.com/south-africa-cannabis-regulations-government-withdraws-ban 2025-03-28T07:17:50.000Z weekly 0.8 https://news.syenza.com/advancing-heart-transplantation-lumped-parameter-model 2025-03-27T12:02:20.000Z weekly 0.8 https://news.syenza.com/addressing-cancer-care-disparities-europe 2025-03-27T08:59:26.000Z weekly 0.8 https://news.syenza.com/advancements-nano-radiopharmaceuticals-colon-cancer 2025-03-26T13:36:03.000Z weekly 0.8 https://news.syenza.com/systems-thinking-in-pharmaceutical-access 2025-07-10T15:55:22.000Z weekly 0.8 https://news.syenza.com/hiv-colorectal-cancer-survival-tailored-strategies 2025-03-26T08:22:07.000Z weekly 0.8 https://news.syenza.com/global-initiative-access-childhood-cancer-medicines 2025-03-25T06:50:04.000Z weekly 0.8 https://news.syenza.com/catalyzing-value-based-care-through-patient-centered-outcomes 2025-03-23T19:56:30.000Z weekly 0.8 https://news.syenza.com/liquid-biopsy-colorectal-cancer-screening-abu-dhabi 2025-03-24T09:09:22.000Z weekly 0.8 https://news.syenza.com/colorectal-cancer-young-women-awareness 2025-03-21T11:13:46.000Z weekly 0.8 https://news.syenza.com/survival-benefits-immune-checkpoint-inhibitors-metastatic-colorectal-cancer 2025-03-21T08:21:29.000Z weekly 0.8 https://news.syenza.com/fda-warning-aspen-pharmacare-compliance-violations-impact 2025-03-20T07:14:16.000Z weekly 0.8 https://news.syenza.com/pharma-innovation-market-access 2025-03-19T12:26:30.000Z weekly 0.8 https://news.syenza.com/global-partnerships-scd-enhancing-care-sickle-cell-africa 2025-03-18T08:40:07.000Z weekly 0.8 https://news.syenza.com/molecular-insights-angiogenesis-colorectal-cancer 2025-03-18T08:40:36.000Z weekly 0.8 https://news.syenza.com/enhancing-colorectal-cancer-screening-rural-medicaid 2025-03-18T07:56:55.000Z weekly 0.8 https://news.syenza.com/journavx-pain-medication-coverage-cost-concerns 2025-03-13T14:06:51.000Z weekly 0.8 https://news.syenza.com/deadline-boosts-colorectal-cancer-screening-uptake-tempo-trial 2025-03-17T08:21:35.000Z weekly 0.8 https://news.syenza.com/dtc-strategy-lilly-novo 2025-03-12T14:25:06.000Z weekly 0.8 https://news.syenza.com/maternal-child-health-south-africa 2025-03-13T05:17:23.000Z weekly 0.8 https://news.syenza.com/tackling-tuberculosis-burden-children-global-perspective 2025-03-12T13:29:54.000Z weekly 0.8 https://news.syenza.com/dialysis-technology-innovations-portable-solutions 2025-03-12T13:27:19.000Z weekly 0.8 https://news.syenza.com/rising-chronic-kidney-disease-burden-global-health-challenge 2025-03-11T08:43:03.000Z weekly 0.8 https://news.syenza.com/cost-savings-impact-comprehensive-medication-management 2025-03-10T11:57:01.000Z weekly 0.8 https://news.syenza.com/ai-moral-decision-making-kidney-allocation 2025-03-10T11:48:35.000Z weekly 0.8 https://news.syenza.com/ai-kidney-disease-detection-eye-screenings-diabetic-patients 2025-03-07T04:31:24.000Z weekly 0.8 https://news.syenza.com/hypertension-young-adults-prevalence-knowledge-south-africa 2025-03-06T13:08:37.000Z weekly 0.8 https://news.syenza.com/ckd-prevalence-hiv-tdf-global-perspective 2025-03-05T15:42:10.000Z weekly 0.8 https://news.syenza.com/south-africa-launches-patient-led-cancer-registry 2025-03-04T13:11:31.000Z weekly 0.8 https://news.syenza.com/fabhalta-c3-glomerulopathy-treatment-ema-endorsement 2025-03-03T15:51:37.000Z weekly 0.8 https://news.syenza.com/fda-accepts-bla-tlx250-cdx-imaging-agent 2025-03-03T16:11:40.000Z weekly 0.8 https://news.syenza.com/promising-results-personalized-cancer-vaccine-kidney-cancer 2025-03-03T09:35:32.000Z weekly 0.8 https://news.syenza.com/ivonescimab-clinical-trials-summit-pfizer-collaboration 2025-02-28T09:33:39.000Z weekly 0.8 https://news.syenza.com/acs-management-innovations-transforming-patient-outcomes 2025-02-28T09:26:06.000Z weekly 0.8 https://news.syenza.com/global-childhood-cancer-access-who-st-jude-initiative 2025-02-27T16:11:47.000Z weekly 0.8 https://news.syenza.com/global-aids-strategy-2030-end-aids-threat 2025-02-26T16:05:04.000Z weekly 0.8 https://news.syenza.com/hypertension-detection-model-htn-ai-cvd-stratification 2025-02-25T09:07:24.000Z weekly 0.8 https://news.syenza.com/cvd-prevention-models-sub-saharan-africa-insights-gaps 2025-02-24T11:09:07.000Z weekly 0.8 https://news.syenza.com/lenacapavir-hiv-prevention-gilead-ema-application 2025-02-21T07:06:13.000Z weekly 0.8 https://news.syenza.com/strengthening-africa-health-partnership-pandemic-preparedness 2025-02-20T16:40:14.000Z weekly 0.8 https://news.syenza.com/urgent-call-for-breast-cancer-africa-control-measures 2025-02-19T15:03:51.000Z weekly 0.8 https://news.syenza.com/journavx-pain-management-fda-approves-non-opioid-treatment 2025-02-19T08:38:11.000Z weekly 0.8 https://news.syenza.com/engineered-heart-muscle-allografts-promise-heart-repair 2025-02-18T10:12:27.000Z weekly 0.8 https://news.syenza.com/output-long-term-survival-aortic-valve-prostheses-biological-mechanical 2025-02-17T09:39:17.000Z weekly 0.8 https://news.syenza.com/pharmacy-benefit-managers-report-drug-costs-regulation 2025-02-14T04:28:43.000Z weekly 0.8 https://news.syenza.com/hpv-vaccination-males-prevent-cervical-lesions 2025-02-14T08:45:22.000Z weekly 0.8 https://news.syenza.com/genetic-testing-south-africa-sudden-unexpected-deaths 2025-02-10T12:59:09.000Z weekly 0.8 https://news.syenza.com/pepfar-funding-pause-global-hiv-progress 2025-02-12T15:31:54.000Z weekly 0.8 https://news.syenza.com/healthcare-at-home-cmc-dubai-innovative-chronic-management 2025-02-06T06:41:45.000Z weekly 0.8 https://news.syenza.com/tariff-impact-on-drugs-generic-biosimilar-market 2025-02-12T09:25:29.000Z weekly 0.8 https://news.syenza.com/cancer-screening-south-africa-urgent-need 2025-02-11T15:05:21.000Z weekly 0.8 https://news.syenza.com/revolutionizing-cervical-cancer-diagnosis-nanotechnology 2025-02-11T08:19:02.000Z weekly 0.8 https://news.syenza.com/promising-results-personalized-cancer-vaccine-rrcc 2025-02-10T12:14:31.000Z weekly 0.8 https://news.syenza.com/evolving-cervical-cancer-treatment-innovations-challenges 2025-02-10T09:18:42.000Z weekly 0.8 https://news.syenza.com/argentina-who-withdrawal-president-milei-exits 2025-02-07T09:24:31.000Z weekly 0.8 https://news.syenza.com/gauteng-hpv-vaccination-campaign-protecting-girls-cervical-cancer 2025-02-07T08:49:23.000Z weekly 0.8 https://news.syenza.com/capvaxive-vaccine-approval-pneumococcal-disease-prevention 2025-02-06T06:42:07.000Z weekly 0.8 https://news.syenza.com/south-africa-innovative-strategy-cervical-cancer-prevention 2025-02-05T09:03:06.000Z weekly 0.8 https://news.syenza.com/cervical-self-sampling-methods-overcoming-barriers 2025-02-05T09:07:39.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-digital-hiv-self-testing-malawi-south-africa-brazil 2025-02-03T12:12:23.000Z weekly 0.8 https://news.syenza.com/nice-approves-gene-therapy-sickle-cell 2025-02-04T08:27:36.000Z weekly 0.8 https://news.syenza.com/cervical-cancer-app-cost-effectiveness 2025-02-03T12:06:15.000Z weekly 0.8 https://news.syenza.com/advances-in-cervical-cancer-classification-deep-learning-models 2025-02-03T16:31:39.000Z weekly 0.8 https://news.syenza.com/ai-decision-support-aortic-stenosis-enhancing-detection 2025-01-31T12:12:27.000Z weekly 0.8 https://news.syenza.com/joint-scientific-consultations-health-tech-eu 2025-01-31T08:21:43.000Z weekly 0.8 https://news.syenza.com/cost-effective-cml-treatment-tyrosine-kinase-inhibitors-south-africa 2025-01-30T15:42:04.000Z weekly 0.8 https://news.syenza.com/trends-endometrial-cancer-mortality-ethnic-disparities-south-africa 2025-01-29T16:08:23.000Z weekly 0.8 https://news.syenza.com/hiv-cancer-care-integration-sub-saharan-africa 2025-01-28T15:38:01.000Z weekly 0.8 https://news.syenza.com/boosting-hpv-vaccine-uptake-young-people-post-pandemic 2025-01-28T07:29:28.000Z weekly 0.8 https://news.syenza.com/bioelectronic-medicine-innovations-non-invasive-neuromodulation 2025-01-27T12:07:52.000Z weekly 0.8 https://news.syenza.com/cervical-cancer-burden-global-trends-future-projections 2025-01-27T10:52:15.000Z weekly 0.8 https://news.syenza.com/datopotamab-deruxtecan-approval-hr-positive-breast-cancer 2025-01-24T14:07:15.000Z weekly 0.8 https://news.syenza.com/surrogate-endpoints-guidance-international-report-hta 2025-01-24T09:33:23.000Z weekly 0.8 https://news.syenza.com/cervical-cancer-prevention-strategies-south-african-women-hiv 2025-01-23T16:13:01.000Z weekly 0.8 https://news.syenza.com/sa_hpra_updates_mpa_meningioma_risk 2025-01-22T08:19:12.000Z weekly 0.8 https://news.syenza.com/mena-generics-biologics-growth-healthcare-innovation 2025-01-22T08:18:08.000Z weekly 0.8 https://news.syenza.com/trump-healthcare-policy-changes-reversing-bidens-orders 2025-01-22T09:05:22.000Z weekly 0.8 https://news.syenza.com/us-withdraws-from-who-impact-global-health 2025-01-21T13:10:38.000Z weekly 0.8 https://news.syenza.com/semaglutide-naion-risk-ema-review-initiated 2025-01-21T08:31:32.000Z weekly 0.8 https://news.syenza.com/cost-effective-cervical-cancer-screening 2025-01-20T12:34:44.000Z weekly 0.8 https://news.syenza.com/advancing-eu-health-technology-assessment-hag-meeting 2025-01-20T08:56:40.000Z weekly 0.8 https://news.syenza.com/national-health-survey-2024-progress-insights-impacts 2025-01-18T19:34:23.000Z weekly 0.8 https://news.syenza.com/medicare-drug-negotiations-ozempic-ibrance-price-cuts 2025-01-17T14:14:11.000Z weekly 0.8 https://news.syenza.com/output-transforming-africa-through-healthcare-biotechnology-africa 2025-01-16T16:34:22.000Z weekly 0.8 https://news.syenza.com/south-sudan-begins-cholera-vaccination-campaign-amid-outbreak 2025-01-15T16:11:11.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-data-collaboration-canadian-drug-agency-cihi 2025-01-15T09:18:09.000Z weekly 0.8 https://news.syenza.com/blueprint-for-transforming-healthcare-models-africa 2025-01-14T16:38:51.000Z weekly 0.8 https://news.syenza.com/abu-dhabis-stem-cells-center-achieves-milestone-in-ipsc-regenerative-medicine 2025-01-14T11:40:05.000Z weekly 0.8 https://news.syenza.com/delayed-thyroid-cancer-diagnoses-pandemic-implications-trends 2025-01-14T08:47:15.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-switching-nonavalent-hpv-vaccine-netherlands 2025-01-13T14:21:39.000Z weekly 0.8 https://news.syenza.com/glp-1-receptor-risks-thyroid-cancer-and-treatment-decisions 2025-01-13T10:55:31.000Z weekly 0.8 https://news.syenza.com/promising-dual-immunotherapy-anaplastic-thyroid-cancer 2025-01-10T09:28:42.000Z weekly 0.8 https://news.syenza.com/valuable-solutions-for-cost-effective-thyroid-diagnosis 2025-01-10T09:32:50.000Z weekly 0.8 https://news.syenza.com/who-prequalifies-first-g6pd-deficiency-test-for-malaria-treatment 2025-01-09T16:18:48.000Z weekly 0.8 https://news.syenza.com/cultural-challenges-ai-maternal-healthcare-africa 2025-01-08T15:10:46.000Z weekly 0.8 https://news.syenza.com/advancing-newborn-screening-sickle-cell-disease-africa-global-health-implications 2025-01-07T16:02:12.000Z weekly 0.8 https://news.syenza.com/glp-1-thyroid-cancer-risk-study-finds 2025-01-07T13:08:14.000Z weekly 0.8 https://news.syenza.com/abu-dhabi-introduces-winrevair-pulmonary-hypertension-treatment 2025-01-07T12:03:56.000Z weekly 0.8 https://news.syenza.com/thyroid-eye-disease-therapy-thrive-2-trial 2025-01-05T21:52:14.000Z weekly 0.8 https://news.syenza.com/global-health-partnerships-expand-lenacapavir-hiv-prep-access 2024-12-20T09:50:51.000Z weekly 0.8 https://news.syenza.com/africas-hidden-health-crisis-antimicrobial-resistance-africa 2024-12-19T16:00:42.000Z weekly 0.8 https://news.syenza.com/biosapien-cancer-drug-delivery-funding-innovation 2024-12-18T14:38:30.000Z weekly 0.8 https://news.syenza.com/lenacapavir-hiv-prevention-breakthrough-global-efficacy 2024-12-17T16:25:00.000Z weekly 0.8 https://news.syenza.com/personalised-precision-medicine-abu-dhabi-cancer-care-initiative 2024-12-17T13:40:08.000Z weekly 0.8 https://news.syenza.com/reevaluating-nices-cost-effectiveness-thresholds-qaly-debate 2025-06-29T15:16:55.000Z weekly 0.8 https://news.syenza.com/improving-access-to-cystic-fibrosis-medication-in-south-africa 2024-12-16T09:38:51.000Z weekly 0.8 https://news.syenza.com/promising-results-imlunestrant-breast-cancer-therapy 2024-12-16T13:31:39.000Z weekly 0.8 https://news.syenza.com/ai-diabetes-risk-prediction-ecg-tool-predicts-10-years-early 2024-12-13T09:56:23.000Z weekly 0.8 https://news.syenza.com/heplisav-b-superior-hepatitis-b-vaccine-efficacy-hiv 2024-12-13T14:11:04.000Z weekly 0.8 https://news.syenza.com/egypt-hepatitis-c-program-model-africa-health-initiatives 2024-12-12T14:35:57.000Z weekly 0.8 https://news.syenza.com/senegal-rwanda-who-maturity-level-3-regulation 2024-12-11T17:07:36.000Z weekly 0.8 https://news.syenza.com/advancing-95-95-95-hiv-targets-roadmap-end-aids-2030 2024-12-11T14:17:20.000Z weekly 0.8 https://news.syenza.com/cross-border-health-security-in-africa-infectious-diseases 2024-12-10T16:28:12.000Z weekly 0.8 https://news.syenza.com/cms-drug-price-negotiations-bridging-us-pricing-disparities 2024-12-10T09:21:48.000Z weekly 0.8 https://news.syenza.com/anti-obesity-medication-coverage 2024-12-09T14:10:34.000Z weekly 0.8 https://news.syenza.com/enhancing-access-innovative-medicines-who-guidance-advanced-hiv-disease 2024-12-09T09:56:40.000Z weekly 0.8 https://news.syenza.com/zepbound-outperforms-wegovy-in-weight-loss-trial 2024-12-06T14:58:47.000Z weekly 0.8 https://news.syenza.com/dark-chocolate-benefits-type-2-diabetes 2024-12-06T08:37:50.000Z weekly 0.8 https://news.syenza.com/advancements-challenges-hiv-cure-research 2024-12-05T03:55:07.000Z weekly 0.8 https://news.syenza.com/egypt-healthcare-partnership-transforming-healthcare-roche-diagnostics-pharma 2024-12-10T06:41:04.000Z weekly 0.8 https://news.syenza.com/hiv-research-impact-medical-innovation-global-health-advances 2024-12-04T13:24:19.000Z weekly 0.8 https://news.syenza.com/progress-towards-triple-elimination-africa 2024-12-03T12:28:39.000Z weekly 0.8 https://news.syenza.com/african-academy-health-sciences-future-leaders-in-healthcare 2024-12-03T12:29:36.000Z weekly 0.8 https://news.syenza.com/strengthening-eu-healthcare-medtech-europe-health-competitiveness 2024-12-03T09:04:35.000Z weekly 0.8 https://news.syenza.com/canada-drug-agency-launches-methods-guide-consultation 2024-12-02T09:00:08.000Z weekly 0.8 https://news.syenza.com/sanofi-340b-rebate-model-reform-drug-pricing-practices 2024-11-29T14:14:03.000Z weekly 0.8 https://news.syenza.com/who-acts-to-combat-mpox-healthcare-initiatives 2024-11-29T09:11:26.000Z weekly 0.8 https://news.syenza.com/hiv-aids-global-progress 2024-11-28T15:31:22.000Z weekly 0.8 https://news.syenza.com/mena-health-challenges-navigating-dual-burden-diseases 2024-11-28T12:46:41.000Z weekly 0.8 https://news.syenza.com/smartening-african-pharmaceutical-supply-chain-with-ibm-ai 2024-11-27T13:27:59.000Z weekly 0.8 https://news.syenza.com/enhancing-primary-health-care-services-strategies-and-insights 2024-11-27T11:57:33.000Z weekly 0.8 https://news.syenza.com/global-diabetes-trends-and-treatment-gaps-1990-2022-analysis 2024-11-26T08:39:39.000Z weekly 0.8 https://news.syenza.com/transforming-healthcare-key-trends-in-south-africa-healthcare-technology 2024-11-26T15:50:54.000Z weekly 0.8 https://news.syenza.com/battling-antimicrobial-resistance-northwest-syria 2024-11-26T12:05:22.000Z weekly 0.8 https://news.syenza.com/boosting-biopharma-smes-europe 2024-11-26T07:12:46.000Z weekly 0.8 https://news.syenza.com/urgent-call-universal-diabetes-care-europe-political-apathy 2024-11-25T09:39:35.000Z weekly 0.8 https://news.syenza.com/lawsuits-challenge-340b-drug-pricing-program-eli-lilly-johnson-johnson-hrsa 2024-11-21T09:16:08.000Z weekly 0.8 https://news.syenza.com/who-investment-round-2023-securing-funding-transparency-challenges 2024-11-22T08:55:46.000Z weekly 0.8 https://news.syenza.com/hpv-vaccination-south-africa-model-for-cervical-cancer-prevention 2024-11-21T16:09:33.000Z weekly 0.8 https://news.syenza.com/diabetes-diagnosis-retinal-images-dianet-v2-revolutionizing-deep-learning 2024-11-21T12:47:15.000Z weekly 0.8 https://news.syenza.com/joint-efforts-to-combat-mpox-outbreak-response 2024-11-20T14:37:27.000Z weekly 0.8 https://news.syenza.com/rising-diabetes-prevalence-middle-east-north-africa 2024-11-20T09:05:46.000Z weekly 0.8 https://news.syenza.com/diabetes-impact-south-africa-crisis-prevalence-solutions 2024-11-19T17:03:54.000Z weekly 0.8 https://news.syenza.com/gcc-healthcare-concerns-key-challenges-solutions-residents 2024-11-19T10:01:41.000Z weekly 0.8 https://news.syenza.com/enhancing-rare-disease-decision-making-through-data-linkage 2024-11-19T07:31:26.000Z weekly 0.8 https://news.syenza.com/nice-ai-guidelines-transparency-human-oversight 2024-11-18T08:58:22.000Z weekly 0.8 https://news.syenza.com/ai-ready-diabetes-dataset-revolutionizes-research 2024-11-15T19:27:41.000Z weekly 0.8 https://news.syenza.com/global-diabetes-strategies-systems-approach-who-goals 2024-11-18T14:00:23.000Z weekly 0.8 https://news.syenza.com/effective-management-of-diabetes-in-arab-region-insights-and-strategies 2024-11-14T12:22:07.000Z weekly 0.8 https://news.syenza.com/improving-cervical-cancer-screening-hpv-self-collection-tests 2024-11-13T19:12:36.000Z weekly 0.8 https://news.syenza.com/strengthening-amr-surveillance-collaborative-approach-africa 2024-11-14T16:19:34.000Z weekly 0.8 https://news.syenza.com/pharmacy-clinics-healthcare-south-africa-transforming-landscape 2024-11-13T15:39:31.000Z weekly 0.8 https://news.syenza.com/mohap-astrazeneca-enhanced-early-lung-cancer-detection 2024-11-13T12:18:23.000Z weekly 0.8 https://news.syenza.com/transforming-healthcare-africa-launch-africa-healthtech-marketplace 2024-11-12T16:29:24.000Z weekly 0.8 https://news.syenza.com/diabetes-crisis-mena-region-challenges-solutions 2024-11-12T11:59:47.000Z weekly 0.8 https://news.syenza.com/diabetes-crisis-europe-urgent-public-health-economic-challenge 2024-11-11T19:23:07.000Z weekly 0.8 https://news.syenza.com/global-cancer-disparities-addressing-public-health-needs 2024-11-11T18:57:46.000Z weekly 0.8 https://news.syenza.com/g20-health-working-group-prioritizes-resilience-equity-climate-change 2024-11-11T06:46:03.000Z weekly 0.8 https://news.syenza.com/chancellor-announces-50-million-medicines-manufacturing-investment 2024-11-08T09:15:33.000Z weekly 0.8 https://news.syenza.com/building-resilient-health-system-south-africa 2024-11-07T08:59:19.000Z weekly 0.8 https://news.syenza.com/addressing-healthcare-challenges-for-older-adults-turkey 2024-11-07T12:00:57.000Z weekly 0.8 https://news.syenza.com/endometrial-cancer-research-treatments 2024-11-05T13:18:25.000Z weekly 0.8 https://news.syenza.com/drc-launches-r21-malaria-vaccine-combat-child-mortality 2024-11-06T14:01:43.000Z weekly 0.8 https://news.syenza.com/oman-healthcare-development-vision-self-reliance-innovation 2024-11-06T11:55:05.000Z weekly 0.8 https://news.syenza.com/african-ministers-unite-for-health-and-climate-resilience-harare-declaration-climate-health-africa 2024-11-05T13:57:57.000Z weekly 0.8 https://news.syenza.com/burden-of-type-2-diabetes-mellitus-in-saudi-arabia-comprehensive-study 2024-11-05T11:45:30.000Z weekly 0.8 https://news.syenza.com/enhancing-health-economic-evaluations-with-cheers-ai-economic-evaluation 2024-11-05T09:49:46.000Z weekly 0.8 https://news.syenza.com/leveraging-bayh-dole-march-in-rights-to-reduce-drug-prices 2024-11-04T09:13:32.000Z weekly 0.8 https://news.syenza.com/earlier-aortic-stenosis-surgery-recommended-study-insights 2024-11-01T12:18:58.000Z weekly 0.8 https://news.syenza.com/strengthening-cross-border-health-surveillance-in-africa 2024-10-31T13:18:21.000Z weekly 0.8 https://news.syenza.com/strengthening-immunization-eastern-mediterranean-regional-immunization-framework 2024-10-31T11:25:49.000Z weekly 0.8 https://news.syenza.com/africa-cdc-collaboration-paho-join-forces-health-access 2024-10-30T14:03:24.000Z weekly 0.8 https://news.syenza.com/eastern-mediterranean-health-initiatives-healthier-future 2024-10-30T12:03:08.000Z weekly 0.8 https://news.syenza.com/antibiotic-use-sub-saharan-africa-prescription-sources-young-children 2024-10-29T09:56:38.000Z weekly 0.8 https://news.syenza.com/olympus-proximie-partnership-transform-digital-healthcare 2024-10-29T12:16:44.000Z weekly 0.8 https://news.syenza.com/elranatamab_managed_access_agreement 2024-10-29T09:56:01.000Z weekly 0.8 https://news.syenza.com/ozempic-alzheimers-risk-reduction-promise 2024-10-28T18:35:45.000Z weekly 0.8 https://news.syenza.com/hiqa-corporate-plan-2025-2027-strategic-blueprint 2024-10-28T10:19:25.000Z weekly 0.8 https://news.syenza.com/neoadjuvant-chemotherapy-ovarian-cancer-treatment 2024-10-25T17:25:42.000Z weekly 0.8 https://news.syenza.com/rifaximin-antibiotic-resistance-daptomycin-implications 2024-10-25T08:26:28.000Z weekly 0.8 https://news.syenza.com/catalyzing-equitable-ai-healthcare-global-health-initiatives 2024-10-24T13:03:27.000Z weekly 0.8 https://news.syenza.com/advancements-in-cto-pci-technology-for-heart-health 2024-10-24T10:52:27.000Z weekly 0.8 https://news.syenza.com/nice-rejects-donanemab-nhs-rejection-cost-concerns 2024-10-24T06:18:08.000Z weekly 0.8 https://news.syenza.com/advanced-prostate-cancer-treatment-costs-insurance-impact 2024-10-23T18:03:22.000Z weekly 0.8 https://news.syenza.com/dr-congo-launches-mpox-vaccination-campaign-to-tackle-outbreak 2024-10-23T13:06:07.000Z weekly 0.8 https://news.syenza.com/telemedicine-mena-growth-digital-healthcare-revolution 2024-10-23T09:55:09.000Z weekly 0.8 https://news.syenza.com/innovative-pricing-payment-schemes-health-technologies 2024-10-22T15:37:50.000Z weekly 0.8 https://news.syenza.com/enhancing-health-systems-intra-africa-regulatory-reliance 2024-10-22T13:25:52.000Z weekly 0.8 https://news.syenza.com/saudi-healthcare-reform-vision-2030-and-beyond 2024-10-22T09:12:55.000Z weekly 0.8 https://news.syenza.com/transforming-value-based-oncology-care-multifaceted-approach 2024-10-21T13:39:46.000Z weekly 0.8 https://news.syenza.com/draft-european-medicines-strategy-2028-accessibility-innovation 2024-10-21T13:25:03.000Z weekly 0.8 https://news.syenza.com/bupa-genome-sequencing-pilot-uk-customers 2024-10-19T08:51:04.000Z weekly 0.8 https://news.syenza.com/harmoni-2-nsclc-trial-results-transform-treatment-approaches 2024-10-18T16:37:07.000Z weekly 0.8 https://news.syenza.com/keytruda-head-neck-cancer-phase-3-trial-promising-results 2024-10-18T08:05:34.000Z weekly 0.8 https://news.syenza.com/hearing-loss-africa-2030-urgent-measures-needed 2024-10-17T09:30:38.000Z weekly 0.8 https://news.syenza.com/august-2024-analysis-turkiye-ilac-ticareti 2024-10-17T09:09:13.000Z weekly 0.8 https://news.syenza.com/ethical-healthcare-collaboration-decade-innovations 2024-10-17T07:24:16.000Z weekly 0.8 https://news.syenza.com/unaids-urges-greater-access-affordability-lenacapavir 2024-10-16T15:17:58.000Z weekly 0.8 https://news.syenza.com/hiv-aids-update-2024 2024-10-16T16:48:13.000Z weekly 0.8 https://news.syenza.com/early-intervention-tackling-obesity-from-conception 2024-10-16T10:54:36.000Z weekly 0.8 https://news.syenza.com/fda-approves-inavolisib-breast-cancer-treatment 2024-10-15T07:10:18.000Z weekly 0.8 https://news.syenza.com/eye-health-advancements-ongoing-challenges-africa 2024-10-15T14:11:38.000Z weekly 0.8 https://news.syenza.com/transforming-middle-eastern-healthcare-through-digital-healthcare-innovation 2024-10-15T10:57:59.000Z weekly 0.8 https://news.syenza.com/rising-drug-prices-europe-soaring-health-systems-industry 2024-10-15T05:56:16.000Z weekly 0.8 https://news.syenza.com/ema-competing-interests-policy-revision-scientific-committee 2024-10-14T15:00:33.000Z weekly 0.8 https://news.syenza.com/mental-health-care-for-youth 2024-10-14T01:25:46.000Z weekly 0.8 https://news.syenza.com/gileads-initiative-expand-lenacapavir-access-strategy 2024-10-13T12:18:08.000Z weekly 0.8 https://news.syenza.com/iraq-roche-partnership-renewal-enhance-healthcare-services 2024-10-13T12:45:18.000Z weekly 0.8 https://news.syenza.com/strategies-to-reduce-health-insurance-premiums 2024-10-12T13:17:12.000Z weekly 0.8 https://news.syenza.com/fda-approves-opdivo-lung-cancer-approval 2024-10-10T20:17:33.000Z weekly 0.8 https://news.syenza.com/mental-healthcare-for-youth 2024-10-10T15:38:53.000Z weekly 0.8 https://news.syenza.com/nice-evaluates-elacestrant-breast-cancer-therapy 2024-10-10T14:33:27.000Z weekly 0.8 https://news.syenza.com/depression-and-life-satisfaction-in-pregnant-women 2024-10-10T12:32:13.000Z weekly 0.8 https://news.syenza.com/early-adoption-of-ai 2024-10-08T19:10:41.000Z weekly 0.8 https://news.syenza.com/internet-use-and-adolescent-mental-health-the-role-of-parental-support 2024-10-09T12:05:48.000Z weekly 0.8 https://news.syenza.com/boosting-hpv-cervical-cancer-awareness-insights-screening-self-testing 2024-10-09T09:52:23.000Z weekly 0.8 https://news.syenza.com/regulatory-collaboration-in-healthcare 2024-10-08T00:32:46.000Z weekly 0.8 https://news.syenza.com/enhancing-child-mental-health-services-with-digital-interventions 2024-10-08T11:57:50.000Z weekly 0.8 https://news.syenza.com/strategic-phased-launch-tirzepatide-obesity-treatment-england 2024-10-08T04:51:22.000Z weekly 0.8 https://news.syenza.com/mental-health-trends-among-us-youths 2024-10-04T18:27:54.000Z weekly 0.8 https://news.syenza.com/trump-drug-policy-changes-prescription-drug-price-policy 2024-10-06T17:08:54.000Z weekly 0.8 https://news.syenza.com/who-introduces-single-dose-hpv-vaccine-to-boost-cervical-cancer-elimination 2024-10-06T16:27:29.000Z weekly 0.8 https://news.syenza.com/ai-driven-drug-safety 2024-10-02T20:01:13.000Z weekly 0.8 https://news.syenza.com/the-role-of-school-based-health-centres-in-advancing-health-equity 2024-10-03T11:58:49.000Z weekly 0.8 https://news.syenza.com/enhancing-care-in-abu-dhabi-the-new-aba-guidelines-for-autism 2024-10-01T22:03:45.000Z weekly 0.8 https://news.syenza.com/enhancing-mental-health-planning-with-system-dynamics-modelling-in-australia 2025-07-10T15:56:34.000Z weekly 0.8 https://news.syenza.com/youth-mental-health 2024-09-30T23:54:45.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-of-integrated-care-for-children-with-chronic-conditions 2024-10-01T12:04:06.000Z weekly 0.8 https://news.syenza.com/alzheimers-drug-kisunla 2024-09-30T12:10:56.000Z weekly 0.8 https://news.syenza.com/dementia-prevention-in-latin-america 2024-09-26T13:55:13.000Z weekly 0.8 https://news.syenza.com/the-impact-of-atrial-fibrillation-on-quality-of-life-and-healthcare-costs 2024-09-26T11:57:22.000Z weekly 0.8 https://news.syenza.com/hip-fracture-risk-prediction 2024-09-25T15:00:22.000Z weekly 0.8 https://news.syenza.com/healthy-ageing-through-occupational-therapy-for-frail-older-adults 2024-09-25T11:47:59.000Z weekly 0.8 https://news.syenza.com/sedentary-behaviour-on-healthy-ageing 2024-09-23T21:50:26.000Z weekly 0.8 https://news.syenza.com/falls-prevention-in-australia-a-systemic-approach 2024-09-24T11:57:09.000Z weekly 0.8 https://news.syenza.com/fall-tips-program 2024-09-20T21:51:09.000Z weekly 0.8 https://news.syenza.com/biosimilars-in-multiple-sclerosis 2024-09-16T18:11:13.000Z weekly 0.8 https://news.syenza.com/enhancing-health-outcomes-with-geriatric-specific-cancer-rehabilitation 2024-09-19T11:57:47.000Z weekly 0.8 https://news.syenza.com/alzheimers-treatments 2024-09-16T15:13:44.000Z weekly 0.8 https://news.syenza.com/preventing-falls-among-older-adults-a-vital-healthcare-imperative 2024-09-18T04:43:12.000Z weekly 0.8 https://news.syenza.com/hevolution-foundation-ageing-research 2024-09-15T16:22:37.000Z weekly 0.8 https://news.syenza.com/the-economic-impact-of-vision-loss-in-spain 2024-09-17T11:57:51.000Z weekly 0.8 https://news.syenza.com/ethical-ai-adoption-in-elderly-care 2024-09-12T15:16:16.000Z weekly 0.8 https://news.syenza.com/pharmacogenetic-screening 2024-09-12T16:09:49.000Z weekly 0.8 https://news.syenza.com/healthy-ageing-index-and-assessment-of-age-related-outcomes 2024-09-12T11:59:36.000Z weekly 0.8 https://news.syenza.com/thailands-healthcare-system 2024-09-10T23:18:20.000Z weekly 0.8 https://news.syenza.com/healthcare-system-responses-to-ageing-populations 2024-09-11T11:57:07.000Z weekly 0.8 https://news.syenza.com/nice-recommends-abaloparatide-for-osteoporosis 2024-09-09T20:44:48.000Z weekly 0.8 https://news.syenza.com/the-impact-of-immunosenescence-on-ageing 2024-09-10T12:10:35.000Z weekly 0.8 https://news.syenza.com/financial-protection-in-healthcare 2024-09-09T11:58:39.000Z weekly 0.8 https://news.syenza.com/elderly-technology-acceptance 2024-09-06T00:51:15.000Z weekly 0.8 https://news.syenza.com/sub-saharan-africas-aging-population 2024-09-04T15:58:47.000Z weekly 0.8 https://news.syenza.com/understanding-modifiable-risk-factors-for-dementia-insights-from-a-15-year-study 2024-09-05T11:57:54.000Z weekly 0.8 https://news.syenza.com/elderly-healthcare-innovations 2024-09-04T16:06:47.000Z weekly 0.8 https://news.syenza.com/unlocking-the-economic-potential-of-healthy-ageing 2024-09-04T11:55:48.000Z weekly 0.8 https://news.syenza.com/caring-for-an-ageing-us-population 2024-09-03T14:46:15.000Z weekly 0.8 https://news.syenza.com/impact-of-social-support-on-quality-of-life-among-the-elderly 2024-09-03T11:58:30.000Z weekly 0.8 https://news.syenza.com/medical-ethics-in-the-uae 2024-08-28T21:52:32.000Z weekly 0.8 https://news.syenza.com/remote-health-assessments-with-multimodal-technologies 2024-08-29T11:56:17.000Z weekly 0.8 https://news.syenza.com/community-pharmacies-and-hiv-testing 2024-08-27T22:05:13.000Z weekly 0.8 https://news.syenza.com/real-world-walking-behaviours-and-early-stage-heart-failure 2024-08-28T12:00:47.000Z weekly 0.8 https://news.syenza.com/pro-symptom-monitoring 2024-08-27T12:58:39.000Z weekly 0.8 https://news.syenza.com/autism-screening-with-advanced-technology-insights-from-the-start-app 2024-08-27T13:03:12.000Z weekly 0.8 https://news.syenza.com/early-intensive-behavioural-intervention-eibi-for-autism 2024-08-27T05:34:31.000Z weekly 0.8 https://news.syenza.com/remote-patient-monitoring-in-oncology 2024-08-22T16:06:19.000Z weekly 0.8 https://news.syenza.com/enhancing-osteoarthritis-management-through-health-economics 2024-08-21T17:37:17.000Z weekly 0.8 https://news.syenza.com/ai-act-healthcare-impact 2024-08-20T22:24:52.000Z weekly 0.8 https://news.syenza.com/a-value-framework-for-next-generation-sequencing-in-europe-access-to-precision-medicine 2024-08-21T08:15:05.000Z weekly 0.8 https://news.syenza.com/expanding-value-metrics-in-healthcare 2024-08-20T00:49:45.000Z weekly 0.8 https://news.syenza.com/the-economic-impact-of-obesity-in-turkiye-a-micro-costing-analysis 2024-08-20T12:03:17.000Z weekly 0.8 https://news.syenza.com/physician-hospital-integration 2024-08-16T15:58:39.000Z weekly 0.8 https://news.syenza.com/evaluating-ai-systems-for-diabetic-retinopathy-screening 2024-08-14T23:15:11.000Z weekly 0.8 https://news.syenza.com/abre-study-optimising-treatment-for-iliofemoral-venous-obstruction 2024-08-15T12:01:48.000Z weekly 0.8 https://news.syenza.com/value-attribution-in-combination-therapies 2024-08-13T23:46:18.000Z weekly 0.8 https://news.syenza.com/psoriasis-treatment-and-healthcare-resource-utilisation 2024-08-14T11:56:11.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-of-bowelscreen-extension 2024-08-12T20:11:31.000Z weekly 0.8 https://news.syenza.com/gaps-in-psoriasis-care-a-global-perspective 2024-08-13T11:55:53.000Z weekly 0.8 https://news.syenza.com/disparities-in-hpv-vaccination 2024-08-09T21:23:28.000Z weekly 0.8 https://news.syenza.com/hpv-vaccination-coverage-in-japan 2024-08-07T17:14:08.000Z weekly 0.8 https://news.syenza.com/the-urgent-need-for-measles-and-rubella-eradication 2024-08-08T11:55:17.000Z weekly 0.8 https://news.syenza.com/immunisation-programmes-in-spain 2024-08-06T18:23:11.000Z weekly 0.8 https://news.syenza.com/global-disparities-in-pneumonia-vaccine-access 2024-08-07T12:18:42.000Z weekly 0.8 https://news.syenza.com/new-anti-obesity-medications 2024-08-05T13:35:35.000Z weekly 0.8 https://news.syenza.com/impact-of-air-pollution-on-birth-outcomes-evidence-from-northern-ireland 2024-08-06T12:03:34.000Z weekly 0.8 https://news.syenza.com/target-product-profiles-in-health-technology 2024-08-02T19:16:42.000Z weekly 0.8 https://news.syenza.com/enhancing-copd-management-insights-from-recent-meta-analysis-on-utility-values 2024-08-01T22:44:03.000Z weekly 0.8 https://news.syenza.com/adolescent-scoliosis-in-gansu-province-a-comprehensive-study 2024-08-01T10:05:14.000Z weekly 0.8 https://news.syenza.com/socioeconomic-status-lung-cancer-screening 2024-07-31T14:31:59.000Z weekly 0.8 https://news.syenza.com/understanding-the-cost-and-funding-of-gene-therapies 2024-07-31T12:46:57.000Z weekly 0.8 https://news.syenza.com/paediatric-biobanks 2024-07-29T23:49:31.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-of-immune-checkpoint-inhibitors-in-advanced-endometrial-cancer 2024-07-28T16:33:11.000Z weekly 0.8 https://news.syenza.com/revealing-the-hidden-impact-family-spillover-effects 2024-07-29T12:08:01.000Z weekly 0.8 https://news.syenza.com/from-skepticism-to-support-healthcare-providers-acceptance-of-digital-interventions-in-substance-used-disorders-treatment-in-kenya 2024-07-26T17:02:29.000Z weekly 0.8 https://news.syenza.com/modernising-ai-medical-devices-regulation-fdas-firm-based-approach 2024-07-25T23:09:23.000Z weekly 0.8 https://news.syenza.com/abu-dhabi-strategic-healthcare-partnerships-global-collaborations 2024-07-24T21:43:22.000Z weekly 0.8 https://news.syenza.com/genome-wide-sequencing-in-rare-diseases 2024-07-24T17:16:26.000Z weekly 0.8 https://news.syenza.com/antenatal-hcv-screening-in-egypt-paving-the-path-to-elimination 2024-07-24T12:00:47.000Z weekly 0.8 https://news.syenza.com/respiratory-syncytial-virus 2024-07-24T14:38:42.000Z weekly 0.8 https://news.syenza.com/the-economic-burden-of-liver-transplantation-for-hepatitis-b-in-italy 2024-07-23T07:45:16.000Z weekly 0.8 https://news.syenza.com/impact-of-brain-cancer-care-coordinators-on-healthcare-utilisation 2024-07-20T21:12:05.000Z weekly 0.8 https://news.syenza.com/rare-diseases-modern-strategies-for-enhanced-primary-care 2024-07-22T12:27:11.000Z weekly 0.8 https://news.syenza.com/juvenile-idiopathic-arthritis-uk 2024-07-19T17:08:16.000Z weekly 0.8 https://news.syenza.com/access-to-essential-medicines-for-rheumatic-diseases-in-children 2024-07-19T02:23:04.000Z weekly 0.8 https://news.syenza.com/paediatric-rheumatology-care-in-africa-hope-and-resilience 2024-07-19T01:59:16.000Z weekly 0.8 https://news.syenza.com/economic-burden-of-juvenile-idiopathic-arthritis-in-spain 2024-07-17T07:43:23.000Z weekly 0.8 https://news.syenza.com/juvenile-arthritis-meeting-the-benchmark-with-health-technology 2024-07-17T12:00:47.000Z weekly 0.8 https://news.syenza.com/juvenile-arthritis-jia 2024-09-13T22:35:04.000Z weekly 0.8 https://news.syenza.com/enhancing-early-diagnosis-and-care-for-juvenile-idiopathic-arthritis 2024-07-15T21:50:52.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-of-skin-cancer-prevention-strategies 2024-07-16T10:49:37.000Z weekly 0.8 https://news.syenza.com/cracking-the-code-making-ai-in-healthcare-reliable-and-fair 2024-07-15T12:22:44.000Z weekly 0.8 https://news.syenza.com/forecasting-innovations-in-cutaneous-malignant-melanoma-treatment-in-sweden 2025-07-10T15:59:05.000Z weekly 0.8 https://news.syenza.com/enhancing-skin-cancer-prevention-in-a-primary-care-setting 2024-07-12T01:49:04.000Z weekly 0.8 https://news.syenza.com/addressing-valvular-heart-disease-in-saudi-arabia 2024-07-11T02:19:16.000Z weekly 0.8 https://news.syenza.com/social-media-in-skin-cancer-awareness-and-prevention 2024-07-10T17:58:34.000Z weekly 0.8 https://news.syenza.com/digital-interventions-for-skin-cancer-prevention 2024-07-10T12:14:19.000Z weekly 0.8 https://news.syenza.com/abrocitinib-cost-effectiveness-atopic-dermatitis-japan 2024-07-16T06:43:40.000Z weekly 0.8 https://news.syenza.com/optimising-skin-cancer-prevention-cost-effective-strategies-for-outdoor-workers 2024-07-09T12:01:12.000Z weekly 0.8 https://news.syenza.com/transferability-of-ai-methods-for-diabetes-modelling-in-health-technology-assessment 2024-07-08T13:44:01.000Z weekly 0.8 https://news.syenza.com/transforming-healthcare-with-artificial-intelligence-global-insights 2024-07-08T12:03:50.000Z weekly 0.8 https://news.syenza.com/statistical-pitfalls 2024-07-05T17:14:15.000Z weekly 0.8 https://news.syenza.com/innovative-funding-models-for-non-communicable-diseases 2024-07-04T19:57:18.000Z weekly 0.8 https://news.syenza.com/the-evolution-of-consent-in-biomedical-ai-ensuring-privacy-and-equity 2024-07-04T11:46:10.000Z weekly 0.8 https://news.syenza.com/transformation-of-health-technology-assessment-in-turkiye 2024-07-02T18:02:52.000Z weekly 0.8 https://news.syenza.com/fremanezumab-cost-effective-relief-for-chronic-migraine 2024-07-03T13:22:08.000Z weekly 0.8 https://news.syenza.com/mental-health-asia 2024-07-02T18:17:26.000Z weekly 0.8 https://news.syenza.com/pharmacoeconomic-comparison-of-anaprazole-and-ilaprazole-for-duodenal-ulcer-treatment-in-china 2024-07-02T11:35:11.000Z weekly 0.8 https://news.syenza.com/the-role-of-real-world-evidence-in-cms-price-negotiations 2024-06-28T16:57:32.000Z weekly 0.8 https://news.syenza.com/enhancing-global-health-through-cost-effectiveness-analysis 2024-06-28T12:00:52.000Z weekly 0.8 https://news.syenza.com/significant-bias-nutrition-research 2024-06-27T17:59:02.000Z weekly 0.8 https://news.syenza.com/clinical-trial-screening-with-gpt-4-the-rectifier-framework 2024-06-26T23:40:48.000Z weekly 0.8 https://news.syenza.com/the-role-of-pull-incentives-in-addressing-antimicrobial-resistance 2024-06-26T13:05:46.000Z weekly 0.8 https://news.syenza.com/a-new-approach-to-cardiovascular-risk-assessment-for-statin-therapy 2024-06-25T18:26:42.000Z weekly 0.8 https://news.syenza.com/cost-saving-life-saver-the-impact-of-palivizumab-on-preventing-rsv-hospitalisations-in-colombian-infants 2024-06-27T14:30:35.000Z weekly 0.8 https://news.syenza.com/tuberculosis-care-in-indonesia 2024-06-27T14:32:20.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-of-idegasp-in-diabetes-management-insights-from-arise-study 2024-06-24T14:16:53.000Z weekly 0.8 https://news.syenza.com/understanding-the-cost-and-clinical-impact-of-multisystem-inflammatory-syndrome-in-children-mis-c 2024-06-21T17:34:15.000Z weekly 0.8 https://news.syenza.com/striking-the-balance-optimising-hepatitis-b-treatment-strategies 2024-06-21T12:16:28.000Z weekly 0.8 https://news.syenza.com/cost-effectiveness-multiple-sclerosis 2024-06-27T14:30:53.000Z weekly 0.8 https://news.syenza.com/enhancing-surgical-recovery-predictions-with-ai-a-new-approach 2024-06-20T12:36:15.000Z weekly 0.8 https://news.syenza.com/the-economic-benefits-of-preventive-health-programs 2024-06-20T10:40:32.000Z weekly 0.8 https://news.syenza.com/the-shift-to-value-based-drug-pricing-in-the-united-states 2024-06-19T03:16:32.000Z weekly 0.8 https://news.syenza.com/cost-savings-on-generic-drugs-transparent-pricing-models 2024-06-18T18:26:39.000Z weekly 0.8 https://news.syenza.com/brucellosis-control-in-armenia-a-holistic-approach 2024-06-18T14:17:45.000Z weekly 0.8 https://news.syenza.com/grace-patient-centric-care 2024-06-17T18:14:08.000Z weekly 0.8 https://news.syenza.com/universal-early-parenting-programmes-cost-effectiveness 2024-06-14T18:32:34.000Z weekly 0.8 https://news.syenza.com/the-economic-burden-of-knee-arthroplasty-revisions-a-cost-analysis-from-turkiye 2024-06-14T17:29:34.000Z weekly 0.8 https://news.syenza.com/health-state-valuation 2024-06-13T21:36:12.000Z weekly 0.8 https://news.syenza.com/enhancing-clinician-accuracy-in-eeg-pattern-classification-with-ai 2024-06-12T15:51:17.000Z weekly 0.8 https://news.syenza.com/advancing-pneumococcal-disease-prevention-in-japan-with-pcv20 2024-06-12T11:45:13.000Z weekly 0.8 https://news.syenza.com/europe-medtech-sector-opportunities-and-challenges 2024-06-11T15:40:24.000Z weekly 0.8 https://news.syenza.com/the-impact-of-time-horizons-on-qaly-calculations-in-healthcare 2024-06-10T18:20:31.000Z weekly 0.8 https://news.syenza.com/mcdm-diabetes-management 2024-06-10T12:59:06.000Z weekly 0.8 https://news.syenza.com/unveiling-the-future-of-personalised-sleep-medicine 2024-06-07T20:38:37.000Z weekly 0.8 https://news.syenza.com/nurturing-trust-in-healthcare-embracing-generative-ai 2024-06-09T01:57:21.000Z weekly 0.8 https://news.syenza.com/real-world-evidence-abaloparatide-approval-osteoporosis 2024-06-06T13:12:33.000Z weekly 0.8 https://news.syenza.com/health-technology-assessment-in-essential-health-benefit-package-design 2024-06-05T18:53:09.000Z weekly 0.8 https://news.syenza.com/healthcare-decision-making-with-mcda-framework-the-saudi-arabian-perspective 2024-06-05T11:16:45.000Z weekly 0.8 https://news.syenza.com/prevention-is-better-than-cure-the-costs-of-the-pandemic-accord 2024-06-04T23:25:58.000Z weekly 0.8 https://news.syenza.com/health-technology-assessment-in-south-africa 2024-06-04T16:36:18.000Z weekly 0.8 https://news.syenza.com/economic-evaluations-for-dementia-interventions 2024-06-03T17:59:12.000Z weekly 0.8 https://news.syenza.com/pm-competency-framework-for-the-mtp-industry 2024-06-02T22:21:32.000Z weekly 0.8 https://news.syenza.com/cancer-survivors 2024-06-02T18:56:19.000Z weekly 0.8 https://news.syenza.com/the-potential-of-the-pandemic-accord 2024-06-01T18:29:27.000Z weekly 0.8 https://news.syenza.com/equity-in-mced 2024-05-30T14:47:35.000Z weekly 0.8 https://news.syenza.com/the-future-of-peer-review-in-scientific-manuscripts-embracing-artificial-intelligence 2024-05-28T18:12:17.000Z weekly 0.8 https://news.syenza.com/optimizing-primary-healthcare-systems-in-low-and-middle-income-countries 2024-05-28T12:22:53.000Z weekly 0.8 https://news.syenza.com/european-epidemic-intelligence-challenges-in-data-reporting 2024-05-27T19:40:37.000Z weekly 0.8 https://news.syenza.com/quality-adjusted-life-year-qaly-in-modern-healthcare-decision-making 2024-05-26T17:49:51.000Z weekly 0.8 https://news.syenza.com/patient-empowerment-in-their-pockets-chatbots-in-healthcare 2024-05-24T19:49:46.000Z weekly 0.8 https://news.syenza.com/patient-safety-culture-african-healthcare 2024-05-24T18:55:49.000Z weekly 0.8 https://news.syenza.com/namibia-mother-to-child-transmission-elimination-of-hiv-hep-b 2024-05-23T21:07:50.000Z weekly 0.8 https://news.syenza.com/ai-ml-fairness-healthcare 2024-05-22T21:40:24.000Z weekly 0.8 https://news.syenza.com/if-paper-cuts-could-kill-the-world-health-organization-launches-its-antimicrobial-resistance-campaign 2024-05-21T15:21:43.000Z weekly 0.8 https://news.syenza.com/self-management-of-vaginal-pessaries-a-viable-alternative-for-pelvic-organ-prolapse 2024-05-21T13:35:26.000Z weekly 0.8 https://news.syenza.com/the-cell-and-gene-therapies-healthcare-transformation 2024-05-21T06:52:35.000Z weekly 0.8 https://news.syenza.com/treatment-effect-estimation-with-ai-the-cure-framework 2024-05-20T22:34:34.000Z weekly 0.8 https://news.syenza.com/use-of-ai-in-genetic-diagnosis-identifying-rare-diseases 2024-05-17T15:52:26.000Z weekly 0.8 https://news.syenza.com/strategies-for-fair-drug-pricing-balancing-pharmacy-viability-and-cost-containment 2024-05-16T13:41:52.000Z weekly 0.8 https://news.syenza.com/transforming-healthcare-south-africas-nhi-law-signed 2024-05-15T15:14:56.000Z weekly 0.8 https://news.syenza.com/south-africas-medical-technology-master-plan-launched 2024-05-13T16:48:28.000Z weekly 0.8 https://news.syenza.com/the-shifting-nature-and-impact-of-health-technology-assessment 2024-05-13T14:47:06.000Z weekly 0.8 https://news.syenza.com/drug-discovery-with-ai-a-glimpse-into-the-future-of-pharmaceuticals 2024-05-13T02:00:34.000Z weekly 0.8 https://news.syenza.com/pay-for-performance-in-brazilian-healthcare-success-and-impact 2024-05-14T18:38:44.000Z weekly 0.8 https://news.syenza.com/advancing-cardiac-care-ai-in-aortic-stenosis-management 2024-05-10T17:01:35.000Z weekly 0.8 https://news.syenza.com/sustainable-pricing-in-diabetes-cost-effective-medication-access 2024-05-09T14:34:22.000Z weekly 0.8 https://news.syenza.com/medical-diagnostics-the-meeting-point-of-ai-and-policies 2024-05-08T13:39:34.000Z weekly 0.8 https://news.syenza.com/biosimilar-competition-and-patient-out-of-pocket-costs 2024-05-06T22:44:29.000Z weekly 0.8 https://news.syenza.com/managing-access-to-medicines-in-the-future-innovations-and-strategies 2024-05-06T15:59:24.000Z weekly 0.8 https://news.syenza.com/medical-ai-future-sustainable-reimbursement-strategies 2024-05-06T00:11:55.000Z weekly 0.8 https://news.syenza.com/fast-track-city-program-impact-accelerating-the-end-of-aids 2024-05-05T18:01:45.000Z weekly 0.8 https://news.syenza.com/cancer-care-and-the-importance-of-ai-in-furthering-oncology 2024-05-02T11:39:51.000Z weekly 0.8 https://news.syenza.com/community-facility-linkage-interventions-enhancing-child-health-outcomes 2024-05-01T12:07:16.000Z weekly 0.8 https://news.syenza.com/insights-into-austrias-pricing-and-pharmaceutical-policy 2024-04-30T17:09:52.000Z weekly 0.8 https://news.syenza.com/the-relevance-of-ai-in-mastering-polypharmacy-management 2024-04-29T18:35:56.000Z weekly 0.8 https://news.syenza.com/life-sciences-summit-finalists-set-to-transform-healthcare 2024-04-29T11:27:40.000Z weekly 0.8 https://news.syenza.com/managed-access-of-dostarlimab-for-endometrial-cancer 2024-04-29T01:58:44.000Z weekly 0.8 https://news.syenza.com/patient-public-engagement-transforming-ghanas-health-system 2024-04-28T16:59:59.000Z weekly 0.8 https://news.syenza.com/enhancing-efficiency-of-literature-review-in-healthcare-research-via-gpt-4 2024-04-26T06:41:34.000Z weekly 0.8 https://news.syenza.com/advancing-healthcare-the-role-of-real-world-evidence-in-decision-making 2024-04-25T07:08:36.000Z weekly 0.8 https://news.syenza.com/an-update-on-the-economic-impact-of-adult-immunisation 2024-04-24T08:20:13.000Z weekly 0.8 https://news.syenza.com/copd-management-evidence-report-on-ensifentrine 2024-04-23T07:46:53.000Z weekly 0.8 https://news.syenza.com/the-african-medicine-agencys-role-in-advancing-healthcare 2024-04-22T07:16:37.000Z weekly 0.8 https://news.syenza.com/economics-in-clinical-trials-a-guide-to-value-based-decisions 2024-04-21T09:07:19.000Z weekly 0.8 https://news.syenza.com/the-influence-of-ai-on-risk-adjustment-models-in-healthcare 2024-04-20T09:26:38.000Z weekly 0.8 https://news.syenza.com/ais-transformative-role-in-healthcare-code-of-conduct 2024-04-18T18:50:58.000Z weekly 0.8 https://news.syenza.com/a-cost-effectiveness-analysis-of-emicizumab-treatment-in-non-severe-haemophilia-a-patients 2024-04-17T14:10:59.000Z weekly 0.8 https://news.syenza.com/innovative-technology-policy-simulation-modelling-in-healthcare 2024-04-16T15:40:18.000Z weekly 0.8 https://news.syenza.com/policy-of-innovative-health-technology-biobanks-in-abu-dhabi 2024-04-15T15:11:30.000Z weekly 0.8 https://news.syenza.com/vaccination-strategies-impact-indias-maximising-immunisation-impact 2024-04-14T08:17:11.000Z weekly 0.8 https://news.syenza.com/digital-health-the-impact-of-standardising-dhi-terminology 2024-04-13T15:37:19.000Z weekly 0.8 https://news.syenza.com/evaluating-the-impact-of-molnupiravir-in-covid-19-treatment 2024-04-12T14:33:10.000Z weekly 0.8 https://news.syenza.com/the-clinical-and-economic-impact-of-universal-cmv-screening-in-newborns 2024-04-11T20:50:38.000Z weekly 0.8 https://news.syenza.com/ai-in-healthcare-value-creation-and-competitive-advantage 2024-04-10T06:34:19.000Z weekly 0.8 https://news.syenza.com/strategic-cost-implications-of-medical-countermeasure-stockpiling 2024-04-09T14:09:37.000Z weekly 0.8 https://news.syenza.com/evaluating-the-cost-effectiveness-of-adebrelimab-in-es-sclc 2024-04-08T08:50:35.000Z weekly 0.8 https://news.syenza.com/innovations-in-surgery-clinical-and-economic-implications 2024-04-05T06:19:39.000Z weekly 0.8 https://news.syenza.com/the-cost-effectiveness-of-gaitsmart-rehabilitation-programme 2024-04-04T16:10:08.000Z weekly 0.8 https://news.syenza.com/ai-enhanced-speech-restoration-for-aphasia-patients 2024-04-04T07:57:56.000Z weekly 0.8 https://news.syenza.com/clinical-trials-in-saudi-arabia-an-insight-from-pdc-cro 2024-04-03T18:31:38.000Z weekly 0.8 https://news.syenza.com/economic-impact-of-diabetes-and-high-deductible-health-plans 2024-04-02T17:39:23.000Z weekly 0.8 https://news.syenza.com/forecasting-multidimensional-poverty-south-africas-policy-design 2024-04-01T15:01:08.000Z weekly 0.8 https://news.syenza.com/fda-cleared-devices-the-future-of-ai-in-medical-imaging 2024-03-30T18:42:22.000Z weekly 0.8 https://news.syenza.com/the-cost-of-mental-health-care-a-cost-sharing-law 2024-03-30T16:26:16.000Z weekly 0.8 https://news.syenza.com/cost-of-hpv-vaccination-a-global-economic-perspective 2024-03-28T15:17:53.000Z weekly 0.8 https://news.syenza.com/unlocking-the-potential-of-digital-twins-in-healthcare 2024-03-28T07:22:23.000Z weekly 0.8 https://news.syenza.com/opportunities-and-challenges-in-global-innovation-policies 2024-03-27T14:53:08.000Z weekly 0.8 https://news.syenza.com/cost-effective-treatment-a-closer-look-at-sglt2-inhibitors 2024-03-26T17:48:24.000Z weekly 0.8 https://news.syenza.com/machine-learning-to-improve-diagnosis-of-long-qt-syndrome 2024-03-25T19:28:05.000Z weekly 0.8 https://news.syenza.com/cost-saving-implications-of-correct-antibiotic-use 2024-03-25T06:11:57.000Z weekly 0.8 https://news.syenza.com/preventing-cardiovascular-disease-the-financial-implications 2024-03-24T08:24:27.000Z weekly 0.8 https://news.syenza.com/anifrolumab-in-systemic-lupus-erythematosus-management 2024-03-22T07:21:52.000Z weekly 0.8 https://news.syenza.com/artificial-intelligence-in-predicting-cardiac-amyloidosis-in-tavr 2024-03-21T09:36:21.000Z weekly 0.8 https://news.syenza.com/the-economic-burden-of-end-stage-renal-disease-in-sudan 2024-03-20T09:48:36.000Z weekly 0.8 https://news.syenza.com/the-crucial-role-of-pharmacogenetic-testing-in-thiopurine-therapy 2024-03-19T09:06:42.000Z weekly 0.8 https://news.syenza.com/colonoscopy-screening-for-ulcerative-colitis-cost-effectiveness 2024-03-18T10:22:15.000Z weekly 0.8 https://news.syenza.com/precision-medicine-a-new-paradigm-in-healthcare 2024-03-17T16:55:17.000Z weekly 0.8 https://news.syenza.com/the-black-box-phenomenon-in-artificial-intelligence 2024-03-17T13:54:44.000Z weekly 0.8 https://news.syenza.com/willingness-to-pay-for-innovative-oncology-treatments 2024-03-16T16:18:10.000Z weekly 0.8 https://news.syenza.com/managing-fatigue-in-inflammatory-rheumatic-diseases 2024-03-15T17:41:28.000Z weekly 0.8 https://news.syenza.com/economic-impact-on-kidney-disease-progression-and-outcomes 2024-03-14T10:56:36.000Z weekly 0.8 https://news.syenza.com/leveraging-ai-for-pathology-reports-in-cancer-research 2024-03-14T06:54:50.000Z weekly 0.8 https://news.syenza.com/the-evolution-of-ai-in-clinical-settings-chatgpt-training 2024-03-12T17:16:56.000Z weekly 0.8 https://news.syenza.com/impact-of-socioeconomic-status-on-cancer-survival-rates 2024-03-11T16:19:18.000Z weekly 0.8 https://news.syenza.com/the-cost-effectiveness-of-celiac-disease-screening-an-analysis 2024-03-11T15:20:30.000Z weekly 0.8 https://news.syenza.com/using-ai-in-cardiovascular-disease-diagnosis 2024-03-08T21:00:04.000Z weekly 0.8 https://news.syenza.com/navigating-budgetary-challenges-in-south-africas-hiv-response 2024-03-08T07:24:39.000Z weekly 0.8 https://news.syenza.com/evaluating-ai-in-healthcare-implementing-approaches 2024-03-07T17:10:44.000Z weekly 0.8 https://news.syenza.com/the-socioeconomic-impact-of-cervical-cancer-in-the-uk 2024-03-06T20:24:31.000Z weekly 0.8 https://news.syenza.com/assisted-reproductive-technology-through-artificial-intelligence 2024-03-06T14:59:10.000Z weekly 0.8 https://news.syenza.com/risk-prediction-in-healthcare-and-cost-effectiveness-analysis 2024-03-05T07:20:40.000Z weekly 0.8 https://news.syenza.com/advancing-obesity-treatment-with-endoscopic-sleeve-gastroplasty 2024-03-07T14:19:36.000Z weekly 0.8 https://news.syenza.com/high-court-on-south-african-national-health-insurance-bill 2024-03-01T06:17:11.000Z weekly 0.8 https://news.syenza.com/a-global-perspective-on-orphan-medicines-and-rare-diseases 2024-02-29T13:21:46.000Z weekly 0.8 https://news.syenza.com/the-impact-of-universal-health-coverage-on-poverty-reduction-in-low-and-middle-income-countries 2024-02-28T16:09:24.000Z weekly 0.8 https://news.syenza.com/swarm-learning-in-clinical-ai-an-application-in-immunology 2024-02-27T18:47:44.000Z weekly 0.8 https://news.syenza.com/public-health-transformation-in-africa-a-call-to-action 2024-02-27T07:14:21.000Z weekly 0.8 https://news.syenza.com/health-economics-and-outcomes-research-in-global-healthcare 2024-02-26T07:20:50.000Z weekly 0.8 https://news.syenza.com/data-science-hub-in-kenya-innovating-health-equity 2024-02-25T11:06:27.000Z weekly 0.8 https://news.syenza.com/chmps-february-2024-meeting-new-drug-recommendations 2024-02-24T16:32:14.000Z weekly 0.8 https://news.syenza.com/a-look-at-saudi-arabias-pharmaceutical-market-in-2024 2024-02-23T11:43:13.000Z weekly 0.8 https://news.syenza.com/telehealth-services-for-mental-health-care-a-secret-shopper-study 2024-02-22T18:51:45.000Z weekly 0.8 https://news.syenza.com/ai-in-preemptive-medicine-and-population-health 2025-02-04T13:13:18.000Z weekly 0.8 https://news.syenza.com/digital-health-and-ai-in-low-and-middle-income-countries 2024-02-21T09:33:11.000Z weekly 0.8 https://news.syenza.com/artificial-intelligence-in-predicting-glioblastoma-treatment-survival 2024-02-20T10:51:17.000Z weekly 0.8 https://news.syenza.com/health-technology-access-pool-htap-by-the-who 2024-02-19T16:39:53.000Z weekly 0.8 https://news.syenza.com/singapores-evolving-healthcare-landscape 2025-02-04T13:13:44.000Z weekly 0.8 https://news.syenza.com/value-based-procurement-a-european-conference 2024-02-18T12:59:36.000Z weekly 0.8 https://news.syenza.com/world-healthy-lifestyle-awareness-day-the-power-of-ai-for-personalised-health 2024-02-15T18:22:50.000Z weekly 0.8 https://news.syenza.com/bridging-the-survival-gap-the-fight-against-childhood-cancer 2024-02-15T13:58:09.000Z weekly 0.8 https://news.syenza.com/ai-intervention-in-epilepsy-diagnosis-and-treatment 2025-02-04T13:16:03.000Z weekly 0.8 https://news.syenza.com/artificial-intelligence-in-indonesian-healthcare 2024-02-14T19:29:20.000Z weekly 0.8 https://news.syenza.com/understanding-and-alleviating-healthcare-system-pressure-a-conceptual-framework 2024-02-14T15:40:29.000Z weekly 0.8 https://news.syenza.com/how-artificial-intelligence-can-enhance-epilepsy-management 2024-02-13T10:52:38.000Z weekly 0.8 https://news.syenza.com/health-technology-assessment-review-exploring-consultation-2 2024-02-12T12:33:50.000Z weekly 0.8 https://news.syenza.com/reforming-primary-healthcare-with-pharmacy-first-initiative 2024-02-10T11:16:41.000Z weekly 0.8 https://news.syenza.com/value-based-medication-benefits-in-diabetes-management 2024-02-09T20:18:27.000Z weekly 0.8 https://news.syenza.com/ai-in-healthcare-advancements-and-challenges 2025-02-04T13:14:38.000Z weekly 0.8 https://news.syenza.com/biopharmaceutical-pioneers-on-global-health-challenges 2024-02-08T10:29:45.000Z weekly 0.8 https://news.syenza.com/harnessing-ai-for-healthcare-a-new-dawn-for-south-africa 2024-02-07T17:17:23.000Z weekly 0.8 https://news.syenza.com/ai-in-cardiology-through-the-use-of-medical-devices 2024-02-08T08:17:09.000Z weekly 0.8 https://news.syenza.com/enhancing-healthcare-capacity-with-artificial-intelligence 2024-02-06T20:20:50.000Z weekly 0.8 https://news.syenza.com/human-centered-design-in-ai-driven-clinical-decision-making 2024-02-06T11:15:40.000Z weekly 0.8 https://news.syenza.com/clinical-trials-and-the-role-of-ai-in-healthcare 2025-02-04T13:15:11.000Z weekly 0.8 https://news.syenza.com/cms-final-rule-streamlining-the-prior-authorisation-process 2024-02-05T08:02:10.000Z weekly 0.8 https://news.syenza.com/relevance-of-clinical-ai-in-oncology-on-world-cancer-day 2025-02-04T13:15:37.000Z weekly 0.8 https://news.syenza.com/the-role-of-ai-in-drug-discovery 2025-02-04T13:17:28.000Z weekly 0.8 https://news.syenza.com/4th-fair-pricing-forum 2024-02-02T20:21:24.000Z weekly 0.8 https://news.syenza.com/mobile-digital-health-platforms-use-in-tavr 2024-02-02T16:01:48.000Z weekly 0.8 https://news.syenza.com/the-emergence-of-ai-in-precision-medicine 2025-02-04T13:17:52.000Z weekly 0.8 https://news.syenza.com/the-intersection-of-health-economics-ai-and-health-outcomes 2024-02-01T20:31:28.000Z weekly 0.8 https://news.syenza.com/the-future-of-medical-innovations-new-tools-and-programs 2024-02-01T17:16:18.000Z weekly 0.8 https://news.syenza.com/ai-addressing-global-health-challenges 2024-02-01T20:36:42.000Z weekly 0.8 https://news.syenza.com/ai-in-population-health-exploring-sub-fields-and-applications 2024-02-01T20:59:43.000Z weekly 0.8 https://news.syenza.com/health-disparities-a-foray-into-race-ethnicity-and-socioeconomic-status 2024-01-31T15:44:06.000Z weekly 0.8 https://news.syenza.com/building-public-trust-in-the-age-of-ai 2025-02-04T13:18:36.000Z weekly 0.8 https://news.syenza.com/a-glimpse-into-the-pbac-december-2023-meeting-outcomes 2024-01-30T17:08:00.000Z weekly 0.8 https://news.syenza.com/whos-guidance-of-ethics-and-governance-ai-usage 2024-01-30T16:39:12.000Z weekly 0.8 https://news.syenza.com/advancements-in-cervical-cancer-elimination 2024-01-29T17:07:07.000Z weekly 0.8 https://news.syenza.com/the-synergy-of-ai-and-neuroscience 2025-02-04T13:18:50.000Z weekly 0.8 https://news.syenza.com/digital-rehabilitation-for-copd-patients-nice-recommends 2024-01-26T17:55:37.000Z weekly 0.8 https://news.syenza.com/ai-advancing-obesity-research-and-treatment 2025-02-04T13:19:07.000Z weekly 0.8 https://news.syenza.com/sotatercept-for-pulmonary-arterial-hypertension-patients 2024-01-26T14:00:15.000Z weekly 0.8 https://news.syenza.com/ai-is-enhancing-gastroenterology-and-hepatology 2025-02-04T13:19:29.000Z weekly 0.8 https://news.syenza.com/the_critical_role_of_validation_in_health_economic_modeling 2024-01-24T17:07:00.000Z weekly 0.8 https://news.syenza.com/the-patient-centric-approach-in-health-economics 2024-01-24T15:43:55.000Z weekly 0.8 https://news.syenza.com/the-intersection-of-biomedical-engineering-and-ai-in-medicine 2025-02-04T13:19:48.000Z weekly 0.8 https://news.syenza.com/pharmacists-in-vaccination-services-a-middle-eastern-perspective 2024-01-23T19:12:41.000Z weekly 0.8 https://news.syenza.com/the-economic-impact-of-ai-in-healthcare 2025-02-04T13:20:14.000Z weekly 0.8 https://news.syenza.com/bridging-the-healthcare-gap-medical-ai-and-quality-care 2024-01-21T18:14:30.000Z weekly 0.8 https://news.syenza.com/unmasking-chronic-kidney-disease-and-economic-implications 2024-01-22T17:19:46.000Z weekly 0.8 https://news.syenza.com/evaluating-machine-learning-in-health-economics 2024-01-21T12:54:55.000Z weekly 0.8 https://news.syenza.com/improving-risk-stratification-and-identifying-high-cost-members 2024-01-20T18:22:48.000Z weekly 0.8 https://news.syenza.com/the-impact-of-health-protection-schemes-in-bangladesh 2024-01-19T18:19:29.000Z weekly 0.8 https://news.syenza.com/the-economic-burden-of-early-stage-chronic-kidney-disease-in-japan 2024-01-18T15:35:14.000Z weekly 0.8 https://news.syenza.com/ethical-understanding-in-ai-governance-for-healthcare 2024-01-18T13:57:42.000Z weekly 0.8 https://news.syenza.com/a-potential-solution-for-acute-heart-failure-hospitalisation 2024-01-17T18:39:37.000Z weekly 0.8 https://news.syenza.com/the-future-of-surgical-decision-making-in-value-based-healthcare 2024-01-17T15:21:18.000Z weekly 0.8 https://news.syenza.com/direct-oral-anticoagulants-efficacy-versus-vitamin-k-antagonists 2024-01-16T12:40:20.000Z weekly 0.8 https://news.syenza.com/improvements-in-frailty-care-as-cost-effective 2024-01-15T15:52:59.000Z weekly 0.8 https://news.syenza.com/balancing-innovation-with-human-connection-with-ai 2024-01-13T15:57:20.000Z weekly 0.8 https://news.syenza.com/unlocking-the-potential-of-ai-in-telemedicine 2024-01-17T15:22:27.000Z weekly 0.8 https://news.syenza.com/ispors-top-10-heor-trends-for-2024-2025 2024-01-13T07:19:59.000Z weekly 0.8 https://news.syenza.com/ais-presence-and-localisation-in-the-global-south 2024-01-16T19:07:10.000Z weekly 0.8 https://news.syenza.com/the-case-for-universal-varicella-zoster-virus-vaccination 2024-01-13T05:33:36.000Z weekly 0.8 https://news.syenza.com/ais-evolution-in-healthcare-enhancing-medical-treatment-and-diagnosis 2024-01-17T15:23:26.000Z weekly 0.8 https://news.syenza.com/harnessing-ai-in-healthcare-a-unique-opportunity-for-diabetes-treatment-in-india 2024-01-13T05:33:11.000Z weekly 0.8 https://news.syenza.com/groundbreaking-medical-innovations-in-2023-fda-approvals 2024-01-10T17:24:31.000Z weekly 0.8 https://news.syenza.com/ais-evolution-in-healthcare-advancements-challenges-and-ethical-considerations 2025-02-04T13:22:19.000Z weekly 0.8 https://news.syenza.com/ai-strengthening-healthcare-in-the-uae 2025-02-07T12:37:28.000Z weekly 0.8 https://news.syenza.com/pharmaceutical-pricing-and-reimbursement-in-latin-america 2024-01-09T19:17:56.000Z weekly 0.8 https://news.syenza.com/ais-role-in-early-cancer-diagnosis-explored-in-new-research 2025-02-04T13:23:02.000Z weekly 0.8 https://news.syenza.com/ais-role-in-global-health-policy-explored-in-new-research 2024-01-09T10:57:56.000Z weekly 0.8 https://news.syenza.com/antimicrobial-resistance-cost-in-two-ghanaian-hospitals 2024-01-09T09:03:36.000Z weekly 0.8 https://news.syenza.com/ais-role-in-orthopedics-advancements-and-challenges 2025-02-04T13:23:33.000Z weekly 0.8 https://news.syenza.com/a-closer-look-at-access-to-essential-medicines-in-south-sudan 2024-01-08T09:53:22.000Z weekly 0.8 https://news.syenza.com/ai-in-fertility-treatment-improving-outcomes 2024-01-08T08:56:50.000Z weekly 0.8 https://news.syenza.com/ais-potential-in-public-health-facilities-in-the-global-south 2024-01-08T08:55:27.000Z weekly 0.8 https://news.syenza.com/an-analysis-of-the-south-african-medical-scheme-landscape 2024-01-04T20:47:21.000Z weekly 0.8 https://news.syenza.com/ai-revolutionizing-healthcare-in-africa-opportunities-and-challenges 2024-01-03T18:26:04.000Z weekly 0.8 https://news.syenza.com/ais-role-in-public-health-and-infectious-diseases 2024-01-03T17:15:26.000Z weekly 0.8 https://news.syenza.com/a-leap-forward-in-asthma-management-with-ai 2024-01-02T18:39:12.000Z weekly 0.8 https://news.syenza.com/the-power-of-prevention-the-untapped-potential-of-adult-immunisation-programmes 2023-12-31T23:31:59.000Z weekly 0.8 https://news.syenza.com/a-closer-look-at-global-health-research-and-development 2023-12-18T17:48:29.000Z weekly 0.8 https://news.syenza.com/5030-2 2024-02-09T22:31:00.000Z weekly 0.8 https://news.syenza.com/implementing-ai-in-public-health-organizations 2023-12-26T10:49:21.000Z weekly 0.8 https://news.syenza.com/ais-approaches-to-maternal-and-neonatal-health-in-low-resource-settings 2023-12-23T16:47:53.000Z weekly 0.8 https://news.syenza.com/ai-interventions-in-climate-change-a-potential-solution-for-the-nhs-and-beyond 2023-12-23T09:13:17.000Z weekly 0.8 https://news.syenza.com/ai-in-clinical-trials 2023-12-20T14:45:08.000Z weekly 0.8 https://news.syenza.com/ai-enhances-global-eye-health-access-and-clinical-decision-making 2023-12-20T07:43:54.000Z weekly 0.8 https://news.syenza.com/demographic-representation-in-oncology 2023-12-19T15:46:22.000Z weekly 0.8 https://news.syenza.com/the-cost-effectiveness-of-efgartigimod-alfa-vyvgart-in-the-treatment-of-myasthenia-gravis-an-insight 2023-12-18T15:22:42.000Z weekly 0.8 https://news.syenza.com/importance-of-gender-and-sex-considerations-in-ai 2023-12-15T20:50:43.000Z weekly 0.8 https://news.syenza.com/compensating-for-digital-health-inequality-in-the-national-health-service-of-england 2023-12-15T20:57:58.000Z weekly 0.8 https://news.syenza.com/access-to-ai-in-medical-education-innovating-and-inclusive 2023-12-15T07:12:14.000Z weekly 0.8 https://news.syenza.com/the-power-of-public-health-a-look-at-south-africas-hiv-treatment-programme 2023-12-15T21:01:52.000Z weekly 0.8 https://news.syenza.com/addressing-the-disparity-treating-childhood-cancer-in-low-and-middle-income-countries 2023-12-18T15:17:49.000Z weekly 0.8 https://news.syenza.com/the-european-commissions-artificial-intelligence-act-a-first-in-ai-regulation 2024-02-09T07:39:03.000Z weekly 0.8 https://news.syenza.com/ai-in-resource-poor-healthcare-settings-a-beacon-of-hope 2023-12-12T15:57:15.000Z weekly 0.8 https://news.syenza.com/pioneering-treatments-for-paroxysmal-nocturnal-hemoglobinuria 2024-02-09T22:08:07.000Z weekly 0.8 https://news.syenza.com/navigating-the-ai-landscape-in-healthcare-ethics-and-access 2023-12-12T15:57:52.000Z weekly 0.8 https://news.syenza.com/a-new-dawn-in-breast-cancer-treatment-ultra-hypofractionated-radiotherapy 2024-02-09T22:18:36.000Z weekly 0.8 https://news.syenza.com/machine-learning-for-the-pharmaceutical-sector-the-beginning-of-a-uprising-in-productivity-and-innovation 2024-04-25T13:47:06.000Z weekly 0.8 https://news.syenza.com/the-national-health-insurance-bill-passed-at-ncop 2024-01-12T20:57:18.000Z weekly 0.8 https://news.syenza.com/unravelling-the-impact-of-bolsa-familia-program-on-birth-weight-indicators-in-brazil 2024-02-18T17:39:17.000Z weekly 0.8 https://news.syenza.com/navigating-the-complexities-of-generics-and-biosimilars-in-portugal 2024-02-09T22:40:43.000Z weekly 0.8 https://news.syenza.com/the-changing-landscape-of-medicaid-managed-care-a-deep-insight 2024-02-18T17:48:03.000Z weekly 0.8 https://news.syenza.com/spinal-muscular-atrophy-a-comprehensive-review-of-newborn-screening-treatment-and-ethical-considerations 2024-05-13T19:19:42.000Z weekly 0.8 https://news.syenza.com/exploring-the-potential-of-generative-artificial-intelligence-genai-in-healthcare-overcoming-the-productivity-paradox 2024-06-26T23:56:55.000Z weekly 0.8 https://news.syenza.com/igniting-drug-discovery-in-africa-a-renewed-partnership 2024-06-27T00:00:54.000Z weekly 0.8 https://news.syenza.com/the-value-based-pricing-and-market-access-of-valbenazine-a-cost-effective-evaluation-in-japan 2024-07-01T15:57:16.000Z weekly 0.8 https://news.syenza.com/navigating-the-maze-the-eu-pharma-legislation-review-and-its-implications 2024-07-01T16:00:42.000Z weekly 0.8 https://news.syenza.com/unravelling-the-impact-of-the-340b-program-on-us-healthcare 2024-07-01T19:54:09.000Z weekly 0.8 https://news.syenza.com/the-unapproved-antibiotic-fixed-dose-combinations-in-india-a-public-health-concern 2024-07-03T13:16:28.000Z weekly 0.8 https://news.syenza.com/using-ai-to-increase-positive-health-outcomes-a-discussion-with-kaiser-permanentes-chief-medical-officer 2024-07-03T13:20:29.000Z weekly 0.8 https://news.syenza.com/sanofis-role-in-access-to-innovation-for-moroccos-healthcare-transformation 2024-07-03T13:43:48.000Z weekly 0.8 https://news.syenza.com/navigating-uncertainty-a-review-of-health-economic-evaluations 2024-07-03T13:34:28.000Z weekly 0.8 https://news.syenza.com/the-dawn-of-a-new-era-deep-learning-in-cardiovascular-imaging 2024-05-13T17:02:43.000Z weekly 0.8 https://news.syenza.com/bridging-the-gap-enhancing-access-to-medicines-through-cross-sector-collaboration 2024-07-03T13:32:43.000Z weekly 0.8 https://news.syenza.com/revamping-medical-regulations-a-call-for-comprehensive-reform 2024-05-13T17:08:54.000Z weekly 0.8 https://news.syenza.com/high-cost-medicines-a-global-perspective-and-policy-recommendations 2024-07-03T13:25:18.000Z weekly 0.8 https://news.syenza.com/eu-pharmaceutical-legislation-ispor-plenary-day-2 2023-11-14T19:23:57.000Z weekly 0.8 https://news.syenza.com/the-power-of-telehealth-and-cgm-technology-in-diabetes-management 2024-07-01T20:03:01.000Z weekly 0.8 https://news.syenza.com/the-future-of-healthcare-the-potential-and-challenges-of-virtual-wards 2024-07-01T19:57:34.000Z weekly 0.8 https://news.syenza.com/insights-from-the-ispor-panel-on-the-european-health-data-space 2023-11-13T22:11:39.000Z weekly 0.8 https://news.syenza.com/medical-device-procurement-unravelling-the-role-of-health-technology-assessment 2024-03-19T16:49:56.000Z weekly 0.8 https://news.syenza.com/sahpra-medsafetyweek-campaign 2024-09-10T22:54:24.000Z weekly 0.8 https://news.syenza.com/hypertension-management 2024-01-23T19:43:04.000Z weekly 0.8 https://news.syenza.com/global-healthcare-decision-making 2024-09-10T22:58:40.000Z weekly 0.8 https://news.syenza.com/multiplex-antigen-near-patient-tests 2024-09-10T23:03:04.000Z weekly 0.8 https://news.syenza.com/covid-19-and-pregnancy-risk 2025-07-13T17:41:45.000Z weekly 0.8 https://news.syenza.com/centre-of-excellence-for-adult-cardiac-surgery 2024-09-11T16:31:51.000Z weekly 0.8 https://news.syenza.com/the-power-of-innovation-centres-in-us-healthcare 2024-09-13T22:39:38.000Z weekly 0.8 https://news.syenza.com/patient-reported-outcomes-measures-vbc-ai-epros 2023-11-02T14:18:34.000Z weekly 0.8 https://news.syenza.com/improving-healthcare-delivery-the-fda-and-cms-policy-alignment-for-cardiovascular-devices 2024-09-13T22:42:50.000Z weekly 0.8 https://news.syenza.com/value-based-care-and-care-management 2024-05-09T13:17:13.000Z weekly 0.8 https://news.syenza.com/social_determinants_of_health 2024-09-13T22:50:44.000Z weekly 0.8 https://news.syenza.com/cied-infections-and-early-intervention 2024-09-13T22:55:27.000Z weekly 0.8 https://news.syenza.com/value-based-care-and-the-moonshot-proposal 2024-05-09T13:17:14.000Z weekly 0.8 https://news.syenza.com/unveiling-the-impact-of-transparency-in-coverage-data-on-healthcare-prices 2024-09-13T22:58:17.000Z weekly 0.8 https://news.syenza.com/aco-reach-an-innovative-step-towards-health-equity 2024-09-13T23:00:08.000Z weekly 0.8 https://news.syenza.com/pioneering-pain-management-high-frequency-electrical-stimulation-devices 2024-09-13T23:02:50.000Z weekly 0.8 https://news.syenza.com/exploring-the-heor-competencies-framework-by-ispor 2023-11-01T14:30:58.000Z weekly 0.8 https://news.syenza.com/the-quintuple-aim-a-new-direction-for-healthcare-improvement 2024-05-09T13:17:14.000Z weekly 0.8 https://news.syenza.com/google-ai-for-health-program-selects-five-african-startups 2024-09-13T23:11:05.000Z weekly 0.8 https://news.syenza.com/unveiling-the-economic-burden-of-untreated-mental-illness 2024-09-13T23:17:57.000Z weekly 0.8 https://news.syenza.com/a-new-framework-for-assessing-digital-health-technologies 2024-09-13T23:20:36.000Z weekly 0.8 https://news.syenza.com/the-future-of-health-technology-assessment-hta-in-greece-trends-and-predictions 2024-09-13T23:22:43.000Z weekly 0.8 https://news.syenza.com/a-comprehensive-review-of-covid-19-treatments-efficacy-and-economic-evaluation 2024-09-13T23:25:50.000Z weekly 0.8 https://news.syenza.com/ais-role-in-reducing-healthcare-waste-and-cost 2024-05-09T13:17:15.000Z weekly 0.8 https://news.syenza.com/introducing-sahpras-online-directory-for-over-the-counter-medicines 2024-09-13T23:29:14.000Z weekly 0.8 https://news.syenza.com/venture-capital-in-north-american-and-european-healthcare-technology 2024-05-09T13:17:16.000Z weekly 0.8 https://news.syenza.com/understanding-antibiotics-misuse-in-nigeria-a-detailed-study 2024-09-15T18:21:28.000Z weekly 0.8 https://news.syenza.com/general-catalyst-venture-capitalism-value-based-healthcare 2024-05-09T13:17:17.000Z weekly 0.8 https://news.syenza.com/unleashing-the-potential-of-gene-therapies-overcoming-hta-challenges 2024-09-15T18:07:05.000Z weekly 0.8 https://news.syenza.com/transforming-healthcare-with-prevention-a-cost-effective-strategy 2024-09-15T18:08:40.000Z weekly 0.8 https://news.syenza.com/teenagers-offer-fresh-perspectives-to-combat-obesity 2024-09-15T18:13:31.000Z weekly 0.8 https://news.syenza.com/the-introduction-of-ai-powered-chatbots-could-be-a-game-changer-pharmacy-practice 2024-09-15T18:28:06.000Z weekly 0.8 https://news.syenza.com/ai-derived-software-in-chest-x-ray-analysis-a-nice-perspective 2024-09-15T18:30:23.000Z weekly 0.8 https://news.syenza.com/falsified-medical-products-in-francophone-sub-saharan-africa-the-role-of-regulatory 2024-09-15T18:32:23.000Z weekly 0.8 https://news.syenza.com/value-based-medicine-improving-healthcare 2023-10-08T12:12:13.000Z weekly 0.8 https://news.syenza.com/ai-and-value-based-care-machine-learning-healthcare-reducing-healthcare-waste 2024-05-09T13:17:18.000Z weekly 0.8 https://news.syenza.com/abu-dhabi-global-healthcare-week-partners-with-digital-health-new-york-to-boost-digital-health-ecosystem 2023-10-08T15:03:19.000Z weekly 0.8 https://news.syenza.com/sacubitril-valsartan-a-cost-effective-solution-for-heart-failure-management 2023-10-07T15:43:48.000Z weekly 0.8 https://news.syenza.com/artificial-intelligence-potential-in-orthopaedic-healthcare 2024-05-09T13:17:18.000Z weekly 0.8 https://news.syenza.com/direct-acting-oral-anticoagulants-a-comparative-study-on-value-and-pricing 2023-10-06T07:58:05.000Z weekly 0.8 https://news.syenza.com/clinical-pharmacists-and-health-coaches-improve-diabetes-management 2023-10-04T11:02:46.000Z weekly 0.8 https://news.syenza.com/the-evolution-and-impact-of-combination-therapies-in-treating-stage-iii-and-iv-melanoma 2023-10-02T17:42:23.000Z weekly 0.8 https://news.syenza.com/artificial-intelligence-assistive-technology 2024-05-09T13:17:19.000Z weekly 0.8 https://news.syenza.com/cardiovascular-therapies-access 2023-09-29T08:21:14.000Z weekly 0.8 https://news.syenza.com/oracle-healthcare-strides 2024-05-09T13:17:20.000Z weekly 0.8 https://news.syenza.com/intraoperative-telemedicine-program-shows-room-for-improvement-actfast-3-study 2024-05-08T17:32:40.000Z weekly 0.8 https://news.syenza.com/collaborative-intelligence-the-future-of-ai-and-human-learning-in-healthcare 2024-05-09T13:17:20.000Z weekly 0.8 https://news.syenza.com/the-global-impact-of-nice-decision-outcomes-in-health-technology-assessment 2023-09-27T07:55:59.000Z weekly 0.8 https://news.syenza.com/innovative-health-care-models-prove-cost-effective-amidst-pandemic-pressures 2023-09-26T15:27:03.000Z weekly 0.8 https://news.syenza.com/the-electronic-clinical-dementia-rating-ecdr-a-promising-tool-for-dementia-screening 2023-09-25T17:00:47.000Z weekly 0.8 https://news.syenza.com/alphamissense-and-genetic-sequencing 2024-05-09T13:17:21.000Z weekly 0.8 https://news.syenza.com/ai-ml-ecg-interpretation-home-monitoring-cardiac-care 2024-05-09T13:18:55.000Z weekly 0.8 https://news.syenza.com/patent-exclusivities-and-high-costs-the-challenge-of-generic-competition-for-glp-1-receptor-agonists 2023-09-22T10:42:57.000Z weekly 0.8 https://news.syenza.com/nice-guidelines-set-to-reduce-unnecessary-colonoscopies 2023-09-21T11:16:46.000Z weekly 0.8 https://news.syenza.com/ais-role-in-early-disease-detection-revolutionizing-cardiovascular-risk-assessment-through-ocular-imaging 2024-05-09T13:18:56.000Z weekly 0.8 https://news.syenza.com/transforming-medical-technology-the-launch-of-the-innovative-devices-access-pathway-in-the-uk 2023-09-20T05:38:06.000Z weekly 0.8 https://news.syenza.com/who-launches-groundbreaking-online-repository-for-evidence-informed-decision-making-tools 2023-09-19T16:08:22.000Z weekly 0.8 https://news.syenza.com/harnessing-the-power-of-causal-loop-diagrams-for-health-systems-research-in-low-and-middle-income-settings 2023-09-18T14:19:33.000Z weekly 0.8 https://news.syenza.com/ai-based-remote-test-for-parkinsons-disease-severity-shows-promise 2024-05-09T13:18:57.000Z weekly 0.8 https://news.syenza.com/technologies-reshaping-biotherapeutics-manufacturing-an-eu-perspective 2023-09-15T11:37:53.000Z weekly 0.8 https://news.syenza.com/ai-for-early-identification-of-breast-cancer-efficient-and-accurate-diagnosis 2024-05-09T13:18:57.000Z weekly 0.8 https://news.syenza.com/how-pieces-technologies-ai-is-driving-clinical-efficiency 2024-05-09T13:18:58.000Z weekly 0.8 https://news.syenza.com/usp-and-sahpra-a-partnership-for-health-regulatory-excellence 2023-09-14T05:44:53.000Z weekly 0.8 https://news.syenza.com/the-evolution-of-virtual-care-in-respirology 2023-09-13T06:59:46.000Z weekly 0.8 https://news.syenza.com/abu-dhabi-health-department-signs-mou-with-xlife-sciences-to-boost-life-sciences-sector 2023-09-12T05:18:54.000Z weekly 0.8 https://news.syenza.com/the-rise-of-virtual-care-in-hematology-and-oncology-a-comprehensive-review 2023-09-12T12:17:38.000Z weekly 0.8 https://news.syenza.com/the-transitional-coverage-for-emerging-technologies-pathway-a-balance-between-innovation-and-patient-safety 2023-09-08T04:39:34.000Z weekly 0.8 https://news.syenza.com/the-benefits-and-risks-of-medical-ai-chatbots 2024-05-09T13:18:59.000Z weekly 0.8 https://news.syenza.com/syenzas-news-roundup-launching-a-new-era-of-healthcare-insights 2023-09-07T05:57:34.000Z weekly 0.8 https://news.syenza.com/robot-assisted-surgery-a-promising-tool-yet-to-prove-superiority 2023-09-07T04:47:54.000Z weekly 0.8 https://news.syenza.com/enhancing-electronic-health-record-data-quality 2024-05-09T13:19:00.000Z weekly 0.8 https://news.syenza.com/virtual-care-a-new-era-in-neurology 2023-09-06T05:07:39.000Z weekly 0.8 https://news.syenza.com/the-importance-of-timeliness-in-outbreak-response-introducing-the-whos-early-action-review 2023-09-05T05:56:40.000Z weekly 0.8 https://news.syenza.com/understanding-juvenile-idiopathic-arthritis-and-its-coverage-under-medical-schemes-in-south-africa 2023-09-04T04:07:30.000Z weekly 0.8 https://news.syenza.com/ai-and-annotated-medical-images-openpath-plip-and-medical-twitter 2024-05-09T13:19:00.000Z weekly 0.8 https://news.syenza.com/bridging-the-gap-the-crucial-role-of-private-healthcare-in-achieving-universal-health-coverage 2023-09-01T11:01:54.000Z weekly 0.8 https://news.syenza.com/integrating-digital-twins-in-clinical-trials-for-enhanced-cancer-care 2024-05-09T13:19:01.000Z weekly 0.8 https://news.syenza.com/promising-results-from-study-but-more-work-needed-for-healthcare-equity-in-kenya 2023-08-31T14:42:09.000Z weekly 0.8 https://news.syenza.com/revolutionising-communication-neuroprosthetic-system-transforms-neural-activity-into-speech-for-paralyzed-individuals 2024-05-09T13:19:02.000Z weekly 0.8 https://news.syenza.com/medicines-new-zealand-unveils-2022-transfer-of-value-reports-to-enhance-transparency 2023-08-30T15:51:57.000Z weekly 0.8 https://news.syenza.com/medicare-drug-price-negotiations-expected-to-generate-1-8-billion-in-savings-by-2026 2023-08-29T14:07:39.000Z weekly 0.8 https://news.syenza.com/further-research-required-for-aortic-valve-reconstruction-procedure-says-nice 2023-08-28T07:06:01.000Z weekly 0.8 https://news.syenza.com/transforming-paediatric-care-virtual-care-modalities-prove-effective-and-promising-in-quebec 2023-08-24T13:47:15.000Z weekly 0.8 https://news.syenza.com/the-potential-expansion-of-irelands-seasonal-influenza-vaccination-programme-an-evaluation 2023-08-23T16:57:32.000Z weekly 0.8 https://news.syenza.com/major-updates-from-the-pharmaceutical-benefits-advisory-committee 2023-09-07T05:05:39.000Z weekly 0.8 https://news.syenza.com/thermidas-a-breakthrough-in-non-invasive-skin-temperature-measurement 2023-08-21T12:13:48.000Z weekly 0.8 https://news.syenza.com/ensuring-medicine-supply-chain-resilience-in-disasters-a-grounded-approach 2023-08-18T11:36:42.000Z weekly 0.8 https://news.syenza.com/empowering-ethiopia-horizon-europe-grants-e4m-to-tackle-non-communicable-diseases 2023-08-17T11:47:15.000Z weekly 0.8 https://news.syenza.com/empowering-pharmacists-south-african-court-ruling-greenlights-pharmacist-prescribed-arvs 2023-11-30T18:38:38.000Z weekly 0.8 https://news.syenza.com/unlocking-health-equity-through-digital-health-technologies 2023-08-15T11:44:16.000Z weekly 0.8 https://news.syenza.com/advancing-antibiotic-use-and-preventing-hearing-loss-in-babies-evidence-generation-plan-for-genedrive-mt-rnr1-id-kit 2023-08-14T13:08:24.000Z weekly 0.8 https://news.syenza.com/unlocking-the-value-of-biosimilars-challenges-and-solutions 2023-08-11T07:06:51.000Z weekly 0.8 https://news.syenza.com/decoding-research-integrity-hierarchy-of-evidence-and-randomised-control-trials 2023-08-16T17:06:29.000Z weekly 0.8 https://news.syenza.com/who-approves-essential-medicines-for-multiple-sclerosis-while-obesity-drugs-are-excluded 2023-08-10T03:25:50.000Z weekly 0.8 https://news.syenza.com/exposing-the-hidden-costs-hospitals-charging-500-more-for-medicines 2023-08-11T07:33:48.000Z weekly 0.8 https://news.syenza.com/buprenorphine-and-telehealth-a-new-era-in-opioid-use-disorder-treatment 2023-08-07T15:39:24.000Z weekly 0.8 https://news.syenza.com/bridging-the-gap-between-inpatient-and-outpatient-care-a-shift-in-european-healthcare-policies 2023-08-10T08:23:43.000Z weekly 0.8 https://news.syenza.com/decoding-research-integrity-a-deep-dive-into-evaluating-scientific-papers 2023-08-16T17:06:35.000Z weekly 0.8 https://news.syenza.com/boosting-adr-reporting-assessing-knowledge-attitude-and-practices-among-uae-hospital-pharmacists 2023-08-03T08:28:42.000Z weekly 0.8 https://news.syenza.com/closing-the-global-health-gap-progress-against-hiv-tb-and-malaria 2023-08-11T06:50:39.000Z weekly 0.8 https://news.syenza.com/unravelling-the-mystery-of-long-covid-hiqa-reviews-potential-interventions 2023-08-11T07:33:10.000Z weekly 0.8 https://news.syenza.com/rising-incidence-of-diabetes-in-children-amidst-covid-19-a-comprehensive-analysis 2023-08-11T07:33:10.000Z weekly 0.8 https://news.syenza.com/unleashing-the-power-of-cell-and-gene-therapies-the-road-to-market-access-success 2023-08-11T07:31:31.000Z weekly 0.8 https://news.syenza.com/unravelling-the-politics-behind-indias-pm-jay-health-insurance-scheme 2023-07-26T12:26:21.000Z weekly 0.8 https://news.syenza.com/antibiotics-or-placebo-the-effectiveness-cost-of-treating-children-with-lower-respiratory-tract-infection 2023-08-11T07:07:22.000Z weekly 0.8 https://news.syenza.com/transforming-healthcare-indonesias-nhi-success-story-and-lessons-for-the-world 2023-08-16T17:06:47.000Z weekly 0.8 https://news.syenza.com/new-research-sheds-light-on-factors-influencing-medical-scheme-enrolment-decisions 2023-08-11T07:29:09.000Z weekly 0.8 https://news.syenza.com/eunethta-21-publication-of-second-joint-clinical-assessment-introducing-the-evoke-spinal-cord-stimulation 2023-08-10T08:18:30.000Z weekly 0.8 https://news.syenza.com/risk-of-bleeding-in-patients-undergoing-coronary-interventions-on-dual-and-triple-therapies-a-retrospective-study 2023-08-11T07:33:48.000Z weekly 0.8 https://news.syenza.com/new-hope-for-sickle-cell-disease-groundbreaking-gene-therapies-under-review 2023-08-11T07:33:49.000Z weekly 0.8 https://news.syenza.com/unlocking-the-future-of-healthcare-the-power-of-national-health-insurance-in-south-africa 2023-08-10T08:29:17.000Z weekly 0.8 https://news.syenza.com/unlocking-the-economic-potential-of-dementia-research-a-call-for-increased-investment 2023-08-11T07:33:49.000Z weekly 0.8 https://news.syenza.com/revamping-health-management-for-sustainable-development-goals-insights-from-kenya-malawi-and-uganda 2023-08-11T07:29:27.000Z weekly 0.8 https://news.syenza.com/breaking-down-the-financial-burden-of-health-expenses-in-india 2023-08-11T07:33:50.000Z weekly 0.8 https://news.syenza.com/sahpra-egyptian-drug-authority-forge-new-partnership-for-pharmaceutical-progress 2023-07-13T13:09:29.000Z weekly 0.8 https://news.syenza.com/revolutionizing-lung-cancer-detection-the-role-of-ai-derived-cad-software 2023-08-11T07:10:49.000Z weekly 0.8 https://news.syenza.com/strengthening-global-health-economics-through-brics-health-pharmaceutical-association-of-africa 2023-08-11T07:55:12.000Z weekly 0.8 https://news.syenza.com/revolutionising-oncology-medicine-a-precision-approach-that-cuts-costs-and-boosts-roi 2023-08-11T07:11:13.000Z weekly 0.8 https://news.syenza.com/the-power-of-pharmacist-interventions-in-improving-glycemic-control-for-diabetes-patients-a-multicenter-study-in-malaysia 2023-08-11T07:27:05.000Z weekly 0.8 https://news.syenza.com/lessons-for-specialty-care-payment-reforms-insights-from-marylands-gbr-model 2023-07-07T15:14:28.000Z weekly 0.8 https://news.syenza.com/alarming-rise-in-breast-and-cervical-cancers-in-low-and-middle-income-countries-breaking-down-screening-barriers 2023-07-06T14:48:06.000Z weekly 0.8 https://news.syenza.com/eunethta-21-shares-draft-on-medicinal-jca-timelines-in-d5-4-deliverable 2023-08-11T07:33:50.000Z weekly 0.8 https://news.syenza.com/unlocking-the-power-of-systems-thinking-in-policymaking-a-path-to-stronger-health-systems 2023-07-06T15:16:53.000Z weekly 0.8 https://news.syenza.com/revolutionizing-healthcare-in-australia-and-new-zealand-strengthening-medicare-and-pae-ora-reforms 2023-06-30T19:28:18.000Z weekly 0.8 https://news.syenza.com/cms-sheds-light-on-the-future-of-medical-schemes-and-nhi-in-south-africa 2023-06-30T13:39:18.000Z weekly 0.8 https://news.syenza.com/public-procurement-of-medicines-in-europe-key-findings-and-best-practices 2023-08-10T08:06:49.000Z weekly 0.8 https://news.syenza.com/assessing-and-implementing-digital-health-solutions-challenges-and-opportunities 2023-06-27T14:18:11.000Z weekly 0.8 https://news.syenza.com/artificial-intelligence-in-healthcare 2023-08-16T17:07:28.000Z weekly 0.8 https://news.syenza.com/sahpra-and-partners-successfully-complete-second-cohort-of-clinical-assessors-short-course 2023-06-20T20:12:12.000Z weekly 0.8 https://news.syenza.com/mystery-caller-study-on-emergency-contraception-in-germany 2023-07-04T05:21:15.000Z weekly 0.8 https://news.syenza.com/great-news-for-pain-and-cns-management-in-rsa 2023-06-14T12:58:30.000Z weekly 0.8 https://news.syenza.com/saudi-arabia-hosts-1st-meeting-of-arab-authorities-controlling-medicines 2023-06-05T07:17:01.000Z weekly 0.8 https://news.syenza.com/new-treatment-option-for-active-lupus-nephritis 2023-06-15T06:19:22.000Z weekly 0.8 https://news.syenza.com/the-updated-medscheme-specialised-drug-list-for-2023-has-been-published 2023-08-11T07:35:06.000Z weekly 0.8 https://news.syenza.com/equity-in-global-health-research-lessons-from-the-8quity-tool 2023-08-11T06:51:19.000Z weekly 0.8 https://news.syenza.com/addressing-concerns-for-successful-implementation-of-national-health-insurance-in-south-africa 2023-06-05T07:17:03.000Z weekly 0.8 https://news.syenza.com/who-identifies-emerging-innovations-in-global-health 2023-06-05T07:17:03.000Z weekly 0.8 https://news.syenza.com/political-economy-analysis-reveals-challenges-facing-primary-health-care-in-eastern-and-southern-africa 2023-08-11T07:29:41.000Z weekly 0.8 https://news.syenza.com/icer-cadth-and-nice-collaborate-to-increase-transparency-in-health-technology-evaluations 2023-06-05T07:17:03.000Z weekly 0.8 https://news.syenza.com/prioritizing-mental-health-in-south-african-medical-schemes-challenges-and-opportunities 2023-06-14T12:59:49.000Z weekly 0.8 https://news.syenza.com/icer-report-on-lecanemab-efficacy-cost-and-equity-concerns-for-alzheimers-treatment 2023-08-11T07:55:20.000Z weekly 0.8 https://news.syenza.com/update-on-the-hta-coordination-group-subgroup-meetings-held-on-april-25-and-26 2023-08-11T07:31:31.000Z weekly 0.8 https://news.syenza.com/new-preferred-characteristics-for-monoclonal-antibodies-in-malaria-prevention 2023-06-05T07:17:04.000Z weekly 0.8 https://news.syenza.com/tezepelumab-as-an-add-on-maintenance-treatment-for-severe-asthma-recommendations-and-clinical-economic-impact 2023-06-14T12:17:52.000Z weekly 0.8 https://news.syenza.com/clinical-evidence-shows-that-aposhealth-an-fda-cleared-medical-device-improves-pain-stiffness-and-function-in-people-with-knee-osteoarthritis 2023-06-14T12:18:07.000Z weekly 0.8 https://news.syenza.com/quantitative-benefit-risk-assessment-in-medical-product-decision-making-a-good-practices-report-of-an-ispor-task-force 2023-06-05T07:17:05.000Z weekly 0.8 https://news.syenza.com/zambias-national-health-insurance-making-progress-towards-strategic-purchasing-of-quality-care 2023-06-05T07:17:05.000Z weekly 0.8 https://news.syenza.com/pbac-recommends-general-schedule-authority-required-listing-for-empagliflozin-in-chronic-heart-failure-with-lvef-40 2024-01-23T23:04:26.000Z weekly 0.8 https://news.syenza.com/iberian-healthcare-collaboration-spain-portugal-unite-for-health-technology-assessments 2023-06-05T07:17:05.000Z weekly 0.8 https://news.syenza.com/global-pull-incentive-needed-to-future-proof-antibiotic-innovation-says-ohe-report 2023-06-05T07:17:05.000Z weekly 0.8 https://news.syenza.com/medscheme-released-updated-medicine-exclusion-list-april-2023 2023-06-05T07:17:27.000Z weekly 0.8 https://news.syenza.com/genedrive-mt-rnr1-id-kit-to-detect-genetic-variation-and-protect-hearing-in-babies-early-value-appraisal 2023-06-14T12:18:37.000Z weekly 0.8 https://news.syenza.com/abu-dhabi-recognises-abu-dhabi-stem-cells-center-adscc-as-a-centre-of-excellence-in-hematopoietic-stem-cell-transplantation 2023-06-14T12:18:50.000Z weekly 0.8 https://news.syenza.com/darwin-eu-is-calling-for-new-data-partners 2023-08-10T08:18:38.000Z weekly 0.8 https://news.syenza.com/did-cvds-recover-post-covid-19 2023-08-11T07:27:13.000Z weekly 0.8 https://news.syenza.com/boosting-local-medicine-production-in-uganda-how-import-fees-are-affecting-the-industry 2023-06-05T07:17:28.000Z weekly 0.8 https://news.syenza.com/multiple-myeloma-is-the-second-most-common-type-of-blood-cancer-with-approximately-450-new-cases-diagnosed-annually-in-norway 2023-08-11T07:08:44.000Z weekly 0.8 https://news.syenza.com/the-evidence-for-cannabidiol-is-building 2023-06-14T12:19:16.000Z weekly 0.8 https://news.syenza.com/hta-must-consider-health-equity-for-progress 2023-06-14T12:59:50.000Z weekly 0.8 https://news.syenza.com/mobocertinib-added-in-nice-guidelines 2023-08-11T07:03:19.000Z weekly 0.8 https://news.syenza.com/comprehensive-review-of-methods-to-assess-uncertainty-in-health-economic-evaluations 2023-06-14T12:59:50.000Z weekly 0.8 https://news.syenza.com/examining-medicine-shortages-and-their-consequences-through-economic-clinical-and-economic-lens 2023-08-10T08:24:32.000Z weekly 0.8 https://news.syenza.com/the-launch-of-the-gulf-health-economics-association 2023-08-10T08:06:51.000Z weekly 0.8 https://news.syenza.com/increases-in-drug-prices-are-of-concern-to-worldwide-health-systems 2023-06-14T13:01:22.000Z weekly 0.8 https://news.syenza.com/heor-theater-focusing-on-discussions-from-the-ispor-hta-roundtable 2023-08-11T07:33:50.000Z weekly 0.8 https://news.syenza.com/whatsapp-used-in-research-but-is-this-ethical 2023-06-05T07:17:30.000Z weekly 0.8 https://news.syenza.com/regulators-are-formally-adopting-real-world-evidence-when-will-health-technology-assessment 2023-06-05T07:17:30.000Z weekly 0.8 https://news.syenza.com/iran-and-saudi-arabia-reopen-embassies-paving-the-way-for-healthcare-collaboration 2023-06-05T07:17:31.000Z weekly 0.8 https://news.syenza.com/lack-of-compliance-with-emhs-redistribution-guidelines-in-ugandan-health-facilities 2024-04-30T14:20:29.000Z weekly 0.8 https://news.syenza.com/hiqa-publishes-report-on-repatriation-of-paediatric-hsct-services-to-ireland 2024-04-30T13:41:43.000Z weekly 0.8 https://news.syenza.com/boston-childrens-develops-revolutionary-heart-valve-for-children 2024-04-30T12:21:11.000Z weekly 0.8 https://news.syenza.com/innovation-week-in-abu-dhabi-wrapped-up 2024-04-30T12:03:31.000Z weekly 0.8 https://news.syenza.com/abu-dhabi-doh-is-hosting-doh-innovation-week-2023 2024-02-18T16:13:22.000Z weekly 0.8 https://news.syenza.com/comparing-healthcare-reimbursement-processes-for-keytruda-in-israel-uk-and-australia 2024-02-09T21:47:34.000Z weekly 0.8 https://news.syenza.com/hiqa-publishes-rapid-assessment-on-gene-expression-profiling-tests-for-breast-cancer 2024-02-18T17:25:29.000Z weekly 0.8 https://news.syenza.com/using-health-policy-and-systems-research-to-influence-national-health-policies 2024-02-18T16:46:59.000Z weekly 0.8 https://news.syenza.com/department-of-health-abu-dhabi-doh-has-published-a-policy-on-thiqa-coverage-for-assisted-reproductive-treatment-and-services 2024-02-18T16:32:48.000Z weekly 0.8 https://news.syenza.com/opportunity-to-undertake-an-msc-in-health-economics-at-the-university-of-london 2024-02-16T06:47:37.000Z weekly 0.8 https://news.syenza.com/the-annual-bhf-conference-is-taking-place-in-cape-town-from-14-17-may-2023 2024-02-16T06:37:28.000Z weekly 0.8 https://news.syenza.com/who-published-a-thematic-brief-regarding-the-working-for-health-2022-2030-action-plan 2024-02-09T21:02:57.000Z weekly 0.8 https://news.syenza.com/upadacitinib-a-convenient-and-effective-alternative-treatment-for-spondyloarthritis 2024-02-08T09:34:40.000Z weekly 0.8 https://news.syenza.com/the-eu-butts-heads-with-big-pharma-to-make-medicines-cheaper 2024-02-08T09:11:22.000Z weekly 0.8 https://news.syenza.com/italian-trade-agency-supports-160-companies-exhibiting-at-arab-health-2023 2024-02-04T15:21:37.000Z weekly 0.8 https://news.syenza.com/use-of-clinical-trials-information-system-becomes-mandatory-for-new-clinical-trial-applications-in-the-eu 2024-02-04T14:52:55.000Z weekly 0.8 https://news.syenza.com/sahpra-approves-pfizers-paxlovid-as-oral-treatment-for-mild-to-moderate-covid-19-in-high-risk-adults 2024-01-12T20:23:01.000Z weekly 0.8 https://news.syenza.com/surgical-repair-vs-non-surgical-treatment-for-rotator-cuff-tears-is-surgery-worth-the-cost 2024-01-12T20:39:42.000Z weekly 0.8 https://news.syenza.com/biosimilars-can-save-millions-in-nhs-hospitals-a-longitudinal-analysis 2024-01-12T20:05:29.000Z weekly 0.8 https://news.syenza.com/understanding-the-latest-cmscript-on-amputations-under-pmb-regulations 2024-01-12T19:43:15.000Z weekly 0.8 https://news.syenza.com/heads-of-hta-agencies-group-convene-in-lisbon-for-fourth-meeting 2024-01-12T18:04:13.000Z weekly 0.8 https://news.syenza.com/gathering-and-analyzing-patient-experience-data-in-a-real-world-setting-is-a-key-challenge-for-many 2024-01-12T17:57:47.000Z weekly 0.8 https://news.syenza.com/ispor-releases-top-10-heor-trends-report-for-2022-2023 2024-01-12T17:25:03.000Z weekly 0.8 https://news.syenza.com/abu-dhabi-launches-drug-and-poison-information-service-to-improve-healthcare-outcomes 2024-01-12T17:07:52.000Z weekly 0.8 https://news.syenza.com/getreal-conference-2026-transforming-evidence 2026-06-12T09:55:23.000Z weekly 0.8 https://news.syenza.com/real-world-evidence-conference-advancing-insights-innovations 2026-06-12T09:51:07.000Z weekly 0.8 https://news.syenza.com/scope-summit-2027-market-access-real-world-evidence-streams 2026-06-12T09:39:53.000Z weekly 0.8 https://news.syenza.com/13th-rwe-market-access-pricing-reimbursement-2026-europe 2026-06-12T09:37:47.000Z weekly 0.8 https://news.syenza.com/european-rwe-market-access-summit-2026-jca-pico-strategy-edition 2026-06-12T09:42:01.000Z weekly 0.8 https://news.syenza.com/access-eu-26-forum 2026-06-12T09:32:59.000Z weekly 0.8 https://news.syenza.com/world-evidence-pricing-access-congress-2027 2026-06-12T09:33:12.000Z weekly 0.8 https://news.syenza.com/world-orphan-drug-congress-2026-rare-disease-therapies-access 2026-06-01T22:51:51.000Z weekly 0.8 https://news.syenza.com/rare-disease-innovation-world-orphan-drug-congress-2026-insights 2026-06-01T22:52:50.000Z weekly 0.8 https://news.syenza.com/rare-disease-access-world-orphan-drug-congress-2026 2026-06-01T22:53:20.000Z weekly 0.8 https://news.syenza.com/world-orphan-drug-congress-2026-advancing-rare-therapies 2026-06-01T22:54:22.000Z weekly 0.8 https://news.syenza.com/htai-2026-meeting-shaping-hta-impact 2026-06-01T22:55:13.000Z weekly 0.8 https://news.syenza.com/htai-2026-annual-meeting-shaping-health-technology-assessment 2026-06-01T22:55:59.000Z weekly 0.8 https://news.syenza.com/ichom-2026 2026-05-26T13:24:08.000Z weekly 0.8 https://news.syenza.com/2nd-annual-pharma-pricing-market-access-innovation-summit 2026-05-26T15:46:50.000Z weekly 0.8 https://news.syenza.com/ispor-europe-2026 2026-05-26T15:46:42.000Z weekly 0.8 https://news.syenza.com/amcp-nexus-2026 2026-05-26T15:46:32.000Z weekly 0.8 https://news.syenza.com/dias-2026-real-world-evidence-conference 2026-05-26T15:46:26.000Z weekly 0.8 https://news.syenza.com/ispor-healthcare-investment-summit-2026 2026-05-26T15:46:21.000Z weekly 0.8 https://news.syenza.com/ispor-asia-pacific-summit-2026 2026-05-26T15:46:11.000Z weekly 0.8 https://news.syenza.com/42nd-annual-ispe-meeting 2026-05-26T15:46:05.000Z weekly 0.8 https://news.syenza.com/getreal-institute-annual-conference-2026 2026-07-02T10:43:37.000Z weekly 0.8 https://news.syenza.com/world-orphan-drug-congress-usa 2026-06-12T09:15:41.000Z weekly 0.8 https://news.syenza.com/htai-2026-annual-meeting 2026-06-11T20:18:24.000Z weekly 0.8 https://news.syenza.com/cookie-policy-eu 2026-05-29T13:26:18.000Z monthly 0.6 https://news.syenza.com/medical-editorial-disclaimer 2026-05-29T14:40:44.000Z monthly 0.6 https://news.syenza.com/sponsorship 2026-05-26T16:01:51.000Z monthly 0.6